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Executive summary
Background: Three key observations have been made about the mortality changes of the last
century and a half. First, mortality has been improving continuously. Second, the age pattern
of mortality improvements has been changing. Third, there are additional opportunities for
longevity extension at the highest ages. We face ongoing challenges and questions when seek-
ing to measure and understand the pattern and consequences of the mortality dynamics that
underlie these findings. The individual articles of this thesis address these specific challenges
and questions.
Objectives: Based on these three key findings, four thematic clusters have been derived. The
first cluster addresses the issue of how survival progress is measured, and proposes an al-
ternative measure for this purpose. The second cluster refers to the mortality dynamics at
the upper and the lower boundary of age-specific mortality, and thus aims to shed light on
different aspects of these dynamics, such as on the levels and locations of these boundaries.
The third cluster poses methodological questions about how best to measure and explain life
expectancy changes and lifespan variability, as well as about the extent to which increasing
longevity affects the lifetime risk of contracting a disease in the context of changing age pat-
terns of mortality improvement. Recognizing the unused potential for longevity extension at
the highest ages as well as the different patterns of lifespan variability since the 1950s, the
fourth cluster aims to show the benefits of using lifespan variability to evaluate mortality fore-
casting approaches.
Outcomes: The individual articles present novel measures as well as empirical applications.
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Executive summary
Cluster one introduces a new measure, which translates differences in the level of survival
improvements between a population and a reference into a lag, expressed in calendar time.
The cluster also includes a proposal for a classification of different settings for the compar-
ison of populations, and discusses their respective shortcomings. Cluster two illustrates the
tremendous decline in the lower boundary of age-specific mortality, as well as its shift to
younger and younger ages over time. Recent trends also suggest that these developments are
likely to continue, at least in the near future. Moreover, the analysis of the maximum levels
of age-specific mortality produces slightly higher levels than those estimated in previous pub-
lications. Cluster three introduces a refined analysis framework for the rectangularization of
the survival curve, as well as two different decomposition methods for the contributions of
mortality dynamics to life expectancy change, and for the contributions of longevity increase
and disease incidence to lifetime risk differentials. The evaluation of mortality forecasting
approaches in cluster four shows that the tested approaches perform fairly well in capturing
life expectancy levels, but that they have difficulties capturing the related lifespan variability
pattern, especially in situations in which life expectancy is changing as lifespan variability is
stagnating or increasing.
Conclusion: Mortality changes over the last one and a half centuries are associated not just
with an increase in the length of the average human lifespan, but with an expansion in the
range of age-specific mortality and shifts in the dynamics of these trends. The enormous life
expectancy gains that have been made, and particularly the development of the lower bound-
ary of age-specific mortality, suggest that there is still enormous room for improving mortality
at all ages. However, the extent of the changes at the lower boundary should also motivate
us to consider potential “failures of success” as consequences of the advancement in the past.
When assessing survival progress, it is clear that in many instances, the patterns and the speed
of improvement are often more informative than the actual levels of advancement, especially
when analyzing key characteristics of mortality, such as life expectancy or infant mortality.
The proposed approaches for measuring the dynamics driving mortality changes highlight the
multiple ways in which lifespan variability and life expectancy have been related since the on-
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Executive summary
set of sustained mortality decline at older ages. Given the still large opportunities for longevity
extension, this topic will remain a key issue for mortality research in the future. The evalua-
tion of mortality forecasting is of prime importance in this context, because it highlights how
problematic deviations from the usual patterns can be. In addition to providing methodological
insights, the outcomes of this thesis shed light on related topics, such as the role distributive
justice plays in further reducing mortality in a population, and the shape of progress in popu-
lations with lagging levels of advancement. The methods proposed in this thesis should prove
useful in addressing such questions.
XVI
1. Background
1.1. The continuity of mortality improvement
The average number of years that humans can expect to live has been increasing for more than
one and a half centuries. Prior to the sustained increase in life expectancy, the global average
lifespan fluctuated at around 30 to 35 years (Riley, 2005). Currently, Japanese females are liv-
ing longest, with an average lifespan of almost 87 years. The rise in life expectancy has been
occurring with a remarkable degree of regularity. Based on the highest annual life expectancy
observed, Oeppen and Vaupel (2002) have suggested that the increase is best illustrated by
a straight line starting around 1840 that increases by approximately a quarter year per year.
Other authors have proposed depicting the increase of life expectancy using a segmented trend
line with three distinct development periods (Vallin and Meslé, 2009). Regardless of whether
life expectancy improvement has been occurring at a single or at different speeds, there is ex-
tensive evidence of the striking regularity of the historic increase in longevity (among others
White, 2002; Riley, 2001; Colchero et al., 2016).
Figure 1.1 visualizes the continuity of mortality improvements. The graph depicts period
estimates for life expectancy at birth for each country with at least one year of data in the
Human Mortality Database (2017a) between 1850 and 2015. To approximate some general
trends, the annual average across all countries with data in the respective year is highlighted
with a thick solid line. Estimates for males are in blue and estimates for females are in red.
Figure 1.1 illustrates the tremendous increase in life expectancy at birth. Based on the av-
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Figure 1.1.: Life expectancy at birth, males and females, various countries, 1850-2015.
The graph includes estimates for all countries included in the Human Mortality
Database (2017a) with at least one year of data between 1850-2015. The annual
average is calculated across all countries, providing a life expectancy estimate in
the respective year. Hence, the number of countries included in the average varies
by year. Life expectancy estimates are based on period life tables, using age-
specific death counts and exposures provided by the Human Mortality Database
(2017a). The abbreviation “LE” stands for life expectancy.
erage value across countries, the average lifespan almost doubled between 1850 and the most
recent years. Despite short-term fluctuations and the influence of strong period effects, such
as the Spanish flu (1918–1920) and the World Wars (1914–1918, 1939–1945); it is clear that
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survival has been continuously improving since at least 1870. However, if we look at the an-
nual cross-country average, we see that the pace of improvement started slowing around 1950.
This trend is likely attributable to the onset of sustained old-age mortality declines (Kannisto,
1994).
Several authors have emphasized the commonalities in the patterns of survival improvement
across countries. Tuljapurkar et al. (2000), for instance, have provided evidence of a roughly
constant rate of exponential mortality decline across the G7 countries. Taking a broader per-
spective, Leon (2011) pointed out that the pace of the life expectancy increase has been similar
across western Europe, Japan, and the USA; but also that some deviating trends can be ob-
served in regions such as eastern Europe. Using a joint perspective, White (2002) showed that
the variability in the level of life expectancy across countries has been decreasing over time.
Additionally, he argued that the earliest industrialized countries have shared a stable rate of
change and a stable degree of variability of life expectancy levels at least since around 1980.
He concluded from these findings that the countries included in his analysis increasingly ap-
pear to have a common mortality trend. While acknowledging the occurrence of short-term
fluctuations, Wilmoth (1998) also emphasized the remarkable stability and regularity of im-
provements. The expectation that past trends will continue in the future prompted him and
other scholars to simply extrapolate past trends to forecast future levels of life expectancy
(Wilmoth, 1998; Torri and Vaupel, 2012).
Over a long run, the general trend in life expectancy and the life expectancy trends of al-
most all of the countries in Figure 1.1 are remarkably regular. Nonetheless, there is still a
considerable degree of inequality in life expectancy levels. For instance, Ribeiro et al. (2016)
provided evidence for spatial inequalities in old-age survival across European regions. They
observed a north-south pattern with higher life expectancy in the southern regions. Moreover,
some scholars have described a divergence of old-age mortality declines across low-mortality
countries (Meslé and Vallin, 2006; Rau et al., 2008). According to Meslé and Vallin (2006),
the trends in the USA and the Netherlands and those in France and Japan can be seen as ex-
3
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emplary groups with differing trends. By analyzing the time point at which countries started
to diverge from some general trend, Ouellette et al. (2014) and Li et al. (2011) found that most
trend breaks occurred between 1970 and the end of the 1980s. Peters et al. (2016) argued
that most of these trends breaks can be explained by the smoking epidemic. Moreover, Thun
et al. (2012) found that the four-stage model of the smoking epidemic, which was originally
published by Lopez et al. (1994), provides a useful description of the mortality trends in many
developed countries. It is therefore possible to speculate that since 1950, tobacco smoking has
been the main driver of the variations in mortality trends across countries. However, in some
eastern European countries in particular, alcohol consumption and other factors have also had
considerable effects on the changes in life expectancy (McKee and Shkolnikov, 2001).
Innovations and changes in nearly every branch of life are responsible for the marked in-
crease in the average lifespan. According to Cutler et al. (2006) the factors that have con-
tributed to rising longevity include better nutrition, improvements in public health, urban-
ization (albeit with some negative effects), vaccination, better medical treatments, and the
long-term effects of improvements in early-life conditions. Advances in education, welfare,
and infrastructure are other potential determinants of the increase in the average lifespan (Ri-
ley, 2001). Researchers have also found correlations between life expectancy and a number
of other development indicators, such as gross domestic product (Preston, 1975; Mackenbach
and Looman, 2013). It is, however, unclear, which of these determinants have been and cur-
rently are the most important. Scholars have observed a complex interplay of all of these
factors with variations over age, period, and cohort (Oeppen and Vaupel, 2002; Riley, 2001).
An attempt to create a theoretical framework for these fundamental changes was made by
Fogel and Costa (1997). They proposed the theory of technophysio evolution. This concept
relates the alteration of human physiology to the steady increase in environmental control that
has occurred over the last 10 generations, and which has been particularly pronounced in the
last three to four generations. Fogel and Costa (1997) characterized this evolution as a long
term and still ongoing process.
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In addition to the determinants responsible for progress across populations, factors that
influence mortality within populations have become increasingly important. Health care sys-
tems, medical care, resource allocation, differences in health-related behaviors, social struc-
ture, and stress seem to have driven recent and current mortality developments within and
across countries (Cutler et al., 2006; Marmot, 2005). The emergence of modern epidemics,
such as the smoking epidemic, have slowed or even reversed mortality improvements (Thun
et al., 2012; Lopez et al., 1994). Although being overweight is probably not as deleterious to
health as smoking tobacco, the obesity epidemic appears to be threatening further health and
mortality improvements in developed countries (Prentice, 2005; Caballero, 2007).
The enormous number of years added to the average lifespan also raises questions about
the health status of people during their additional years of life. Are these years spent in poor
or good health? Three competing hypotheses that attempt to answer this question have been
proposed. The compression of morbidity hypothesis (Fries, 1980) argues that these additional
years are healthy years: The dynamic equilibrium hypothesis (Manton, 1982) assumes that
the proportion of the lifespan spent in poor health remains the same. Finally, the expansion
of morbidity hypothesis (Gruenberg, 1977; Kramer, 1980) argues that the additional years or
life are spent in poor health. Although many studies have favored the compression of morbid-
ity theory, the research outcomes on this issue diverse (Chatterji et al., 2015; Vaupel, 2010).
Thus, it has recently been asserted that the question of whether the additional years are spent
in good or in poor health is the next million-dollar question in demography 1. There are also
different hypotheses about the influence of improved survival on the general health status of
the population. For example, the failure of success hypothesis claims that medicine has saved
the lives of frail individuals in the population in particular, and that this has in turn resulted
in an increasingly unhealthy population (Gruenberg, 1977; Rosen and Haglund, 2005). The
counterpart to this idea could be called the success of success hypothesis, which asserts that
the general health status of the population has been improving. However, given the contro-
1http://demogr.mpg.de/en/news_press/news/news/the_next_million_dollar_
question_in_demography_4802.htm
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versies surrounding health status during the additional years of life, the questions of mortality
decline and population health are linked is similarly debatable.
In light of the expectation of further advances in the various forces of improvement and the
recent mortality trends in developed countries, it is unlikely that the rise in life expectancy
will halt in the near future (Vaupel, 2010; Mathers et al., 2015). Nevertheless, what the levels
and the limits of the average and the maximum lifespan will turn out to be are questions that
continue to be debated. Although Oeppen and Vaupel (2002) have shown that many suggested
limits have already been exceeded in the projected year, opinions about the future of human
life expectancy still range from limited to limitless. For instance, Olshansky et al. (1990) dis-
cussed the evidence in favor of the assumption that life expectancy is limited. They argued
that unless major breakthroughs occur, life expectancy is unlikely to exceed 85 years. How-
ever, in more recent publications, the same authors have revised their view on the limits of
life expectancy (Olshansky et al., 2005). By contrast, De Grey (2006) offered a highly opti-
mistic, almost limitless view on the future of longevity. Based on extrapolations of scientific
progress and political responses, he argued that the cohorts born in the 21st century are likely
to achieve a life expectancy of more than 1000 years. A much more pessimistic perspective
was presented in a recent article by Dong et al. (2016), who argued that even the maximum
lifespan is unlikely to exceed 115 years. However, the results of other recent studies have
convincingly demonstrated that these findings are flawed (Hughes and Hekimi, 2017; Lenart
and Vaupel, 2017; Rozing et al., 2017; de Beer et al., 2017).
1.2. The changing age pattern of mortality
improvement
As populations evolved from having low to high life expectancy, the major drivers of in-
creases in life expectancy shifted from young to old ages. Accordingly, the forces that drove
the progress made at the beginning of the life expectancy revolution differ from the factors that
6
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influence life expectancy in the current context (Christensen et al., 2009; Riley, 2001; White,
2002). At the beginning of the revolution, declines in infant and child mortality as well as in
mortality among adolescents and young adults made the largest contributions to the increase
in the average lifespan. Since the 1950s, however, mortality improvements at older ages are
the primary drivers of rising life expectancy levels (Christensen et al., 2009; Kannisto, 1996;
Rau et al., 2008). This trends is also a consequence of the continuous mortality decline. As
mortality levels across almost all ages have been dropping from one historical minima to the
next, the opportunities for further reductions in mortality at younger ages are narrowing. By
contrast, there are still enormous opportunities for further improvements in mortality at the
highest ages.
Figure 1.2 illustrates the changing effects of mortality reductions at younger and older ages
on increases in life expectancy at birth. The graph depicts the relative contributions of mor-
tality declines to increases in life expectancy at birth between 1900 and 1950 (left panel) and
between 1950 and 2000 (right panel) for several countries, separated into the age ranges of
below and above 30. In each panel, the bars on the left depict the contribution of ages below
30. The bars on the right indicate the contribution of ages above 30. Estimates for males and
females are depicted in blue and red, respectively.
On average, around 75% of the increase in life expectancy between 1900 and 1950 was
generated by mortality decline at ages below 30. Accordingly, only around 25% of the in-
crease was due to mortality declines above age 30. The results of the decomposition between
the years 1950 and 2000 reveals a different pattern: during this period, mortality declines at
ages below 30 generated only around 25% to 50% of the increase in life expectancy, whereas
mortality declines at ages above 30 contributed around 50 % to 75% to the increase in life
expectancy. The period during which mortality improvements at older ages were the main
drivers of life expectancy increase has been described by Kannisto (1994) as the “era of sus-
tained old-age mortality decline.” For several countries, Kannisto (1994) also provided time
points of the onset of this development. For instance, his analysis showed that this trend started
7
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Figure 1.2.: Relative contribution to the increase in life expectancy at birth, males and
females, various countries, 1900-1950 and 1950-2000. The graph depicts all
countries that provide data for the years 1900, 1950, and 2000. The decomposi-
tion is based on the methodology presented in Arriaga (1984), which is concisely
summarized in Preston et al. (2001). The unequal age intervals are justified by
the higher sensitivity of life expectancy to mortality changes at younger ages. All
of the included countries showed an increase in life expectancy at birth over time.
The estimates are based on based on period life tables, using age-specific death
counts and exposures provided by the Human Mortality Database (2017a).
first among females in France (1955 or earlier), Switzerland, Sweden (all 1956), and Denmark
(1962); and much later among women in Spain, New Zealand (both 1974), the Czech Repub-
lic (1975), Ireland (1979), and Estonia (1981). Looking at males, the analysis found that this
trend started first in France (1955 or earlier), Japan (1966), Switzerland (1967), Finland, and
Portugal (both 1970); and later in Denmark, Iceland, East Germany (all 1984), Hungary, the
Czech Republic (1985), and Estonia (1989). On average across all of the countries analyzed,
females experienced the onset in 1968 and males experienced the onset in 1976 (Kannisto,
1994). Vaupel (2010) has noted that as a consequence of improvements in survival at older
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ages, the number of centenarians has been increasing exponentially in Sweden and Japan since
1950.
The shift in the age pattern of mortality improvement is attributable to the success of the
fight against communicable diseases. During the transition, communicable diseases, such
as cholera and other infectious diseases, were replaced as major causes of death by non-
communicable diseases, such as cardiovascular diseases and cancer (Riley, 2001). Although
many regions have experienced this transition, the timing of the onset and the level of progress
achieved differ greatly across the globe. Riley (2005) has dated the start of the earliest health
transitions by populations to 1770 in Europe; to the mid 19th century in America, Asia, and
Oceania; to the late 19th century in the former Soviet Republics; and to the 1920s in Africa
(Riley, 2005). Irrespective of these geographic differences, non-communicable diseases dom-
inate the current global ranking of major causes of death (Feigin et al., 2016). Hence, the
fight against non-communicable diseases, such as cardiovascular and other degenerative dis-
eases, is the major driver of current survival progress (Robine, 2001; Vallin and Meslé, 2004).
However, despite intensive efforts to reduce mortality from non-communicable diseases, the
general process of physical deterioration with age (aging, sometimes also called senescence)
remains untouched. Thus, these efforts have simply resulted in the gaining of extra time prior
to contracting these diseases through the postponement of senescence to higher and higher
ages Vaupel (2010).
Several efforts have been made to conceptualize the shift in the disease and cause-of-death
spectrum of humans. The most prominent examples are arguably the epidemiological transi-
tion theory by Omran (1971) and, based on this work, the more general theory of the health
transition (see, for instance, Riley, 2001; Fogel, 2004)). In the epidemiological transition the-
ory, Omran (1971) described three distinct periods of change during the development from
low to high life expectancy. In the first period, mortality is high and fluctuating due to, for in-
stance, pandemics such as plague (Walter and Schofield, 1989). The second period marks the
onset and the continuation of mortality improvements and increasing life expectancy, which
9
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are generated by success in fighting infectious diseases. In the third period, life expectancy
levels exceed age 70 and non-communicable diseases are the major killers. The epidemio-
logical transition is an appropriate description of the mortality change up until the 1960s/70s.
However, an unprecedented reduction in cardiovascular mortality, which is commonly referred
to as the “cardiovascular revolution” accelerated this progress (Vallin and Meslé, 2004; Frenk
et al., 1991). Together with the delaying of the onset of other degenerative diseases, this de-
velopment marks a fourth stage of a general health transition: namely “the age of delayed
degenerative diseases” (Olshansky and Ault, 1986; Robine, 2001).
The changes in the age pattern of mortality improvement also led to shifts in the lifespan dis-
tribution. Taking a long-term perspective, we can see that increasing life expectancy has been
accommodated by decreasing lifespan variability (Colchero et al., 2016). As a consequence
of mortality improvements that have been occurring mainly at older ages, new and divers pat-
terns of changes in lifespan variability have been emerging that could result in a decoupling of
this long-term relationship (Vaupel et al., 2011; Smits and Monden, 2009). Deaths are being
postponed to older ages, while mortality at younger ages is declining. This pattern results in
decreasing lifespan variability and increasing life expectancy because the old-age mortality
hump in the lifespan distribution becomes more and more compressed. In his canonical work,
Fries (1980) used the term “compression of mortality” to describe these dynamics. How-
ever, with the onset of the decline in old-age mortality, other dynamics became prevalent. A
“shifting of mortality” has been observed, whereby deaths are postponed to higher ages, but
with an approximately constant shape of the lifespan distribution (Kannisto, 1996; Bongaarts,
2005; Canudas-Romo, 2008). When a shifting of mortality occurs, life expectancy increases
alongside constant lifespan variability. Moreover, it has been suggested that an expansion of
mortality at higher ages is possible (Rothenberg et al., 1991; Cheung et al., 2005; Engelman
et al., 2010). In this situation, life expectancy would increase alongside an increase in lifespan
variability due to a shift in the right tail of the lifespan distribution to higher and higher ages,
which is in turn caused by a dispersal of the old-age mortality hump.
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1.3. The potential for further increases in longevity
Due to the continuity of mortality improvements as well as the changing age pattern of these
improvements, opportunities for the further extension of life expectancy and longevity have
become increasingly concentrated at the highest ages. Figure 1.3 illustrates the current situa-
tion in various countries. The figure depicts the average number of person-years lived in the
age intervals 0–69 and 70–109 (partial life expectancy) relative to the respective number of
maximum possible life years in both age intervals; 70 and 40 years, respectively. For each
country, the last year with available data is used, which ranges from 2010 to 2015. Estimates
for females and males are shown in red and blue, respectively. Looking at the figure, we can
see that the populations of almost all of these countries are living close to 100% of the max-
imum possible years between ages zero and 69. Accordingly, only marginal additional gains
in the number of life years could be achieved among people in this age group. But we can also
see that the populations of the analyzed countries are using only 25% to 50% of the maximum
possible years between ages 70 and 109. Accordingly, it is clear that any increases in life
expectancy, and in maximum lifespan will be achieved primarily by reducing the mortality
among people aged 70 and older.
In addition to making further advances in the “classical” drivers of survival improvement,
scholars of various disciplines have proposed a number of groundbreaking ways of prolong-
ing life at the higher ages, such as slowing human aging or eradicating major diseases through
innovative forms of treatment and prevention. Citing findings from animal studies in which
aging patterns have been modified through, for instance, dietary restrictions or the manipula-
tion of genes, some scholars have are proposed that such modifications could be used to slow
human aging and fundamentally change the mortality trajectory (Longo et al., 2015; Sierra
et al., 2009). Moreover, Sierra et al. (2009) presented findings from human observational
studies, clinical trials, and other research settings that could point to strategies for extending
the human lifespan. However, while strategies for altering several “hallmarks of aging” have
been suggested, an effective approach for halting senescence in humans has yet to be devel-
oped (López-Otín et al., 2013).
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Figure 1.3.: Partial life expectancy between ages 0–69 and 70–109, males and females,
various countries, 2010–2015 (estimates for the last year available by coun-
try). The graph depicts partial life expectancy in the last year for which data
are available. Accordingly, the years range from 2010 to 2015. Partial life ex-
pectancy is calculated by Tx2−Tx1
lx1
with x2 > x1, with Tx expressing the person-
years lived above age x and lx being the survivors at age x. It expresses the
average number of person-years lived in specific age-interval (e.g.; x1 to x2).
For this example, age intervals zero to 69 (left) and 70 to 109 are used. Accord-
ingly, in the first interval, the maximum number of person-years is 70; and in
the second interval, the maximum number of person-years is 40. The estimated
partial life expectancy is divided by the respective maximum number of person-
years to calculate the proportion of the living potential used in the two distinct
age intervals. The estimates are based on period life tables, using age-specific
death counts and exposures provided by the Human Mortality Database (2017a).
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Irrespective of the specific strategy proposed, opinions vary about the feasibility and the
consequences of interventions aimed at slowing or stopping the aging process. From ancient
times to the present, there have been those who favor having an extremely long and youthful
life, and those who have warned of the dangers and the negative consequences of altering the
human aging pattern and pursuing extreme longevity (Jeune, 2002). Regardless of whether
any of these interventions succeed, Goldstein and Cassidy (2012) have shown that there are
several ways of reducing mortality that would lead to considerable gains in life expectancy,
and thus to the utilization of the potential for survival at the highest ages. Interestingly, the
slowing of the aging process in humans is the intervention that appears to offer the greatest
promise (Goldstein and Cassidy, 2012).
1.4. Aim of the thesis
The three main findings discussed above – namely, that mortality is continuously improving,
that the age pattern of mortality improvement is changing, and that there are further opportuni-
ties for increasing longevity – are the major cornerstones of this thesis. The individual articles
– the core of this thesis – stand on the shoulders of these well-established demographic facts.
The persistence and the dynamics of mortality improvement, as well as the potential for future
improvements, lead us to question whether existing demographic approaches and measures
are sufficient for understanding these developments going forward. To organize the specific
issues and aims of the articles, four thematic clusters are derived, which are related in dif-
ferent ways to the three key findings (see Figure 1.4). The clusters differ in terms of their
thematic perspectives and their scientific tasks/approaches. In addition to providing some
thematic orientation, the creation of these clusters allow us to map the distinct steps of the
scientific process: namely, the assessment of a specific phenomenon, the exploration of the
phenomenon and the formulation of future/alternative patterns (outlook).
13
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Figure 1.4.: Thematic outline and structure of the doctoral thesis. The graph depicts the
key findings, the thematic clusters, and the different approaches. The black solid
lines express the relation of the different elements with each other. The figure is
an own illustration.
The sole focus of the first cluster, measuring survival progress, is the continuity of mor-
tality improvement. Although declining mortality can be observed in almost all parts of the
world, development levels are not equally distributed. Some populations have not yet com-
pleted the health transition, whereas others are already looking for ways to modify the human
aging pattern in order to further extend the lifespan (Riley, 2005; Sierra et al., 2009). There-
fore, monitoring survival progress is of great societal and political importance. Moreover,
analysis of variations across populations and of deviant cases can provide valuable opportu-
nities for studying the dynamics of specific survival determinants. Given the continuity of
mortality improvement, this approach might be particularly useful for identifying the determi-
nants of mortality dynamics and their respective changes. Hence, this cluster aims to provide
methodological alternatives for assessing survival progress in order to simplify the respective
evaluations and to stimulate a critical examination of reference trends.
The second cluster, investigating mortality dynamics at the boundaries of age-specific mor-
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tality, refers to mortality development at the lower and the upper boundary of the age-specific
mortality trajectory. Continuous improvements have pushed mortality rates to lower and lower
levels. Moreover, in response to the changes in the age patterns of mortality improvement in
developed and developing countries, efforts to prolong lifer are increasingly concentrated on
generating further declines in mortality rates at advanced ages. Obviously, this is because the
opportunities for reducing mortality are greatest at those ages. However, whether these efforts
are having any effect on the lower boundary of age-specific mortality is unknown. Generally,
relatively little is known about the evolution of the lower boundary of age-specific mortality.
While more is known about the development of the maximum level of age-specific mortality,
only a few analyses have examined the specific characteristics of this development, such as
the level of maximum mortality. Additionally, the boundaries of age-specific mortality can
be regarded as extreme cases. Hence, examining the dynamics and the changes in mortality
patterns can help us better understand the plasticity of age-specific mortality, the potential
frontiers of improvement, and the opportunities for overcoming previous limits in order to
make further progress at the edges of the mortality trajectory. In addition to being useful for
the assessment and the exploration of empirical trends, investigating mortality dynamics at
the boundaries can have important implications for developing or refining methods such as
mortality forecasting approaches. The main aim of this cluster is to assess trends and to ex-
plore the consequences and implications of the developments at the boundaries of age-specific
mortality, with a special emphasis on the lower boundary.
The third cluster, mortality dynamics in an era of old-age mortality decline, deals with the
methodological challenges that arise as a result of the sustained decline in old-age mortality.
The shift in mortality improvements from younger to older ages has altered mortality dynam-
ics. Moreover, old-age mortality improvements are likely to generate the greatest additional
gains in life expectancy and longevity in the future. However, these emerging patterns call
into question existing analysis frameworks and specific measurement techniques. Hence, this
cluster addresses different measurement problems in this area, and aims to provide new ap-
proaches for exploring the emerging patterns.
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The fourth cluster, the role of mortality dynamics for future mortality prospects, refers to
the link between mortality forecasting approaches and mortality dynamics. Future life ex-
pectancy increases will be solely based on the exploitation of the potential for prolonging life
at the highest ages. Moreover, as the age patterns of improvement have changed, mortality
dynamics have already been altered at least once. Hence, further improvements might lead to
additional changes in these dynamics. However, regardless of whether this happens or current
trends continue, the methods used to measure these dynamics should be able to capture and
anticipate different kinds of mortality dynamics at the highest ages. It is particularly impor-
tant that mortality forecasting approaches are able to perform these functions because they
are used to estimate future mortality trends. Hence, this cluster aims to explore the capacity
of forecasting approaches to capture different kinds of mortality dynamics, and to provide an
overview (outlook) of the methodological challenges involved in developing forecasting ap-
proaches.
The combined aim of the four clusters rests on the extension of opportunities to capture,
analyze, and evaluate recent and future mortality dynamics; and to assess the likelihood that
potential scenarios will develop in the future. Taken together, the clusters are expected to
provide coherent outcomes that should result in advances in the assessment and exploration
of mortality change in an era of continuous mortality decline, as well as in the projection of
future scenarios.
1.5. Structure of the summary
Chapter one of this summary separately introduces the three demographic key findings, which
provide the basis for the research presented. These findings are related to the continuity of
mortality improvement, the changing age pattern of mortality improvement, and the prospects
for further longevity increases at the highest ages. Based on these cornerstones, the aim of this
16
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thesis is presented in chapter one.
The articles of this thesis are classified into four different thematic clusters. The outcomes
of each cluster, as well as of the respective papers in the cluster, are presented in individual
chapters. The results of the first cluster, measuring survival progress, are described in chapter
two. The outcomes of the second cluster, investigating mortality dynamics at the boundaries of
age-specific mortality, are presented in chapter three. The results of the third cluster, mortality
dynamics in an era of old-age mortality decline, are outlined in chapter four. The outcomes of
the fourth and final cluster, the role of mortality dynamics in future mortality developments,
are presented in chapter five.
Each of the cluster-specific chapters follows the same outline. The chapter opens by intro-
ducing the cluster objectives. Due to the thematic range, each of the articles in cluster three
(chapter four) also has an individual objectives section. The outcomes of the individual papers
are then presented separately. The structure of these sections depends on the content of the
respective article. Each subsection includes both a presentation of an outcome as well as a
discussion and conclusion of the respective finding. The article-specific summaries focus on
the most important outcomes, and are thus shortened and adjusted versions of the original text.
Moreover, although the aim of these summaries is to provide a comprehensive overview, they
do not offer the level of detail of the original article. To ensure that the focus remains on the
respective outcomes, the technical details are reduced to a minimum. However, for the inter-
ested reader, each article summary contains a materials and data section that provides details
on the data and methods used. After the outcomes of the individual articles are discussed, each
cluster-specific chapter closes with a summary of the outcomes of the whole cluster.
Chapter six contains the overall conclusions of the thesis. The sections in this chapter are
structured to cover the outcomes for the three specific tasks – namely, assessment, explo-
ration, and outlook – that underlie the different thematic clusters. The last section of chapter
six presents the conclusions for all of the clusters combined.
17
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Chapter seven contains the original versions of the five main articles, and, if available, the
respective supplemental information.
The appendix contains an overview of the authors’ contributions to the preparation of the
manuscripts, the original versions of the two appended articles, and the affidavit.
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2. Cluster I – Measuring survival
progress
2.1. Cluster objectives
Sklair (1970, p. XIV) defines progress as: “...the end point, temporary or permanent, of any
social action that leads from a less to a more satisfactory solution of the problems of man in
society.”. The prolongation of the lifespan could be seen as the most important outcome of
human actions intended to create a more satisfactory state. A series of advancements ranging
from improvements in sanitation to nutrition to medical care have been instrumental to this
achievement. These continuous and intrinsically motivated efforts to improve living condi-
tions are responsible not only for the steady progress in survival, but for the shift in the age
pattern of mortality improvement. For instance, the “cardiovascular revolution” (Frenk et al.,
1991), which is an outcome of major advances primarily in medicine, might be seen as one
of the more recent breakthroughs in improving quality of life, and as an example of how such
advancements translate into changes in mortality.
In a comparative perspective, survival progress is also an important indicator for tracking
the development of populations. Life expectancy is often used as a central indicator in this
context. Among other advantages, the main benefit of using life expectancy is that it corre-
lates with various economic, political and social indicators (Preston, 1975; Bergh and Nilsson,
2010). For instance, the level of life expectancy is one of three dimensions of the Human
Development Index (United Nations, 2016); and although mortality has declined almost ev-
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erywhere around the globe (Feigin et al., 2016), the level of progress achieved differs greatly
across regions and across social strata (Lim et al., 2016; Marmot, 2005). Therefore, survival
progress as defined in, for example, the Sustainable Development Goals remains instrumental
to the United Nations’ agenda of advancing the development of populations (Maurice, 2015).
Theory building and modeling also benefit from the assessment of progress (Keyfitz, 1975;
Burch, 2018). For instance, the three periods of Omran’s (1971) epidemiological transition
theory are distinguished by the respective pace of survival progress. Because of variations in
levels of achieved progress and speeds of progression, Vallin and Meslé (2004) have even pro-
posed rethinking Omran’s framework and replacing it with a more broadly applicable health
transition theory. The mortality index in the canonical forecasting approach of Lee and Carter
(1992) might be seen as a technical example whereby survival progress – in this case, the pace
of survival progress across ages – is used for modeling and developing methods. In addition to
their relevance in these areas, progress differentials and cases of exceptionally strong or weak
improvements can be used to understand the effects and the dynamics of specific mortality
determinants. For instance, cases in which life expectancy trends deviate from the general
trajectory by, for example, stagnating or declining are often used to investigate the effects on
overall progress of specific determinants, such as lifestyle factors or health care (among others
Drefahl et al., 2014; Nusselder and Mackenbach, 2000; Tarkiainen et al., 2011).
From a technical perspective, there are two different ways to measure survival progress.
The most common way is to look at the extent to which a mortality summary measure such
as life expectancy differs between a comparison and a reference population at a specific point
in time (gap). In some approaches, this gap is translated into an index to make it comparable
across countries; such as in the Human Development Index or in the Global Burden of Dis-
eases studies (Global Burden of Disease Group, 2017; United Nations, 2016). An alternative
to measuring this gap is to compare the pace of improvement over time. For example, annual
increases in life expectancy may be compared between a comparison and a reference popu-
lation. However, both the gap and the slope include only one specific piece of information
20
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about the progression of survival improvement. The gap could be understood as representing
a static perspective, whereas the slope could be seen as reflecting a dynamic perspective. As
both perspectives are needed to get a full picture of the advancement of survival progress, it
would be beneficial to have an alternative measure that combines the gap and the slope in a
single quantity.
The objective of this cluster is to (re)-introduce an alternative concept for the assessment of
survival progress. The measure combines both the gap and the slope into a single value and
translates the delay in development into calendar years; the most common unit used to assess
progress. Moreover, the advantages and the drawbacks of different kinds of reference trends
are discussed.
Paper in this cluster:
Ebeling, Peters, Rau (2018). The concept of equivalent time as a simple indicator for
the assessment of survival progress. Under review in Population Health Metrics.
2.2. The concept of equivalent time
To introduce the concept of equivalent time, survival progress is linked operationally to the
level of life expectancy at birth over time. Thus, countries with higher levels of life expectancy
experience greater advances in survival progress than countries with lower levels of life ex-
pectancy. Likewise, increases and decreases in life expectancy over time reflect advances and
declines in survival progress, respectively. While the former development is expressed by the
difference in the life expectancy levels of two countries at the same point in time (gap), the
latter development is measured by computing the absolute change over a given period of time
within a country or a group of countries (slope; see also Figure 2.1). Hence, the gap might be
understood as a static aspect of development, and the slope as a dynamic aspect of develop-
ment.
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Figure 2.1.: Schematic representation of measuring survival progress.
There is a third, previously neglected dimension for tracking the development of survival
progress that expresses how far back in time we need to go to find the equivalent level of life
expectancy in a country relative to that of a reference group. This indicator is defined as the
length of time the advancement of a country’s life expectancy lags behind that of a reference
population. We label this quantity “equivalent time” (ET ). Figure 2.1 schematically illus-
trates ET and its relationship to the gap and the slope. In cases in which the reference trend is
linearly increasing, ET could be simply computed by dividing the gap by the slope. Thus, ET
combines the static and the dynamic aspects of development in a single quantity, expressed as
the delay in development.
To identify a unique ET , the reference trend must fulfill certain requirements. To exclude
the possibility that there is more than one equivalent value, the reference time series must
change monotonically over time. This could, however, be viewed as a minor issue, because
we see fairly steady improvements in most measures of survival progress, such as life ex-
pectancy and mortality measures like age-standardized death rates. Moreover, to provide a
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straightforward benchmark for progress, the cases chosen as references usually have a steady
pace of development. For the slope, it is not necessary to assume a constant change over time.
It is also possible to directly compare empirical values without calculating a general slope.
The idea of using lags to assess survival progress was already suggested by Stolnitz more
than 60 years ago (Stolnitz, 1955). He applied this approach in studying the delays in mor-
tality decline in non-western countries relative to those in western countries. Surprisingly, we
are not aware of any other study that has applied this approach. More recently, Goldstein and
Wachter used a comparable concept to study the relationship between cohort and period life
expectancy within countries (Goldstein and Wachter, 2006). They defined the lag as “how
far back in time from the current period we have to go to find a cohort with equivalent life
expectancy” (Goldstein and Wachter, 2006, pp. 259). The general idea of time lags has also
been used to evaluate the decline in age-specific mortality by expressing the improvement
in ages with equivalent mortality levels, which are usually called “equivalent ages” (Burger
et al., 2012; Rau and Vaupel, 2014). While these earlier studies focused on detailed aspects
of mortality and survival, our definition of ET is more general, and refers to cross-country
comparisons of overall survival progress.
2.3. Types of reference trends
To demonstrate the added value of ET , we compare the trends in life expectancy among US
males to those of three reference groups based on the gap, the slope, and the ET between
1960 and 2015. The goal in selecting the reference groups was to ensure that we were cover-
ing the spectrum of reference types typically used in comparative studies. We label the three
main types intra-group, inter-group, and supra-group. In the intra-group comparison, a coun-
terfactual of the trends in the country of interest is used as the reference: namely, cancer-free
life expectancy of US males. In the inter-group comparison, a second external group is used
as the reference: namely, Japan, the world leader in LE. Finally, in the supra-group compari-
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son, a more general trend is used as the reference: namely, the average LE of the G7 countries.
Table 2.1.: Classification of different kinds of references for the evaluation of survival
progress. The listed examples are using the reference perspective in at least some
part of their empirical analysis.
Type Example Specific Features Exemplary Study
Intra-group e0,Country A – e
−i
0,Country A w/o health burden i peculiarity or commonality? Aburto et al. (Aburto et al., 2016)
Inter-group e0,Country A – e0,Country B prime example or exception? Meslé and Vallin (Meslé and Vallin, 2006)
Supra-group e0,Country A – e0,Cross-country average common trend? Bongaarts (Bongaarts, 2006)
e0 –Life Expectancy at Birth
Obviously, which references are chosen depends on the research objective. Even if a spe-
cific reference fits the research purpose, it is important to take into account the specific features
of the respective reference type. Table 2.1 provides an overview of specific reference types and
their characteristics. The results stemming from an intra-group comparison are not sufficient
to determine whether the measured lags are a peculiarity of the respective population, or are
occurring across several populations. Moreover, the outcomes of an inter-group comparison
do not tell us whether the reference population is a prime example of the specific gains being
evaluated, or is an outlier. Finally, the results of the supra-comparison do not indicate whether
the more general reference trend is reflective of a common trend across populations.
2.4. Materials and data
The estimates of life expectancy at birth for US males — the comparison group — are based on
death counts and exposures from the Human Mortality Database (Human Mortality Database,
2017b). In the intra-group comparison, cancer-eliminated life expectancy is used as the ref-
erence (see, for instance, (Preston et al., 2001) for more details on cause-elimination life ta-
bles). Cause-specific death counts were obtained from the National Center for Health Statistics
(NCHS) (2016). The total time period analyzed encompasses the years 1960 to 2015. Cancer
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deaths were reconstructed using the International Classification of Diseases (ICD) codes 140–
239 (ICD 7–9) and C00–D48 (ICD 10). The calculations of Japanese life expectancy in the
inter-group comparison and of the life expectancies for the G7 countries in the supra-group
comparison were also based on death count and exposure data from the Human Mortality
Database (2017b). To ensure that the supra-group also covers the years 1960-2015 for coun-
tries that were missed in the most recent life expectancy estimates, values were obtained from
the World Bank (2017). The equivalent time in all three examples was calculated using linear
interpolation between the time series of the comparison population and the reference popula-
tion. The whole analysis was conducted in the language R (R Core Team, 2017).
2.5. Illustrative example: assessing the survival
progress of US males
Figure 2.2 shows the results for all three comparisons. The rows depict the results for the
intra-, inter-, and supra-group comparisons, respectively. The rows display the results for the
intra-, inter-, and supra-group comparisons; while the columns show the life expectancy, the
gaps, the slopes, and the equivalent times. The slopes are calculated as annual increases over
five year periods, assuming a linear change between the respective time points.
The life expectancy level of US males increased continuously between 1960 and 2015
(panel a). Although an increase can also be observed for all three reference groups, the level
of life expectancy differs across the groups, and compared to the US pattern (panels a–c). The
life expectancy gap between US males and the inter-group reference category remained fairly
stable at a level of about three years, while the life expectancy gap between US males and the
intra-group reference category declined from one year higher in 1960 to four years lower in
2015 (panels d–e). The life expectancy gap between US males and the supra-group reference
category increased from very small in 1960 to about three years in 2015 (panel f).
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Figure 2.2.: Life expectancy, gap, slope (annual change over five year periods), and
equivalent time of US life expectancy compared to three references, males,
1960-2015. All of the estimates are based on period life expectancy. The slopes
indicate the annual change between the two years, comprising five-year intervals.
The last group 2010-15 comprises six years. All calculations of the slope assume
a linear change between the two time points. Equivalent time is calculated using
linear interpolation. The various example rest on data from the National Center
for Health Statistics (NCHS) (2016), the Human Mortality Database (2017b) and
the World Bank (2017).
An assessment based on the pace of improvement alone provides limited insights. Both
cancer-free and average G7 life expectancy had almost the same slopes as that of US male life
expectancy across the different year groups. By contrast, Japanese life expectancy increased
more rapidly until 1985-89, but changed at almost the same pace thereafter (panels g–i). Gen-
erally, however, the slopes varied greatly over time, which makes it difficult to derive solid
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conclusions about the advancement of survival progress.
Compared to the gap and the slope, the ET shows larger differentials in the development
levels of the reference groups and larger differences between the groups in the advancement of
survival progress over time. In the intra-group comparison, US male life expectancy in 1975
is the first value, which can be located on the reference trend line. In this year, the survival
progress of US males lagged around 13 calendar years behind the level that hypothetically
could have been achieved if cancer had been eradicated. This lag grew consistently over time
to reach a magnitude of almost 19 calendar years in 2015 (panel j). In the inter-group com-
parison, we even see that the survival progress of US males was two calendar years ahead of
that of Japanese males in 1960. But by 2015, this advantage had turned into a lag of almost
21 calendar years (panel k). In the supra-group comparison, US male life expectancy in 1970
is the first value, which can be located on the G7 average trend line. In this year, the survival
progress of US males lagged around 10 years behind the average level of progress of the G7
countries. After a period of improvement, the lag among US males increased consistently to
reach a level of 12 calendar years by 2015 (panel l).
2.6. Cluster conclusion
In this cluster, a measure for assessing survival progress has been introduced. It is labeled
equivalent time (ET ). The measure complements the current practice of comparing develop-
ment at a single point in time and of comparing changes in development over time. It offers a
simple and intuitive way to express in calendar years the delay in the development of a popula-
tion in comparison to that of a reference population. ET arguably has the potential to become
a standard approach in the toolbox that is used for the assessment of survival progress in both
large-scale cross-country comparisons and case studies, and for the evaluation of single coun-
tries. To illustrateET , period life expectancy has been used, but any other continuous variable
that is monotonically increasing or decreasing over time could be used as well.
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The simplicity of ET is, of course, also a shortcoming. Since it is built on a single variable,
critics might see ET as an oversimplified measure that does not capture the multiple dimen-
sions of development. This criticism is certainly justified. Thus, in cases in which reliable
data on other dimensions are available, the use of more complex measures might indeed be
more appropriate. However, for many countries, and particularly for longer historical periods,
such data are often not available.
The illustrative example depicts a potential application of ET that is complementary to the
classical approaches. The results indicate that the survival progress of US males has been
increasingly falling behind that of other groups, as the large increases in ET found among US
males over the study period demonstrate. For instance, the application ofET showed that rela-
tive to their Japanese peers, US males experienced a delay in LE development of two decades.
This is a remarkable insight given that US life expectancy increased virtually throughout the
whole study period at a pace that was almost comparable to that of the reference categories. At
the same time, the gap between US life expectancy and that of the reference groups remained
fairly stable, at least compared to that of the intra and supra-group reference categories. The
results are even more intriguing given that the US has the highest health care expenditures in
the world (Wang et al., 2013). Moreover, the results show that ET is a more sensitive measure
of advances in survival than the comparison of gaps or slopes.
In addition to introducing another tool for measuring progress and development, we were
able to show that the assessment of the performance of a specific country is not straightfor-
ward. Rather, we illustrated that such assessments are sensitive to the selected indicator (e.g.,
life expectancy), perspective (gap, slope, lag), and reference (e.g., G7 countries). It is therefore
important to use care in interpreting results that are based on a single measure, perspective, or
reference. If possible, multiple factors should be taken into account for each of these dimen-
sions.
28
3. Cluster II – Investigating mortality
dynamics at the boundaries of
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3.1. Cluster objectives
Mortality has been declining for more than 160 years (Oeppen and Vaupel, 2002; Riley, 2001).
Mortality rates at almost all ages have regularly reached unprecedented minima over this pe-
riod. These developments are attributable to continuous advances in nearly every area of life,
which also altered some fundamental aspects of human mortality, such as the cause of the
spectrum. While each of these successive improvements was unprecedented, the mortality
trajectory has retained certain key features (see Figure 3.1). For example, levels of infant
mortality have been consistently similar to mortality levels between ages 60 to 80. Moreover,
adult mortality has shown a log-linear increase over age, and mortality levels between infancy
and early adulthood have followed a U-shaped pattern.
Moreover, as these advances were occurring, major improvements in survival shifted from
younger to older ages (Christensen et al., 2009). The changing age pattern of mortality im-
provement might also be interpreted as a sign that all of the major opportunities for reducing
mortality at younger ages have been exploited. Today, the contributions of the youngest ages
to the increase in the average age at death are small to negligible. Nevertheless, in almost all
countries of the world, mortality at younger ages has been decreasing continuously (Armour-
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Marshall et al., 2012; Verguet et al., 2014). This trend has resulted not only in an increasingly
pronounced U-shaped pattern of mortality between infancy and early adulthood (see Figure
3.1), but in a widening of the range of age-specific death rates.
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Figure 3.1.: Age-specific death rates, France, females, years 1850,1900, 1950, and 2000.
Death rates are smoothed. The rates are plotted on a logarithmic scale. The
estimates are based on age-specific death counts and exposures provided by the
Human Mortality Database (2017a).
The lower boundary of age-specific mortality is located at the inflection point of the U-
shaped mortality pattern between infancy and early adulthood. The upper boundary is reached
at the late-life mortality plateau Gampe (2010). Both the upper and the lower boundary are
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valuable indicators of the dynamics at the edges of human mortality. However, both bound-
aries have unique characteristics that reveal their fundamental differences.
The plasticity of the lower boundary compared to the stability of the upper boundary is per-
haps the most important difference. Gampe (2010) estimated a mortality rate of around 7,000
deaths per 10,000 person-years lived at the upper boundary of age-specific mortality. But
when we look at Figure 3.1, large declines in the lower boundary are immediately evident.
Explanations for the stable upper boundary are diverse, and range from a more homogeneous
population composition at those ages to physiological and genetic aging processes (Wachter,
1999; Pletcher and Curtsinger, 1998; Missov and Vaupel, 2015; Vaupel et al., 1998). Mini-
mum mortality, by contrast, appears to (still) be alterable. Most importantly, improved living
standards (e.g., better sanitation and nutrition) and medical breakthroughs, such as antibiotics
and vaccinations, are the main reasons for the survival gains at childhood and juvenile ages
(Cutler et al., 2006; Blum, 2009; Gore et al., 2011).
After the degree of alterability, the location is the second major difference between mini-
mum and maximum mortality. Maximum mortality is located at the end of the lifespan, which
seems obvious due to the log-linear increase in mortality with age. Minimum mortality is
however reached within a tiny age range at the end of the first decade of life. It marks a
specific point over the life course at which physical and social development levels are most
favorable for avoiding death. The explanations for why mortality levels are lowest in this exact
age range are mainly drawn from evolutionary mechanisms, such as high selection pressure
prior to the beginning of the reproductive period; i.e. the proximity of these ages to the onset
of sexual maturity (Burger et al., 2012; Chu et al., 2008; Levitis, 2011). However, for both
males and females, scholars have observed over the past century temporal changes in related
processes, such as faster body growth or the earlier onset of puberty (Frisch, 1978; Tanner,
1973; Goldstein, 2011; Schönbeck et al., 2012). The location of minimum mortality might be
similarly affected by these shifts.
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Male-female differences are the third key feature that could reveal further disparities be-
tween maximum and minimum mortality. Gampe (2010) did not find any relevant differences
in maximum mortality between males and females, even though most of the data used in her
analysis were for females. Unfortunately, until recently there have been relatively few studies
that examined the level of the plateau and potential sex-specific differences. Among children
and adolescents, mortality is higher for males, even though the absolute gap becomes smaller
with decreasing levels of mortality (Gissler et al., 2009). Surprisingly, external causes of death
as an indicator for sex-specific risk-adverse behavior explain only a minor part of the male-
female differences (Gissler et al., 2009). For example, Gissler et al. (2009) measured a higher
rate of non-external causes for boys than for girls. It therefore appears that additional factors
must be responsible for these differences.
Examining these key features help us better understand about the frontiers of human mortal-
ity improvement because minimum and maximum mortality (the lower and the upper bound-
ary) indicate specific points along the mortality trajectory at which the condition of individuals
as well as the composition of the population are most extreme in terms of mortality severity.
Hence, it could be hypothesized that potential frontiers and fundamental breakthroughs that
might affect all ages in the long run are primarily detectable at the boundaries of age-specific
mortality.
Understanding the development of the mortality boundaries is also important for mortal-
ity modeling. For instance, mortality forecasting approaches usually assume that death rates
have no lower limit. Instead, the logarithm of death rates is used, which allows rates to de-
cline infinitely, while staying between zero and one (see, for instance, Hyndman and Ullah,
2007; Lee and Carter, 1992). Accordingly, examining the evolution of the lower boundary
of age-specific mortality can provide further insights that would help us better understand the
implications of recognizing lower boundaries in mortality forecasting approaches. Moreover,
attempts were made in previous parametric mortality models, such as the Siler model (Siler,
1983) or the Heligman-Pollard model (Heligman and Pollard, 1980), to include mortality at
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all ages. For instance, the Siler models incorporate the lower boundary by adding a constant to
the two terms, which captures the exponentially decreasing and increasing parts of the force
of mortality. In the Heligman and Pollard (1980) model, no specific parameter is added to
model the lower boundary, but the parametrization generates such a pattern. Neither para-
metric models take the pattern of the upper boundary of mortality into account. Accordingly,
the mortality pattern of both models would generate further increases at the highest ages, al-
though the increase in death rates would decelerate (Horiuchi and Wilmoth, 1998) prior to the
leveling-off at the late-life mortality plateau (note that the Heligman and Pollard model shows
some deceleration). However, evidence for a leveling-off and clear empirical proof of the mor-
tality plateau has been provided by studies published long after the publication of the works of
Siler (1983) and Heligman and Pollard (1980), following the development of other parametric
models (see among others Thatcher et al., 1998; Thatcher, 1999; Gampe, 2010). The exam-
ples of mortality forecasting and parametric mortality models demonstrate the added value
of exploring the boundaries of age-specific mortality in order to refine existing approaches or
even develop new models.
Based on these considerations, the objectives of this cluster are to investigate the evolution
of the lower and the upper boundary of mortality, with a special emphasis on the lower bound-
ary. Accordingly, three essential questions should be asked and answered when examining
minimum mortality. These questions are:
• How pronounced are the sex-differences at the lower boundary of age-specific mortal-
ity?
• At which ages is minimum mortality reached, and how have these ages changed over
time?
• How has the level of minimum mortality evolved, and is minimum mortality still de-
creasing?
Given the unprecedented mortality improvements of the past, it is not far-fetched to hypoth-
esize that minimum mortality will be the first death rate to finally hit a lower (natural) limit;
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and that minimum mortality indicates the absolute frontier of human mortality improvement.
For the upper boundary, the question to be answered is simply:
• Where is the level of the late-life mortality?
Thus, the aim is to investigate whether it is possible to find further support for a maximum
mortality level of 70 deaths per 100 person-years lived using an estimation procedure that rep-
resents an alternative to the procedure used by Gampe (2010).
Papers in this cluster:
Ebeling (2018). How has the lower boundary of human mortality evolved and has it
already stopped decreasing? Forthcoming in Demography.
Appended paper: Rau, Ebeling, Peters, Bohk-Ewald, Missov (2017). Where is the level
of the plateau? Published in Living to 100 Monograph.
3.2. Outcomes for the lower boundary of age-specific
mortality
3.2.1. Material and data
Minimum mortality is estimated using cohort and age-specific data because only a cohort
follow-up provides the life course perspective that is needed to clearly identify the lowest
mortality rate over age. Moreover, many forces shape minimum mortality, such as selection
in a cohort. The cohort data used come from the Human Mortality Database (2017c). All of
the estimates are based on data for individuals aged one to 20. The earliest cohort considered
was born in 1900. For some countries, the data start later. The most recent cohort considered
also varies by country. Countries with data covering fewer than 20 cohorts are excluded from
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the analysis.
Although data from the Human Mortality Database cover national populations, and can thus
be considered complete enumerations, the data are still subject to stochastic variation (Udry
et al., 1979; Kirkby and Currie, 2010; Klotz, 2016). In addition, it is usually assumed that the
underlying mortality process is smooth (see also Kirkby and Currie, 2010). Minimum mortal-
ity could be considered to be especially vulnerable to population size and stochastic variation
because of its low intensity. Hence, around the age of minimum mortality, mortality could be
quite noisy. Minimum mortality contains another, rather technical and theoretical problem:
namely, that mortality rates are bound at zero at the lower end. In low-mortality countries
with a small population size, mortality at some ages below 20 is already at such low levels
that the number of age intervals without any deaths is consistently increasing over time. To
deal with zero death rates and stochastic variation, we complemented the analysis of observed
trends with estimates based on a two-dimensional smoothing approach by Camarda (2012),
and applied it over age and cohort (see the original paper for a detailed discussion of model
selection and descriptions of the different models). The method is readily available via the
package “MortalitySmooth” for the statistical programing language R (2017).
The occurrence of period shocks, such as the Spanish flu or a war, can lead to problematic
estimates when two-dimensional smoothing approaches are applied, because in such situa-
tions the respective mortality rates are subject to more than just stochastic variation (Kirkby
and Currie, 2010; Palloni, 1990). When the two dimensions are cohort and age, the situation
becomes especially difficult because the period shocks are located on a backward 45-degree
line in the age-cohort surface. Due to the data structure, the 1915–1919 and 1938–1947 peri-
ods, which cover the Spanish flu and World Wars I and II, are excluded from the analysis. The
approach we used interpolates the emerging gaps, which are generated when the mortality of
the respective ages is ignored.
To avoid potential distortions, the range of ages searched for the minimum mortality level
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was restricted to ages five to 15. This is theoretically reasonable given the range of observed
ages.
3.2.2. The level of minimum mortality
Figure 3.2 shows the minimum mortality levels for males and females in France (see the orig-
inal paper for results for all of the other countries). The graph depicts the level of minimum
mortality per 100,000 person-years lived. The levels are shown on a log scale, using the log-
arithm of two to emphasize level halving. Accordingly, the horizontal contour lines mark the
consecutive halving of the mortality level. The solid lines are minimum mortality estimates
based on the age-cohort smoothing, and the colored area around this line indicates the 95%
confidence interval. The plus signs indicate observed minimum mortality. The squares mark
the observed minimum mortality for cohorts who spent at least one year in the omitted periods
(1915–1919, 1938–1947). Females are depicted in red and males in blue.
In Figure 3.2, we can see that minimum mortality declined from almost 250 deaths per
100,000 person-years lived to around 10 deaths per 100,000 person-years lived over the co-
horts born between 1900 and 1993. Over the course of this decline, the trajectories for French
males and females show four periods with distinct developments (see tags in Figure 3.2). Min-
imum mortality improves only slowly in the first period (I), which encompasses the cohorts
born between 1900 and 1920. The second period (II) is characterized by rapid improvements.
This period spans the cohorts born between 1920 and 1950. In the third period (III), minimum
mortality improvements decelerated, and were close to stagnation at certain points. This trend
lasts up to the cohorts born in the early 1960s. The fourth period (IV), which covers the most
recent cohorts, again shows steady improvements. The trajectory of France is exemplary of
the trajectories observed in the majority of countries analyzed. The only variation that could
be found were small temporal differences and differences in the manifestation of the patterns
in the four periods described. The minimum mortality levels of a few countries only, such as
those of Russia or Belarus, deviate from the general trend. In these countries, the improve-
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Figure 3.2.: Minimum mortality, France, females and males, birth cohorts 1900–1993.
The graph depicts the observed (squares and crosses) as well as the smoothed
(solid line) minimum mortality levels. The observed rates marked with a square
indicate the cohorts who spent at least one year in the omitted periods (World
Wars I and II). The colored area around the smoothed minimum mortality esti-
mates depict the 95% confidence interval, as calculated by the approach of Ca-
marda (2012). Minimum mortality rates are illustrated using the logarithm with
basis two. The solid gray grid lines and the Roman numerals mark the different
periods of development. The age- and cohort-specific death counts and exposure
data were obtained from the Human Mortality Database (2017c).
ments in minimum mortality over the analyzed cohorts are marginal to non-existent.
Based on the broad picture across all of the countries analyzed, it could be concluded that
37
3. Cluster II – Investigating mortality dynamics at the boundaries of age-specific mortality
the level of minimum mortality decreased continuously over the observed time period, and
that the pace of improvement among recent cohorts has been relatively steady. Therefore, the
recent trends do not suggest an imminent end to this decline. Among the best practice coun-
tries, the current levels are about eight deaths per 100,000 person-years for females and about
10 deaths per 100,000 person-years for males (see the original paper for a comparison of the
recent minimum mortality levels across all of the countries analyzed). However, the lower
boundary of mortality has not been decreasing constantly. Especially among the post-war
cohorts, improvements have temporarily slowed, with some countries even experiencing stag-
nating or slightly increasing levels. The reasons why minimum mortality has stagnated are not
entirely clear. Among the potential explanations for this development are the introduction of
mass immunization for several diseases in the 1960s (Riley, 2001); changes in fertility-related
behavior (Billari and Kohler, 2004); and changes in child care (Vandell et al., 2010).
Given that this decline has been steady, it is intriguing that the lower boundary of mor-
tality has still not reached a lowest limit after almost 170 years of continuous mortality im-
provements. The question of whether minimum mortality has a lower limit remains open and
continues to present challenges. If such a limit does exist, mortality might follow a constant
force of mortality, whereby simply good or bad luck are the essential mortality determinants.
However, recent developments in childhood health call into question such an optimistic as-
sumption. For instance, Brüne and Hochberg (2013) have found that since the late 1980s in
particular, the prevalence of chronic diseases in childhood, such as obesity, diabetes, and au-
toimmune diseases has been increasing. They argued that changes in the environment favor
this development; speculating that evolutionary and medical factors — such as thrifty genes,
hygiene, fetal programming, or the extensive intake of cow’s milk — might explain this trend.
Although the rising prevalence of chronic diseases in childhood might not have an immediate
effect on death, it might increase the vulnerability of children, and could thus have an indirect
effect on the level of minimum mortality. However, based on these results, we cannot confirm
that these developments have had any negative impact on minimum mortality levels among
the most recent cohorts.
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3.2.3. The location of minimum mortality
The results for the minimum mortality ages can be seen in Figure 3.3. The observed mortality
rates as well as the smoothed mortality rates are given by age. Hence, the ages of minimum
mortality are also measured in integers. Due to stochastic fluctuations and the impact of the
world wars, minimum mortality ages based on the smoothed mortality estimates are consid-
ered as the basis. Furthermore, the trends across countries are very homogeneous, and show
only small variations. Therefore, we pooled the ages of minimum mortality across countries
and summarized the results for 10 consecutive cohort groups. Due to the varying lengths of
the data available, the number of ages in each of these 10 groups differs.
The age of minimum mortality decreased over the cohorts studied. This trend is also visible
if we look at the ages based on the observed mortality estimates. For the cohorts up to those
born in 1920–1929, the modal value jumps between ages 11 and 12. The distribution of males
and females for the 1930–1939 and 1940–1949 cohorts are right–skewed, which means that
ages higher than the mode are observed more frequently than younger ages. This is, how-
ever, likely an effect of World War II. Although minimum mortality among the cohorts born
in 1950–1959 or later has been relatively consistently located at age 11, the distribution is
shifting toward younger ages. The shift is indicated quite well by the growing frequency of
age 10 as the age of minimum mortality over the respective groups. Accordingly, for the last
two cohort groups, the modal value is already located at age 10, and ages above and below the
mode are almost evenly observed. However, the growing frequency of age nine over the last
two cohort groups could suggest that the shift toward younger ages might be continuing.
The location of the lowest mortality level is closely associated with the onset of sexual ma-
turity. Hence, the change in the location of minimum mortality might be generated by changes
in related mechanisms. Evolutionary theories of aging argue that evolutionary fitness, defined
as the intrinsic rate of natural increase, is most sensitive to mortality changes around the age of
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Figure 3.3.: Distribution of minimum mortality ages, all countries together, females and
males, grouped birth cohorts 1900-1994. The bars show the relative frequency
of the ages in the respective cohort groups; pooled over all of the available coun-
tries. The age of minimum mortality is measured in integers. The number of
countries varies over time in each cohort group, and is indicated by N. The high-
lighted bar represents the modal age in the respective year. The bars correspond
to full ages. The age- and cohort-specific death counts and exposures data were
obtained from the Human Mortality Database (2017c).
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sexual maturity (Hamilton, 1966). Accordingly, selection pressure on age-specific mortality
should be highest around the onset of the reproductive period, when the respective mortality
rates are pushed to their lowest possible levels. Similarly, the age of maturity itself should be
under strong selection pressure as a key age that defines the onset of reproduction. Other au-
thors have also argued that intergenerational transfers, such as parental care, shape selection
pressure, and are thus an important determinant of the shape of human life history, and, in
turn, mortality (Gurven et al., 2012). The investments of older generations in younger genera-
tions therefore lead to a concave shape of selection pressure, which may push mortality down
even further at the onset of the reproductive period, when such investments start to pay off
(Chu et al., 2008; Lee, 2003; Bogin, 1997). As a result of the close relationship between the
location of minimum mortality and sexual maturity, it could be hypothesized that the earlier
occurrence of minimum mortality might be related to temporal changes in different aspects of
childhood development such as body growth, and thus to the earlier occurrence of puberty and
sexual maturity that has been reported by a number of authors (Goldstein, 2011; Tanner, 1973;
Frisch, 1978; Schönbeck et al., 2012). However, the similar locations of minimum mortality
of males and females could be seen as a sign that this is not the case, because different studies
provide evidence for a slightly earlier onset of puberty of females, which also holds for the
transition through the different developmental stages of sexual maturity (Susman et al., 2010;
Lee, 1980). In addition to these factors, Levitis and Martínez (2013) have offered further hy-
potheses for why the juvenile mortality pattern is U-shaped, and for why we therefore see an
inflection point between the decreasing and the increasing parts of mortality over age. How-
ever, the plasticity of minimum mortality challenges all of these concepts. Given the enormous
gains that have been made over a short period of time, it is possible to speculate about whether
human progress has decoupled minimum mortality from evolutionary mechanisms — or has,
at least, weakened the relationship between them.
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3.2.4. Sex–specific differences of minimum mortality
Figure 3.4 shows the absolute male–female differences in the levels of minimum mortality
for all of the countries analyzed. The trajectories of Japan, Russia, France and Norway are
highlighted. A negative difference expresses higher mortality for females and vice versa.
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Figure 3.4.: Absolute male–female minimum mortality differences, Japan, Russia,
France and Norway, birth cohorts 1900-1994. The gray lines depict all of
the other countries included in the analysis. The sex differences are calculated
based on the smoothed minimum mortality estimates. The age- and cohort-
specific death counts and exposures data were obtained from the Human Mor-
tality Database (2017c).
The development of absolute sex-specific differences at the lower boundary of mortality
shows two distinct patterns: female mortality is higher with a consistently growing male dis-
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advantage, followed by a trend toward convergence. Russia is an exception to this overall
pattern. Among the most recent Russian cohorts analyzed, men have a minimum level that is
still around 20 deaths per 100,000 person-years higher than that of females; whereas in, for ex-
ample, Japan, France, and Norway, the absolute male-female differences are almost negligible.
The female excess mortality found in the oldest cohort analyzed is an intriguing pattern.
Tuberculosis could be one explanation for this trend. Several authors have documented higher
tuberculosis death rates among females in the respective age range (10-14) for similar cohorts
and for the calendar years in which the respective cohorts reached their minimum mortality
level (Frost, 1995; Springett, 1952a,b). Other potential explanations for this finding such as
discrimination related to sex or birth order (Modin, 2002) are conceivable, but remain vague
speculations.
The female disadvantage turned relatively rapidly into a male disadvantage, which reached
the maximum level at some point among the interwar cohorts. Since then, a continuous trend
toward convergence can be observed. The male disadvantage is the result of slower improve-
ments in the minimum mortality levels of males than of females. These pace differentials are
striking because the usual determinants of sex-specific differences, such as lifestyle and be-
havioral factors, should be less relevant at these ages. We can speculate that excess mortality
caused by environmental conditions is decreasing more quickly among females than among
males. It is also possible that after this type of excess mortality is no longer relevant, the
gender gap is still primarily driven by biological factors. Currently, it appears that communi-
cable diseases can be excluded as a potential driver, and that external causes of death explain
only a small part of the gender gap (Gissler et al., 2009). Accordingly, non-behavioral causes
and non-communicable diseases could be emerging as the potential drivers. Studies that used
cancer — a leading cause of death in childhood in the developed countries — to illustrate
this development found that boys are more likely than girls to develop a childhood cancer
(Kaatsch, 2010; Dorak and Karpuzoglu, 2012).
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3.3. Outcomes for the upper boundary of age-specific
mortality
3.3.1. Material and data
The level of the late-life mortality plateau is the upper boundary of age-specific mortality. Ac-
cordingly, after the log-linear increase in mortality at adult ages, the force of mortality tends
to decelerate between around the ages 80 to 85. This phenomenon is commonly referred to
as “mortality deceleration” (Horiuchi and Wilmoth, 1998). This deceleration ultimately re-
sults in the late-life mortality plateau, at which mortality remains constant (see, for instance,
Thatcher et al. (1998); Missov and Vaupel (2015)). The explanation for this pattern is most
often drawn from the selective mortality hypothesis, which rests on a simple idea. Popula-
tions are heterogeneous, which means that some individuals in the population are frailer than
others. On average, these frailer individuals tend to die earlier than their more robust peers.
Accordingly, the force of mortality observed on the population level (µx) could be interpreted
as average across these different subpopulations. As these frailer individuals die off, the force
of mortality tends to level off. The general relationship between the population-level hazard
and the risks faced by subpopulations is described in more detail by Vaupel and Yashin (1985)
and Vaupel (2010).
The formalization of this idea originates from the canonical work of Vaupel et al. (1979),
in which the authors introduced frailty models. Assuming that frailty is fixed over the lifetime
for each individual, and that frailty affects the baseline mortality proportionally, the force of
mortality of an individual with frailty z – the simplest frailty model – is expressed by
µx,z = zµ0,x, (3.1)
where µ0,x depicts the baseline force of mortality at age x. Accordingly, the force of mortality
at the population level can be expressed by
µx =
∞∫
0
z µx fx,z dz, (3.2)
44
3. Cluster II – Investigating mortality dynamics at the boundaries of age-specific mortality
where fx,z is the probability density function of frailty among the survivors at age x. Hence,
the force of mortality of the population at age x is the weighted average across individual force
of mortality, where the weights stem from the probability density function of frailty among
the survivors at age x. Vaupel et al. (1979) already assumed that frailty is gamma-distributed
with a mean of one, which was later discussed in more detail by, for instance, Vaupel and
Missov (2014). By combining this assumption with the frequently investigated idea that the
force of mortality at the individual level follows the Gompertz mortality model (Steinsaltz and
Wachter, 2006; Finkelstein and Esaulova, 2006), the force of mortality at the population level
can be expressed by the gamma-Gompertz model, which is described by Vaupel and Missov
(2014) as
µx =
beb(x−M)
1 + γe−bM(ebx − 1) , (3.3)
where b is the slope of the force of mortality over age, M is the modal age at death, and γ
expresses the variance of the gamma distribution. The mortality plateau for this model can
then be expressed by
lim
x→∞
µx =
b
γ
. (3.4)
Our investigation of the mortality plateau rests on this model. Based on the minimum AIC
(Akaike, 1974), the gamma-Gompertz came out as the best model in a comparison of several
parametric mortality models (see the original paper for further details).
All of the estimates are based on death counts and exposures from the Human Mortality
Database (2016). The estimation of the gamma-Gompertz model and of the models used in
the comparison rests on the maximum-likelihood framework, which assumes that age-specific
death counts are Poisson-distributed (Brillinger, 1986). The data cover the age range 80 to
109 and the years 1960 to 2010.
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3.3.2. Level of maximum mortality
Figure 3.5 depicts the distribution of the level of the mortality plateau across all of the countries
and the periods analyzed. The histogram includes estimates for females and males. Addition-
ally, the estimated density curves for females (red) and males (blue) are shown. The boxes at
the top of the graph depict the interquartile range of the estimated mortality plateaus with the
median (solid line) for both sexes combined (gray), and for females and males, respectively.
The median value of the mortality plateau for both sexes combined is slightly below one,
which translates into a probability of dying of≈63%. The median value for females is slightly
above a level of 0.8 (≈55%). For males the median value is slightly below a level of 1.2
(≈70%). However, as the estimates for males in particular have large variations, the median
value provides only limited insights. To investigate the role of population size as a potential
source of variation, we employed a simulation: we fixed b at a level of 0.14 and γ at a level of
0.2, both of which resulted in a mortality plateau of 0.7, and varied the population size (1,000,
1,0000 ,and 100,000 individuals). The results of this simulation clearly show that variation de-
creases with increasing population size. For instance, for a population of 1,000 individuals, the
interquartile range is between the levels of 0.58 and 0.92. However, this finding only partially
explains the variation that is evident in Figure 3.5 ,because even in 1960, more than 10,000
males and females were alive at age 80 in Sweden, one of the smallest countries analyzed.
A separate analysis by period and country also does not explain the variation. Therefore, the
analysis was further restricted to countries with the best grade of data quality (Jdanov et al.,
2008), high life expectancy, and a combined population size of at least 10 million individuals
at the respective ages for the years 2005–2010. Using these criteria, the sample of countries
consists of Belgium, France, Germany, West Germany, Italy, and Japan. The results of this
more restricted analysis show a median value of 0.799 for females (IQR: 0.775–0.829; prob-
ability of dying: 0.55%), and no clear pattern for males. Hence, the median value is 1.246
(1.1324–1.5487; 71%). The considerable difference for males is primarily driven by the vari-
ation in the variance of the gamma-distribution (γ).
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Figure 3.5.: Empirical Density Function of Mortality Plateaus for Women and Men,
1960–2010. Data for Australia, Austria, Belgium, Canada, Denmark, Finland,
France, Germany (West), Italy, Japan, Norway, Spain, Sweden, Switzerland, the
United Kingdom, and the United States. The red curve is estimated density for
women, and the blue curve is estimated density for men for the same countries
and years. The horizontal rectangles are interquartile ranges of the mortality
plateaus for both sexes combined (gray), women (red), and men (blue). The cal-
culations are based on death counts and exposures from the Human Mortality
Database (2016).
Gampe (2010) estimated a level of 0.7 for the late-life mortality plateau, which is also the
upper boundary of age-specific mortality. Of the 637 individuals included in Gampe’s analy-
sis, 573 were females. Thus, her estimates were mainly driven by female mortality trajectories.
However, our results for females are not in line with Gampe’s estimates, as we found a level of
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0.8 for females. For males, we estimated an even higher level of 1.2. Given that Gampe’s esti-
mates are based mainly on females, the sex-specific differences are less surprising. However,
the strong variation across the 16 countries and years analyzed is much more worrisome. All
of our efforts to restrict the analysis failed to considerably reduce these variations. Therefore,
we can carefully claim that our analysis provides evidence of a mortality plateau for females
at a level of 0.8. For males, however, the results are much less clear.
3.4. Cluster conclusion
The age-specific boundaries of mortality can be regarded as extreme cases of the mortality
trajectory. In both cases, humans have characteristics that make them more or less likely to
die. but for the lower boundary, it is not clear whether and, if so, how the continuity of mor-
tality improvements has affected the development. For the upper boundary, the changing age
pattern of mortality improvement might act as an additional force of change. Based on this
starting point, this cluster aimed to assess and explore the development at the boundaries of
age-specific mortality, with a special focus on the lower boundary.
Three key characteristics of the lower boundary — level, location, and sex-specific differ-
ence — have been investigated for this purpose. Given the continuity of mortality improve-
ments, the lower level might be of special interest. Our results show that minimum mortality
has declined continuously across almost all of the countries analyzed, and particularly among
the most recent cohorts. These findings support the expectation that the minimum mortality
levels for both males and females are also likely to decrease in the near future. Apart from
some rare exceptions such as Russia, all of the countries analyzed exhibit strong declines in
the lower boundary over the study period. Moreover, in the majority of these countries, a
stable pattern of improvement could be observed in the cohorts born since the 1970s. Hence,
even after more than 160 years of continuous mortality improvements, opportunities for fur-
ther improvements in the lower boundary of age-specific mortality remain. The results also
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showed higher levels for males in the most recent periods. However, this has not always been
the case. Among the oldest cohorts analyzed, females exhibited higher levels. More detailed
investigations will be needed to explain this development and the excess male mortality in the
most recent cohorts.
The location of minimum mortality decreased over time. Changes in related mechanisms,
such as pubertal timing, are promising candidates for explaining this pattern. The location is
also of general interest for mortality change, because at the minimum mortality age, the physi-
ological and social constitutions of humans are most capable of withstanding death. Following
Belsky et al. (2015), we could argue that aging research should focus on the age groups that
are still in the very early stages of the aging process. In their study, they focused on individuals
aged 26–38. Minimum mortality as such marks the inflection point between decreasing and
increasing mortality, and could thus be interpreted as the point at which aging begins. Hence,
investigating the aging process starting from the age of minimum mortality might be even
more intriguing. We could then ask the following questions: Are there some lessons we can
learn from the findings on minimum mortality about how aging and mortality might be post-
poned to or altered at later ages? Are we able to extend minimum mortality levels to the point
of developing a second mortality plateau at younger ages? Or does minimum mortality reflect
the baseline level of mortality if humans did not age? These are all non-trivial questions for
which there may be no clear answers. However, they invite further investigation of the lower
boundary of human mortality.
For the upper boundary, only the level has been investigated. It turned out that conducting
this analysis alone was an ambitious undertaking. The results for males do not allow us to
make any reliable claim about the level of the late-life mortality plateau. Although our results
support the existence of such a plateau for males, further analysis is required. More impor-
tantly, we will have to wait until the number of male centenarians and semi-supercentenarians
is higher. The results for females suggest a level of 80 deaths per 100 person-years lived. This
is slightly higher then the level of 70 deaths per 100 person-years lived calculated by Gampe
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(2010) using an alternative estimation procedure. The currently available data and our analysis
setting do not permit to make any claims about time trends and changes in the location of the
plateau.
When we look at the lower and the upper boundary together, it becomes clear that the
span of age-specific mortality has increased, and is likely to increase further. This trend is at-
tributable to a decrease in the lower boundary. This is an important finding for the development
of mortality forecasting approaches in particular. These methods are designed to capture and
to map the complete pattern and range of age-specific mortality. Hence, these approaches are
needed to capture even bigger ranges of age-specific mortality, and so far do not require any
assumptions about the minimum values until death rates are allowed to decline. The insights
we gained are also of interest for those studying the frontiers of human mortality improve-
ment. It seems that we are still far from reaching the frontiers at the lower boundary. For the
upper boundary, however, it is difficult to interpret the results in light of potential frontiers.
Using sophisticated approaches and data that cover time trends and include an investigation of
the location of the mortality plateau could help to uncover clues about the upper frontiers.
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an era of old-age mortality decline
4.1. Cluster objectives
The onset of sustainable declines in old-age mortality had a wide range of implications for
disease and mortality dynamics. In particular, lifespan disparity as an indicator of mortal-
ity dynamics has been affected by the change in the age pattern of mortality improvement.
In a long-term perspective, life expectancy and lifespan are closely related: life expectancy
increased, while lifespan variability decreased (Colchero et al., 2016). This dynamic is com-
monly labeled “compression of mortality”; a concept that was introduced in the seminal article
by Fries (1980). However, the onset of the old-age mortality decline led to the emergence of
new patterns that have been characterized as “expansion of mortality” and “shifting of mortal-
ity” (Rothenberg et al., 1991; Engelman et al., 2010; Canudas-Romo, 2008; Kannisto, 1996;
Bongaarts, 2005). Each of these concepts describes different relationships between mean
lifespan and lifespan dispersion. In particular, the shifting of mortality – a shift of the lifes-
pan distribution to higher ages with an approximately constant shape – has been viewed as
the successor to the compression of mortality pattern(Canudas-Romo, 2008; Kannisto, 1996;
Bongaarts, 2005). In this scenario, life expectancy increases alongside stagnating lifespan
variability.
The shifting of mortality is also an appropriate scenario for mortality change, under which
a pattern referred to as the “postponement of senescence” could proceed. The postponement
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of senescence describes a delay in the physical aging process of humans to higher ages, as
distinct from a mere slowing of this aging process. Vaupel (2010) argued that this concept
describes the pattern of changes in the occurrence of diseases and deaths at the population
level, at least since the onset of the sustainable declines in old-age mortality. However, he
also argued that the pattern of health improvements is much less clear than the dynamics of
mortality improvement (Vaupel, 2010). Therefore, the postponement of senescence might be
only one possible scenario that describes how mortality dynamics are altered through changes
in health dynamics. From this example, however, it becomes clear that mortality changes
must be accompanied by changes in health patterns. Moreover, Christensen et al. (2009), for
instance, have reported improvements in several health measures over time.
Considering the complexity of mortality and health dynamics and its effects on several other
aspects of mortality and health, which are generated with the onset of the sustainable declines
in old-age mortality, measuring and quantifying these patterns poses challenges for existing
models and measures. Moreover, the future trajectories of mortality and health patterns are
highly dependent on the extent to which the opportunities for further lifespan extension at the
highest ages are exploited. Therefore, the methods and models applied in this context should
also be able to capture any new dynamics that may arise. However, given the enormous
thematic range in this field, the work in this cluster focuses on three specific phenomena:
• the rectangularization of the survival curve;
• the effects of increasing longevity and changing disease incidence on the lifetime risk
of getting a specific disease; and
• the contributions of different mortality dynamics to the increase in life expectancy.
With a focus on these three phenomena, the objective of this cluster is to provide solutions
for the problems and the incidences of theoretical misspecification that are generated by the
sustainable decline in old-age mortality. Our aim is to develop novel or refined tools and mea-
sures that provide deeper insights into recent changes, and that allow us to evaluate and gain a
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better understanding of potential developments.
Papers in this cluster:
Ebeling, Rau , Baudisch (2018). Rectangularization reconsidered: the maximum inner
rectangle approach. Published in Population Studies.
Ebeling, Modig, Ahlbom, Rau (2018). The effects of increasing longevity and changing
incidence on lifetime risk differentials: a decomposition approach. Published in PLoS
ONE.
Appended paper: Bergeron-Boucher, Ebeling, Canudas-Romo (2015). Decomposing
changes in life expectancy: compression versus shifting mortality. Published in Demo-
graphic Research.
4.2. Outcomes for rectangularization of the survival
curve
4.2.1. Objectives
The rectangularization of the survival curve describes the increasingly rectangular shape of
the survival curve due to the postponement of deaths to higher and higher ages. This concept
has become instrumental to the description and the analysis of the compression of mortality.
Although this phenomenon has been described in earlier work (Pearl and Miner, 1935; Com-
fort, 1956), extensive research has been conducted since its recognition in the seminal article
by Fries (1980). Most of this research has been focused on proving or disproving Fries’ ideas
(see among others Nagnur, 1986; Nusselder and Mackenbach, 1996; Cheung et al., 2005; My-
ers and Manton, 1984).
However, given the current state of knowledge, it can clearly be stated that several of the
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assumptions Fries made in formulating his initial concept have become obsolete. Most impor-
tantly, reductions in oldest-old mortality were not anticipated in the original framework. The
emergence of this trend in turn invalidated several (partly implicit) assumptions of Fries’ the-
ory. For example, the idea that life expectancy has “looming limits” has been rejected (Oeppen
and Vaupel, 2002; Vallin and Meslé, 2009); the contributions of premature mortality improve-
ments to increases in life expectancy have become negligible (Christensen et al., 2009); and
Fries’ assessment (p. 130) that “[. . . ] there has been no detectable change in the number of
people living longer than 100 years [. . . ]” has been disproven (e.g., Vaupel and Jeune, 1995;
Vaupel, 2010). Although we have not witnessed an increase in the maximum observed lifes-
pan since the death of Jeanne Calment at age 122 in 1997 (Robine, 1998), Fries’ prediction
(p. 133) that “human life span may not be fixed but may be slowly increasing, perhaps a month
or so each century” had already been exceeded by more than an order of magnitude with the
increases that occurred between 1980 and 1997 (Wilmoth et al., 2000).
Furthermore, life expectancy gains can only be generated in Fries’ framework by a de-
crease in lifespan variability (see, for instance, also Nagnur, 1986; Nusselder and Macken-
bach, 1996). Compression would be completed when “under ideal conditions” (Fries, 1980,
p. 132) lifespans were scattered in a normal distribution around a mean of 85.6 years, with a
standard deviation of about four years (in 1989, Fries assumed wider intervals). Moreover, a
newly emerging pattern such as the shifting of mortality does not lead to further rectangular-
ization, but to increasing life expectancy (Kannisto, 1996; Bongaarts, 2005; Canudas-Romo,
2008). It is also clear that the almost constant difference between the mean and the modal age
at death (Canudas-Romo, 2010) cannot be combined with normally distributed deaths across
age, even with historically low levels of premature mortality.
Despite all of these drawbacks and flaws, the general underlying idea of rectangularization
remains simple and intuitive, which makes the concept appealing. Furthermore, rectangular-
ization is one of the few theoretical frameworks that incorporates the relationship between
lifespan disparity and life expectancy. For these reasons, and in light of its frequent use in
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mortality and health research, we believe that this concept should be refined and extended to
allow for an incorporation of recent and potential mortality changes.
4.2.2. Maximum inner rectangle approach (MIRA)
When we attempt to extend the concept of rectangularization beyond its classical application
and seek to incorporate recent and potential mortality changes into it, several issues arise.
First, the rectangularization framework needs to be detached from its static perspective. In-
stead, the framework should dynamically capture mortality changes at all ages, and not just in
the premature age range. Second, it would be beneficial if the concept included a measurement
approach capable of differentiating between and quantifying premature/early and late changes
in age-specific mortality. Third, it would be desirable if an extension of Fries’ framework still
allowed us to determine whether there are any impending limits to lifespan.
The framework proposed here, which is called the “maximum inner rectangle approach”
(MIRA), is designed to address those issues. The approach uses two dimensions of rectangu-
larization. We call the classical perspective “outer rectangularization” because it relates the
survival curve, and, accordingly, life expectancy, to the maximum living potential. Hence,
it compares the current experience with a theoretical maximum. There is, however, another
perspective, which we call “inner rectangularization,” that has so far largely been neglected.
Defined as the rectangle with the largest area under the survival curve, it relates current lifes-
pan equality to current life expectancy. The basic idea is illustrated in Figure 4.1. The bold
solid line denotes a hypothetical survival curve starting from a radix of one and reaching zero
at the highest attainable age ω. The thin solid line denotes the classic reference used to esti-
mate the advancement of rectangularization: namely, the outer rectangle, which also expresses
the maximum living potential. The dashed line depicts the newly proposed concept: namely,
the maximum inner rectangle.
Outer rectangularization is the standard perspective of rectangularization, and captures
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Figure 4.1.: Survival curve and its maximum inner rectangle and outer rectangle. Own
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progress in mean lifespan,e0, relative to progress in maximum lifespan, ω. The latter can
be interpreted as the “the maximum living potential,” which also defines the outer frame of
the survival curve or the outer rectangle. It counts the hypothetical number of person-years
that could be lived in a population if everyone survived to the maximum age and then died. In
comparison, the actual number of person-years lived in a population corresponds to the area
under the survival curve, and determines mean lifespan. Mean and maximum lifespan serve
to capture the degree of outer rectangularization of the survival curve. We define the outer
rectangle ratio (ORR) as
ORR =
ω∫
0
la da
ω
=
e0
ω
, (4.1)
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with la being the survival function at age a. The maximum age should be able to move forward
or backward depending on the underlying mortality development. Therefore, we link ω to a
specific survival proportion (k) – such as 1% of the population still alive – so that lω = k.
By definition, 0 ≤ ORR ≤ 1. The ratio relates the observed to the maximum possible
number of person-years lived in a population. For example, if ORR = 0.8, then current living
conditions allow the population to exploit 80% of current maximum lifespan potential.
Inner rectangularization adds a new perspective. In contrast to the outer rectangle, we seek
the largest rectangle under the survival curve. Any inner rectangle (IR) under the survival
curve is horizontally defined by age, x; and is vertically defined by survival to that age, lx.
Consequently, the corresponding area is IRx = x · lx. The first age derivative of IRx then
identifies the age x∗ that corresponds to the maximum inner rectangle (MIR) with an area of
MIR = x∗ · lx∗ (4.2)
as the solution to
d IRx
d x
= 0. (4.3)
Although there is no closed form solution, x∗ can be found numerically given that
µx > 0 ∀ x ∈ [0, ω], (4.4)
where µx denotes the force of mortality (see original paper for further details).
MIR counts “maximum uniformly shared person-years.” It is determined by the maximum
shared lifespan (x∗) and the survival proportion up to this lifespan (lx∗). At ages x < x∗,
the share of the population receiving an equal number of person-years would be larger than
lx∗ , but the number to be received per individual would be smaller than x∗. Likewise, at ages
x > x∗, the number to be received per individual would be larger than x∗, but the share of
the population receiving an equal number of person-years would be smaller than lx∗ . In both
cases, the total number of uniformly shared person-years would be reduced.
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Using this definition of MIR allows us to add an inner perspective to the process of rectan-
gularization. In analogy to the maximum living potential (ω), we can interpret life expectancy
(e0) as a population’s current theoretical maximum number of life years that could be shared
uniformly. Accordingly, with perfectly uniform lifespans, 100% of individuals in a popula-
tion would share a lifespan of length e0. When, however, actual lifespan equality is measured
by MIR, a maximum survival fraction of lx∗ < 100% shares a uniform lifetime of at most
x∗ years. Thus, by relating MIR to e0, we define inner rectangularization as the process of
a population approaching its current lifespan equality potential. It is measured by the inner
rectangle ratio (IRR), which is given by
IRR =
MIR
e0
. (4.5)
The inner rectangle ratio captures a trend that differs from that of the outer rectangle ratio,
because changes in the MIR do not require a change in the mean or the maximum lifespan.
Indeed, the trend could be characterized by a constant mean and a falling maximum lifespan,
or by an increasing mean but a constant maximum lifespan, or even by a falling mean and a
falling maximum lifespan. Though closely related, the inner rectangle ratio differs from the
outer rectangle ratio because it is essentially an index of lifespan equality, while the outer rect-
angle ratio is an index of exploiting maximum living potential. Accordingly, if IRR = 0.8,
then current living conditions allow the population to exploit 80% of its current lifetime equal-
ity potential.
Table 4.1 summarizes the quantities presented here, as well as additional areas and specific
ages included in the MIRA. The table provides the name and the acronym of each measure,
its mathematical expression, and a short interpretation of it.
As far as we know, there are no demographic predecessors to our concept of inner rectan-
gularization. Thus, the age maximizing the inner rectangle provides a novel point of reference
indicating maximum shared lifespan. This point represents the optimal trade-off between past
lifetime and a sufficient number of survivors in terms of lived person-years. Hence, the princi-
ple of inner rectangularization rests on identifying the optimal combination of two (inversely
58
4. Cluster III – Mortality dynamics in an era of old-age mortality decline
Table 4.1.: Quantities of the maximized inner rectangle approach (MIRA).
Name Acronym Expression Interpretation
inner rectangle IRx xlx Age-specific uniformly shared person years
(PY)
maximum shared lifespan x∗ max[xlx] Maximum number of uniformly shared life
years by largest number of survivors
maximum proportion lx∗ lx∗ Largest proportion alive at the maximum
shared lifespan
maximum inner rectangle MIR x∗lx∗ Population’s current maximum amount of
uniformly shared PY
life expectancy e0
ω∫
0
la da Population’s current amount of PY, i.e. mean
lifespan
outer rectangle ω ωl0 Maximum possible PY
inner rectangle ratio IRR MIRe0 Proportion of uniformly shared PY from all
PY lived
outer rectangle ratio ORR e0ω Proportion of PY lived from maximum pos-
sible PY
total rectangle ratio TRR MIRω Proportion of uniformly shared PY lived on
maximum possible PY
related) inputs, age and survival, which unify the biggest area under a curve representing their
respective relationships. Such measures have previously been applied elsewhere. For instance,
the Hirsch index, or the h-index, measures the productivity and the citation impact of scientists
(Hirsch, 2005). It depicts “x publications of a scientist have been cited at least x times.” The
geometric equivalent is a list of all publications by a scientist (y-axis) sorted by the number of
citations (x-axis). This approach is similar to our application, where the survival curves could
be interpreted as a sorted list of life lengths (x-axis) of the population (y-axis).
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4.2.3. Materials and data
MIRA quantities are computed using period life tables, which we estimated from death counts
and corresponding exposures from the Human Mortality Database (2015a). We have chosen
to highlight the trajectories of females in Sweden, Denmark, and Italy because these three
countries provide three exemplary mortality developments. Furthermore, all three countries
have sufficient data coverage over time. In estimating x∗ and lx∗ , a key challenge we faced was
that the data are only available in discrete integer units, but x and lx need to be continuous. We
estimated x∗ in two steps. First, we smoothed the product of x and lx with cubic splines using
R’s splinefun() function (R Core Team, 2017), which allows us to evaluate the function
value at arbitrary precision. Second, we used R’s general purpose univariate optimization
function optimize() to find the maximum. A similar two-step approach with splines has
been used in previous mortality research to estimate the modal age at death (Ouellette and
Bourbeau, 2011). Other age estimates, such as ω or the threshold ages discussed in the next
section, have been calculated using the same procedure.
In several empirical studies on rectangularization, the maximum age ω was not set at the
actual age at which there were no survivors left in the life table population. Wilmoth and
Horiuchi (1999), for instance, set the cutoff age at the point at which 0.1% of the population
are still alive. Rossi et al. (2013) used the 10% threshold; and, most recently, Schalkwijk et al.
(2016) used the 0.1%, 1%, and 10% thresholds. In our study, we opted for a threshold of
1%. Sensitivity analysis revealed that the actual choice for lω had only minor effects on the
results. As the maximum age changes with varying survival fractions, the estimates of TRR
and ORR change quantitatively. However, the patterns of the ratios remain stable over time.
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4.2.4. Illustrative examples of the inner, the outer, and the total
rectangle ratio
Each panel in Figure 4.2 depicts the inner (IRR, black line), the outer (ORR, light gray), and
the total rectangle ratio (TRR, dark gray) for females in Italy (upper left), Denmark (upper
right), and Sweden (lower left). Figure 4.2 illustrates the following key points:
Two important empirical findings can be derived from the results presented in Figure 4.2.
First, we found that outer rectangularization has shown continuous gains over time. This is
a consequence of the straight linear increase in life expectancy (Oeppen and Vaupel, 2002),
which has been faster than the increase in the longest lifespans, as measured by ω. However,
we also detected a considerably slower pace of outer rectangularization since the middle of
the 20th century. Additionally, we saw no convergence of the TRR to the ORR. Both have
been developing almost in parallel for about 160 years. If Fries’ ideas were correct, we would
expect to observe that the TRR undergoes a period of “catching-up” to the ORR until Fries’
“ideal conditions” of a life expectancy of about 85 years are reached. So far, none of the
selected countries has reached this level of life expectancy. Consequently, we should see a
continued narrowing of the gap. It is therefore clear that Fries’ concept of rectangularization
needs to be revised.
Second, we found that inner rectangularization also increased rather uniformly until around
1950; and that the patterns thereafter cannot be summarized with a general trend, because they
are rather country-specific: i.e., there was a steady increase in Italy, a slow increase in Swe-
den, and a slight dip in Denmark for two decades starting in about 1970. The country-specific
patterns suggest that the forces behind this development vary. For instance, the steady increase
in Italy suggests that the rise in life expectancy was accompanied by more growth of the maxi-
mum inner rectangle. The almost stagnating IRR in Sweden between 1960 and 1990 suggests
that life expectancy increased in line with the maximum inner rectangle. Denmark’s deviant
dynamics suggest that the maximum inner rectangle was declining while life expectancy stag-
nated. The differences across countries appear to be attributable to the variation in the onset of
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Figure 4.2.: Inner rectangle ratio, outer rectangle ratio and total rectangle ratio, Italy
(1872-2012), Denmark (1850-2011), and Sweden (1850-2014), females, 1850-
2013. All calculations are based on period life tables in the respective year. The
calculation is based on death counts and exposures from the Human Mortality
Database (2015a).
sustained mortality declines among the oldest-old (Kannisto, 1994), as well as to other factors,
such as smoking among Danish women (e.g., Juel et al., 2000; Jacobsen et al., 2002; Lindahl-
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Jacobsen et al., 2016), and reforms of the health care system (Mackenbach et al., 2011; Peters
et al., 2015).
In this context, the inner rectangle ratio highlights how evenly the magnitudes and the trends
(decrease or increase) of age-specific mortality changes are spread over age. We believe that
these outcomes provide us with a new perspective on lifespan variability. Our intuition is
strengthened by our finding of a correlation between the IRR and other summary measures
of lifespan variability (see the original article for further details). This pattern is especially
pronounced for the time period in which gains in premature survival were instrumental for the
increase in life expectancy.
4.2.5. Applying the MIRA to separate premature from old-age
mortality
Premature and old-age mortality are terms that are frequently used in mortality research, but
they are often loosely defined, which might be sufficient for many applications. However,
in analyzing rectangularization, how these terms are defined is a crucial issue. In Fries’ de-
scription, premature mortality plays a central role. He argued that premature mortality decline
drives the process of rectangularization, and implicitly assumed that premature mortality im-
provements alone are generating life expectancy increase. While how Fries defines premature
ages is unclear, his descriptions suggest that he views life expectancy as a threshold. We argue
that x∗ can be interpreted as an age that allows us to separate premature from old-age mortal-
ity. Accordingly, the threshold in MIRA is based on the longest lifespan that is shared by the
largest fraction of the population.
Figure 4.3 illustrates the relationship between x∗ (horizontal axis) and lx∗ (vertical axis);
i.e., the coordinates for measuring the number of maximum uniformly shared person-years,
again for females in Italy, Denmark, and Sweden. The number of life-years lived in the max-
imum inner rectangle is depicted in the gray contour lines. The two time periods 1850–1950
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Figure 4.3.: Scatterplot between x∗ and lx∗ , females, Italy (1872-2012), Denmark (1850-
2011), and Sweden (1850-2014). All calculations are based on period life tables
in the respective year. Lines are based on a locally weighted smoothing to high-
light the patterns only. Additionally, contour lines visualize the corresponding
number of person-years lived in equality (MIR), since this is determined by the
product of both. The calculation is based on death counts and exposures from the
Human Mortality Database (2015a)
and 1951–2014 are illustrated by dashed and solid lines, respectively.
The share of the life table population dying at old ages is denoted by lx∗ . Consequently,
1− lx∗ equals the proportion dying prematurely. Generally, two trends can be distinguished: a
“vertical” development (until 1950) and a “horizontal” development (after 1950). Premature
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mortality improvements drove progress until 1950, which is illustrated by the increasing share
of survivors. With improving old-age mortality, x∗ shows an accelerated movement toward
higher ages; whereas the corresponding survival fraction at x∗ (lx∗) shows only small gains.
To compare the trajectories resulting from the MIRA, we also analyzed the relationship be-
tween the threshold ages and the corresponding surviving proportions (see the original article)
for the alternative approaches by Zhang and Vaupel (2009) and Gillespie et al. (2014), which
are based on the variance (Gillespie et al., 2014) and the number of life years lost (Zhang and
Vaupel, 2009). These estimates show similar trends. However, within the 150 years of life ex-
pectancy development analyzed, the proportion dying at old age had changed relatively little
under the threshold ages suggested by Zhang and Vaupel (2009) and Tuljapurkar et al. (2000).
In both cases, the change amounted to less than 15 percentage points; a shift we consider to
be rather small. In contrast, our measure shows a shift of about 65 percentage points, from
20% dying at old age in 1850 to about 85% dying at old age in the most recent years. These
numbers seem to be more in line with the findings of, for example, Christensen et al. (2009),
who estimated that almost 80% of recent gains in life expectancy for Japanese women were
caused by survival improvements among the elderly.
The patterns of all three approaches suggest that there was a switch at around 1950 from
avoiding premature deaths to extending the premature age range. This dynamic also points
to a potential minimum proportion of individuals dying prematurely. Depending on the un-
derlying definition of threshold ages, the share dying prematurely varies between 10%–15%
(MIRA), 15%–20% (Gillespie et al., 2014), and 30%–35% (Zhang and Vaupel, 2009) un-
der current mortality conditions. Hence, Fries’ prediction that premature mortality would be
almost completely eradicated seems rather unlikely. We can, however, see that the definition
and the measurement of premature mortality are issues that have been unresolved at least since
Lexis (1877).
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4.3. Outcomes for estimating the effect of increasing
longevity and changing disease incidence on the
lifetime risk of getting a specific disease
4.3.1. Objectives
Summary measures of population health combine information on mortality and health out-
comes to indicate population health within a single index (Murray et al., 2000). Moreover,
these summary measures are useful in several situations, such as when analyzing the benefits
of health interventions, identifying and quantifying health inequalities within the population,
or monitoring changes in the health of a population and comparing levels of health across pop-
ulations (Murray et al., 2000). Especially for the last two purposes, understanding differen-
tials of summary measures between different time points or populations is essential. However,
these differentials are not always easy to interpret because of confounding factors, such as the
age structure of the population. To address these specific problems, decomposition techniques
are applied (Canudas-Romo, 2003). These methods allow us to quantify the contributions of
specific components to these differentials.
To examine the nature of such changes, Vaupel and Canudas-Romo (2002) provided a gen-
eral procedure for the decomposition of population averages, which include a wide range of
population summary measures. In addition to providing a formal derivation, they proposed a
framework consisting of three different kinds of explanations that can be adapted to almost any
evaluation of population summary measure differentials. They defined a level-0 explanation,
which includes data or methodological problems. Their level-1 explanation refers to direct
changes in the quantity of interest, such as improving health. The level-2 explanation captures
possible confounding effects, such as changes in the population age structure. Given a specific
population summary, decomposition methods allow us to quantify the contributions of fac-
tors belonging to level-1 or level-2 explanations, respectively. For many summary measures,
such decomposition techniques have already been developed (see, for instance, Nusselder and
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Looman, 2004).
The lifetime risk of getting a disease is another specific example of a summary measure. It
expresses the probability of developing a certain disease throughout one’s lifetime or from a
certain age onward (remaining lifetime risk). It is a useful indicator for monitoring the burden
of a disease in a population, and is frequently used in cancer research (Sasieni et al., 2011;
Wun et al., 1998; Feuer et al., 1993; Goldberg et al., 1956). In many studies, lifetime risk is
estimated based on longitudinal data for cohorts, such as the Rotterdam study, the Framing-
ham Heart Study, or population register data (Heeringa et al., 2006; Vasan et al., 2002). In
these approaches, lifetime risk refers to the observed lifetimes of individuals. However, life-
time risk has also been calculated using cross-sectional data (Sasieni et al., 2011; Goldberg
et al., 1956; Karampampa et al., 2015). In such an analysis, lifetime risk rests on observed
disease and death patterns at a specific point in time. For at least two reasons, using cross-
sectional lifetime risks is a valuable alternative to relying on estimates based on longitudinal
data. First, the data requirements are much lower when using lifetime risk, since having data
with a sufficiently long follow-up time is not necessary. Second, a cross-sectional lifetime risk
summarizes the current burden in a population, whereas a lifetime risk based on longitudinal
data primarily summarizes past trends. Hence, a cross-sectional lifetime risk is a useful indi-
cator for the above-mentioned situations in which summary measures are applied.
When calculating lifetime risk, the death (mortality rates) and disease (incidence rates) pat-
terns at a specific point in time are assumed to apply as if a real cohort were passing through
time. Accordingly, the disease of interest and death as the competing risk are the two possi-
bilities for exiting from the population. The resulting lifetime risk estimate is determined by
age-specific incidence and survival. Hence, differences in lifetime risk over time or between
populations can arise from differences in incidence or in survival, but changes in just one of
the two are unlikely in reality. Indeed, different authors have acknowledged that comparisons
of cross-sectional lifetime risks suffer from increasing longevity, and thus from the interplay
of mortality and health changes (Sasieni et al., 2011; Karampampa et al., 2015). For example,
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a study on hip fractures documented an increasing lifetime risk, despite declining age-specific
incidence rates (Karampampa et al., 2015).
Given that old-age mortality declines appear to be sustainable, a pivotal task we face is to
better understand the influence of mortality dynamics on population summary measures of
health. Using lifetime risk as a specific example, our research question may be formulated as
follows:
• How much of the change in lifetime risk can be attributed to (I) changing survival; and
(II) how much can be attributed to changing disease incidence?
Hence, the objective of this study is to provide a methodological solution for the outlined
problem that allows us to answer this question.
4.3.2. Decomposition approach for lifetime risk differentials
Assuming that incidence rates depict the first occurrence of the disease of interest, the rate of
either dying or getting diagnosed at age x, µx, can be written as
µx = mx + Ix (4.6)
where mx is the death rate at age x and Ix is the incidence rate of getting a disease at age x
(Sasieni et al., 2011; Ahmad et al., 2015). The probability of staying alive and healthy within
one age interval x can be expressed by exp[−µx]1. Hence, the fraction alive and healthy at age
xi can be calculated by exp[−
∑
x≤y<xi
µy]
2. The lifetime risk of contracting a disease from age
1To allow readers to comprehend the omitted steps and further details, the notation in this part of the thesis is
similar to that in the original paper. This notation differs from that used in the rest of the thesis.
2Please note that the equations in this part differ from those published in the original article. In the original
article, the equations, which express survival, contain an incorrect summation index. Please see the correction
attached to the original article for further details. At the time of the submission of this thesis, an official
correction was processed by the journal.
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x onward, lrx, can then be calculated by
lrx =
∑
x≤xi≤ω
Ixi exp[−
∑
x≤y<xi
µy] =
∑
x≤xi≤ω
Ixi exp[−
∑
x≤y<xi
Iy] exp[−
∑
x≤y<xi
my], (4.7)
where ω denotes the highest age attained.
We are interested in decomposing the change in the lifetime risk of contracting a given
disease; denoted with ∆, between two time points A and B, or, more generally, the difference
between two populations:
∆ = lrx,A − lrx,B. (4.8)
In the further derivation, we write φxi for Ixi exp[−
∑
x≤y<xi
Iy] and lxi for exp[−
∑
x≤y<xi
my].
Given the general definition of lifetime risk of Equation 4.7, we can then rewrite Equation 4.8
to
∆ =
∑
x≤xi≤ω
[lxi,A − lxi,B]
φxi,A + φxi,B
2︸ ︷︷ ︸
Contribution of Changing Survival Conditions
+
∑
x≤xi≤ω
[φxi,A − φxi,B]
lxi,A + lxi,B
2︸ ︷︷ ︸
Contribution of Changes in Incidence
. (4.9)
Equation 4.9 provides two distinct interpretable terms (see the original paper for further details
on the derivation). The left term expresses the contribution of changing survival conditions
to the difference in the lifetime risk between populations A and B. The right term expresses
the contributions of changes in disease incidence to the difference in the lifetime risk be-
tween populations A and B. Note that the methodological outline is based on previous studies
that provided general results for mathematical problems of this kind (Kitagawa, 1955; Gupta,
1991).
Table 4.2 presents three hypothetical examples to that illustrate the decomposition as pre-
sented in Equation 4.9. In the first example (I), survival improves as reflected in the lx–
columns, while the incidence proportions are unchanged. The lifetime risk rose by 12 per-
centage points from lrA = 0.24 to lrB = 0.36 . Because we subtracted B from A, we obtained
a negative value. The contribution to the increase in the lifetime risk from changes in the inci-
dence proportions (last column) is obviously zero, since iA,x and iB,x do not differ at any age.
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Table 4.2.: Illustration of the decomposition method with hypothetical examples.
(I) Changes in age-specific survival. (II) Changes in age-specific incidence.
(III) Changes in age-specific survival and incidence. In all three examples, we
decomposed the change from A to B (A−B).
Contribution of Change
in Age-Specific
Scenario Age x lA,x lB,x φA,x φB,x Survival† Incidence‡
1 1.0 1.0 0.0 0.0 0.00 0
(I) Change in 2 0.7 0.8 0.2 0.2 -0.02 0
Survival 3 0.2 0.4 0.3 0.3 -0.06 0
4 0.1 0.2 0.4 0.4 -0.04 0
lrA = 0.24 lrB = 0.36 ∆ = −0.12
∑
-0.12 0
1 1.0 1.0 0.0 0.0 0 0.00
(II) Change in 2 0.7 0.7 0.2 0.1 0 0.07
Incidence 3 0.2 0.2 0.3 0.4 0 -0.02
4 0.1 0.1 0.4 0.2 0 0.02
lrA = 0.24 lrB = 0.17 ∆ = 0.07
∑
0 0.07
1 1.0 1.0 0.1 0.2 0.000 -0.100
(III) Changes in 2 0.5 0.8 0.2 0.1 -0.045 0.065
Survival and Incidence 3 0.3 0.4 0.3 0.4 -0.035 -0.035
4 0.1 0.2 0.4 0.2 -0.030 0.030
lrA = 0.33 lrB = 0.48 ∆ = −0.15
∑
-0.11 -0.04
† Estimated by first part of Equation 4.9.
‡ Estimated by second part of Equation 4.9.
As expected, the difference in the lifetime risk can be completely attributed to improvements
in survival.
A complementary picture is provided by the second example (II). Age-specific survival
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does not differ between time points A and B. Instead, the age-specific incidence proportions
changed over time. The overall reduction in lifetime risk of 0.07 is therefore equivalent to the
sum of the contributions from the different age categories.
Although all of the examples are hypothetical, the third example (III) is probably closest
to reality because the contributions to lifetime risk differences originate from changes in age-
specific survival, as well as from changes in age-specific incidence proportions. The lifetime
risk increased by 15 percentage points, from 0.33 to 0.48. Our decomposition method allows
us to disentangle the overall effect into contributions due to varying mortality conditions and
varying age-specific incidence proportions. It turns out that the increase in lifetime risk is due
to a combination of higher incidence proportions and higher survival. In addition to offering
this qualitative assessment, we can state that improved survival contributed almost three times
more (0.11) to the increase in lifetime risk than the actual incidence risk (0.04).
4.3.3. Materials and data
We also applied the method to the remaining lifetime risk of being diagnosed with myocardial
infarction, colorectal cancer, or hip fracture among Swedish males at age 60. Note that the
decomposition can be applied to lifetime risk starting at any age. For the different diseases, we
compared the lifetime risk between two different time points. These time points are 1987 and
1994 for colorectal cancer, 1994 and 2014 for hip fractures, and 1994 and 2004 for myocardial
infarction.
The incidence estimates for the three disease outcomes were obtained from Swedish registry
data maintained by Statistics Sweden and the National Board of Health and Welfare (Modig
et al., 2013). For myocardial infarction and hip fracture, the first event occurring after age 60
after a seven-year disease-free period was identified using data from the National Patient Reg-
ister. For colorectal cancer, information on the date of cancer diagnosis was collected from
the Swedish Cancer Register. The incidence counts have been smoothed across age and time
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to reduce random fluctuations using the MortalitySmooth package in R (R Core Team, 2017;
Camarda, 2012). In our example, death rates are based on death counts and exposures of the
total Swedish male population provided by the Human Mortality Database (2015b) (see the
original article for a discussion on the impact of using death rates of the total population on
the estimation of lifetime risk).
4.3.4. Decomposition of the lifetime risk of myocardial infarction,
hip fracture and colorectal cancer for Swedish males
The left panel of Figure 4.4 depicts the time trends of lifetime risk for the respective diseases3.
The dots mark the time points that are selected for the decomposition. The selection is based
on the pattern of the respective lifetime risks. Accordingly, for myocardial infarction, we have
chosen the end points of a period with almost stagnating levels of lifetime risk. For hip frac-
ture, the time points mark the boundaries of a period of slightly increasing lifetime risk. For
colorectal cancer, the time points mark the boundaries of a period of increasing lifetime risk.
The right panel illustrates the results of the decomposition. The bars show the contributions of
changing survival and of changing incidence, as well as the total change in the lifetime risk.
In the case of myocardial infarction, the lifetime risks are similar at the two time points,
which could lead us to conclude that there have been no improvements in the incidence above
age 60. However, when applying the decomposition, it becomes clear that the declining in-
cidence should have generated a decrease in the lifetime risk of more than three percentage
points, but that increasing longevity prevented such a decrease from occurring. If mortality
had changed between the two time points, the mortality improvements — and, hence, the
higher number of individuals surviving to older ages — would have resulted in an increase in
3After the adjustment for the incorrect summation index, the empirical results changed slightly. Therefore, the
estimates in Figure 4.4 differ slightly from those in the graph of the original article. Please see the correction
attached to the original article for further details. At the time of the submission of this thesis, an official
correction was processed by the journal.
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Figure 4.4.: Remaining Lifetime Risk at Age 60 and Lifetime Risk Decomposition
for Myocardial Infarction, Hip Fracture, and Colorectal Cancer, Sweden,
Males. Lifetime risk estimates are based on combing death counts, exposures and
disease incidence of a certain period in a multiple-decrement life table. Death
counts and exposures are provided by the Human Mortality Database (2015b).
Information on disease incidence are obtained from Swedish registry data main-
tained by Statistics Sweden and the National Board of Health and Welfare (Modig
et al., 2013).
the lifetime risk of more than 2.5 percentage points. In sum, the counteracting factors resulted
in an overall change in the lifetime risk of less than a half percentage point.
For hip fracture, we observe a slight but steady increase over time in the remaining life-
time risk above age 60. This rise is, however, entirely driven by increasing longevity. Given
the same mortality at both time points, the declining incidence should have contributed to a
decrease in the lifetime risk of more than 1.5 percentage points; whereas given the same in-
cidence at both time points, the survival improvements should have generated an increase of
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more than three percentage points. Accordingly, the total change sums up to an increase of
more than 1.5 percentage points.
Colorectal cancer is an example of a disease for which the lifetime risk increased relatively
steeply over a short period of time. Unlike in the other two examples, the incidence con-
tributed to a rise in the remaining lifetime risk at age 60. Consequently, the incidence between
1987 and 1994 increased. Rising incidence alone should have generated an increase in the
lifetime risk of more than 2.5 percentage points. Moreover, the effects of improving survival
on changes in the lifetime risk are different from those in the other two examples. Because, on
average, colorectal cancer occurred earlier, its impact on longevity advancement was smaller.
Hence, given the same incidence at both time points, the contribution of increasing survival
should have resulted in an increase of slightly more than 0.25 percentage points. Thus, the
total change sums up to an increase in the lifetime risk of more than three percentage points.
As we have seen from these empirical examples, whether increasing longevity influences
the development of lifetime risk, depends on the timing of the respective disease. In recent
decades, mortality improvements have been especially large at higher ages (Christensen et al.,
2009). Accordingly, the lifetime risks of diseases that tend to occur at higher ages are influ-
enced to a greater extent by increasing survival. This is because improved survival causes a
higher number of people to survive to the ages at which disease incidence is highest. Thus,
even when the incidence of a disease is going down, the declines at those ages are offset by the
higher number of people at risk. Conversely, for diseases that tend to occur at ages at which
survival improvements have been marginal, incidence declines of the same magnitude should
have a stronger effect on lifetime risk. That is because the numbers of survivors at those ages
differ only marginally between the two populations.
The decomposition method presented above allows us to quantify these conflicting dynam-
ics. The method can also be extended beyond the application presented here. In addition to
being useful for quantifying the contributions of incidence and survival to changes in life-
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time risk, the general procedure can be adjusted to incorporate the contributions of changes in
disease-related mortality and case fatality.
4.4. Outcomes for estimating the contributions of
different mortality dynamics to the increase in life
expectancy
4.4.1. Objectives
Our main objective has been to gain a better understanding of the influence of mortality
dynamics on changes in summary measures of mortality, particularly in changes in life ex-
pectancy. Several techniques have been developed for decomposing changes in life expectancy
using different components, such as cause of death and age, for discrete (Andreev et al., 2002;
Pollard, 1982; Arriaga, 1984; Pressat, 1985) as well as continuous changes (Vaupel and Romo,
2003; Beltrán-Sánchez et al., 2008; Vaupel, 1986; Keyfitz, 1977; Horiuchi et al., 2008). These
methods have been instrumental to efforts quantify and understand the changing age pattern
of mortality improvement.
With the emergence of alternative patterns of mortality change, there has been an increasing
interest in understanding the contribution of such dynamics to changes in life expectancy. For
instance, Goldstein and Cassidy (2012) investigated how different kinds of mortality change
translate into life expectancy changes. They found that slowing the relative increase of mor-
tality with age would have the biggest impact on the level of life expectancy, given current
levels of mortality. However, alternative dynamics such as a shifting of mortality – i.e., a pure
postponement of deaths to higher ages without changing the relative increase – would also
generate considerable gains in life expectancy.
So far, the compression of mortality and the shifting of mortality have arguably been the
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dominant dynamics that have shaped mortality change since the onset of the sustained decline
in old-age mortality (see among others Fries, 1980; Nusselder and Mackenbach, 1996; Bon-
gaarts, 2005; Canudas-Romo, 2008). Hence, from that point onward, these dynamics have
also driving changes in life expectancy. However, the specific forces generating changes in
life expectancy differ for each of these patterns. The compression of mortality produces gains
in life expectancy through declines in lifespan variability; while the shifting of mortality gen-
erates increases in life expectancy due to changes in the timing of mortality, without having an
impact on lifespan variability. Although the approach by Goldstein and Cassidy (2012) allows
us to quantify the impact of a particular dynamic on the level of life expectancy, it is solely
based on a perturbation analysis. Hence, their method does not allow us to decompose a life
expectancy differential into the respective contributions of the compression and the shifting of
mortality. In general, methods that are designed to quantify the contributions of these dynam-
ics to changes in life expectancy have, until recently, been lacking 4. Hence, the objective of
this study is to provide a methodological approach as well as some empirical results to answer
the following questions:
• What is the impact of the compression and the shifting of mortality on the increase in
life expectancy over time?
• How did one process replace the other, and to what extent did they do so?
4.4.2. Decomposing the contributions of different mortality
dynamics to differentials in life expectancy
The following outline of the decomposition methodology uses the Gompertz mortality model
as an example. However, the general idea can also be applied to other parametric mortality
models (see the original article for results for other models).
4A recent publication by de Beer and Janssen (2016), which provides such an approach, might be seen as a
follow-up to the approach suggested in the article.
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Figure 4.5 shows the distribution of deaths for Gompertz parameters under two scenarios.
It illustrates how changes in mortality can be decomposed into effects due to the compres-
sion and the shifting of mortality. Assuming a general change in mortality between the two
distributions (arrow denoted as A), the shifting effect is the hypothetical change that results
only if the modal age at death (M ) changes between those two distributions (arrow B). The
variability effect (compression) is the hypothetical change produced if only the slope of the
hazard function (β) changes from one distribution to another (arrow C). The latter transforma-
tion C, of changing the slope of the hazard distribution, also changes the shape of the density
distribution, and thus its variability (Wilmoth, 1997).
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Figure 4.5.: Illustration of the shifting and the variability effects in the density function
of the distribution of deaths for simulated data from a Gompertz model.
The different distributions shown rest on the combination of shape parameters
β1 = 0.10 and β2 = 0.13 and modal ages at death M1 = 75 and M2 = 90.
Following the illustration in Figure 4.5, the change in life expectancy at birth over time, e˙0,t,
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can be expressed by
e˙0,t = ∆β + ∆M, (4.10)
where ∆β and ∆M are the gains in life expectancy resulting from changes in the shape pa-
rameter and modal age at death, respectively. Following Vaupel and Romo (2003), a dot on
top of a variable denotes its derivative with respect to time.
Following the work of Horiuchi et al. (2013) and Missov et al. (2015), the Gompertz mortal-
ity model can be calculated using the modal age at death. Accordingly, the force of mortality
can be expressed by
µx,t = βte
βt(x−Mt), (4.11)
where βt is the shape parameter at time t of the Gompertz hazard function µx,t, and Mt is the
modal age at death. The change over time in the force of mortality (µ˙x,t) can be decomposed
into the respective components of change for the shape (β˙t) and the mode (M˙t), which can be
expressed by
µ˙x,t = β˙t
[
µx,t(
1
βt
+ x−Mt)
]
− M˙t [βtµx,t]. (4.12)
The components of change for the shape (β˙t) and the modal age at death (M˙t) are each mul-
tiplied by a weighting function. For simplicity, these weighting functions are summarized by
fβ(µx,t) for the shape and fM(µx,t) for the mode. Equation 4.12 then changes to
µ˙x,t = β˙t fβ(µx,t) − M˙t fM(µx,t). (4.13)
The change in life expectancy at birth over time can be expressed by
e˙0,t =
∫ ω
0
l˙a,t da = −
∫ ω
0
la,t
∫ a
0
µ˙x,t dx da, (4.14)
where l˙a,t is the time derivative of the survival function la,t. Equation 4.13 can now be substi-
tuted in Equation 4.14, which results in
e˙0,t = −β˙t
∫ ω
0
la,t
∫ a
0
fβ(µx,t) dx da︸ ︷︷ ︸
∆β
+ M˙t
∫ ω
0
la,t
∫ a
0
fM(µx,t) dx da︸ ︷︷ ︸
∆M
. (4.15)
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The first term in Equation 4.15 expresses the gain in life expectancy due to a change in the
shape, (∆β), capturing the compression of mortality; while the second term expresses the
gain in life expectancy due to a shift in the modal age at death (∆M ), capturing the shifting
of mortality.
4.4.3. Materials and data
The Siler mortality model is used for the illustration of the decomposition method (Siler,
1983). Using the parameterization of the Gompertz mortality model with the modal age at
death, the force of mortality of can be expressed by
µx,t = αt e
−btx + ct + βteβt(x−Mt), (4.16)
where α and c are capturing the initial level of infant and background mortality, the parameters
b and β are the constant rates of mortality change with age for infant and adult mortality, and
M is the modal age at death. By including the infant and background parameters, the Siler
model provides a more detailed estimation of the compression and the shifting effects because
it captures mortality at all ages. However, it must be noted that the Siler model appears to
have some shortcomings in capturing the U-shaped mortality trajectory at infant, childhood
and adolescent ages. It has also problems in capturing the deceleration of mortality at old
ages. Nevertheless, it is useful for illustrating the method and for analyzing the impact of both
mortality dynamics. The effect sizes calculated should, however, be interpreted with care (see
the original paper for a further discussion on the accuracy of the method).
The decomposition is applied to the mortality of Swedish females and to the average fe-
male mortality in selected countries of the Human Mortality Database (HMD 2015c) (see the
original paper for further details). The parameters of the mortality models are estimated for
each country independently, and then averaged across all countries (with equal weights) to
obtain the HMD average. The Siler models are fitted to the observed mortality trends using
the maximum-likelihood framework and assuming that age-specific death counts are Poisson-
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distributed (Brillinger, 1986).
4.4.4. Decomposition results using the Siler mortality model
To illustrate the accuracy of the method, the decomposition has been applied to the differences
in life expectancy at birth between the years 1900–1905, 1950–1955 and 2000–2005. Table
4.3 shows the results for each setting, as well as for for each parameter in the Siler model.
Although the method requires some adjustments to allow us to apply the continuous functions
to discrete data and to capture the change over time (e.g., linear, exponential; see the original
paper for further details) of the respective quantities, the results suggest that the proposed de-
composition method provides fairly accurate results, which can be seen by the similar values
for the life expectancy differentials and the sum of the contributions of the individual param-
eters.
To tackle the two research questions, Figure 4.6 depicts the results of the Siler decomposi-
tion for five-year periods between 1900–2010 for females in Sweden and the average across
the countries of the Human Mortality Database. Each bar in the graph corresponds to the
decomposition of the life expectancy differential between the start and the end year of the
respective five-year period. The colors highlight the contributions of the individual parame-
ters, with blue referring to the compression of mortality and orange referring to the shifting of
mortality. Apart from showing some fluctuations in years affected by war or larger epidemics,
Figure 4.6 clearly illustrates that the compression of mortality was the dominant force in in-
creasing life expectancy until the 1950s. Thereafter, the shifting of mortality, measured by the
change in the modal at at death, became instrumental to increasing life expectancy. Given the
patterns shown in Figure 4.6, the transition from the compression to the shifting of mortality
as the major driver proceeded relatively rapid. However, when we look at the relative rather
than the absolute contributions (as shown in Figure 4.6), we see a more gradual shift from one
to the other with an onset in the 1940s becoming visible.
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Table 4.3.: Female life expectancy at age 0 (e0,t) and its decomposition due to changes in
the Siler parameters, Sweden and the HMD average, 1900, 1950, and 2000.
By rounding the numbers to the second decimal point in the table, the sum of the
contributions (
∑
∆i) might differ slightly from the difference in life expectancy
(e˙0,t). The estimation is based on age-specific death counts and exposures from
the Human Mortality Database (2015c).
1900 1950 2000
e0,t 56.06 72.78 81.68
e0,t+5 58.00 74.44 82.34
e˙0,t 1.94 1.66 0.66
∆α 0.52 0.06 0.01
∆b 0.54 0.02 -0.04
∆c 0.69 0.44 0.02
∆β -0.17 0.03 0.05
∆M 0.34 1.11 0.62
∆α+∆b+ ∆c+∆β+∆M 1.94 1.66 0.66
The proposed method allows us to quantify the contributions of the compression and the
shifting of mortality to the increase in life expectancy. However, because the procedure rests
on the parametric mortality models, the results are sensitive to the selected model, and to
whether the model used includes mortality at young and middle ages. Moreover, the method
provides accurate results for decomposition over short time horizons, such as five or 10 years.
But with longer time horizons, the sum of the individual parameter contributions start to devi-
ate slightly from the initial difference in life expectancy. This is due to the approximation of
the equations to discrete data, as well as the assumption of how a respective quantity changes
between two time points.
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Figure 4.6.: Trends over time of the Siler parameters’ contribution to changes in female
life expectancy at age 0 (e˙0,t), Sweden and HMD average, 1900-2010. The
Siler models have been fitted using the Poisson-likelihood. The estimation is
based on age-specific death counts and exposures from the Human Mortality
Database (2015c).
4.5. Cluster conclusion
The individual articles in this cluster aim to provide methodological solutions for problems,
which are generated by sustained declines in old-age mortality. The maximum inner rectan-
gle approach is the only approach that also contains a theoretical component. The two other
approaches are decomposition methods for different types of differentials. However, in all
three cases, the approaches aim to capture the influence of recent mortality changes, and they
can also be used to anticipate and capture the patterns that may arise from further expected
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improvements in old-age survival such as an expansion of mortality.
The three approaches tackle different problems that arise following the onset of sustained
declines in old-age mortality. The classical idea of the rectangularization of the survival curve
did not include the possibility that life expectancy would increase due to the decline in mor-
tality at advanced ages. Therefore, a theoretical refinement was necessary. The maximum
inner rectangle extends the whole concept by introducing a second type of rectangularization,
which captures the degree of equality across the total person-years lived. The decomposition
method for lifetime risk differentials captures the problem that arises incidentally from declin-
ing old-age mortality: namely, population aging. Migration and fertility are also important
factors in this process. However, for summary measures of health and mortality, which rest
on an observed or derived (from a model) population age structure, the increase in longevity
must be taken into account when time trends or differentials are compared. Lifetime risk is a
concrete example of such a measure, but the proposed procedure can also be applied to other
summary measures that rest on the population age structure. The onset of the sustained decline
in old-age mortality was also the time point at which dynamics other than the compression of
mortality became instrumental for the change in life expectancy. The proposed decomposition
method represents a first attempt to quantify the importance of these dynamics for the overall
increase in the average lifespan; and to analyze whether, and, if so, how these dynamics (the
shifting and the compression of mortality) have replaced each other.
The presented approaches can also be used to analyze and explain the dynamics of future
mortality prospects. The progressive exploitation of opportunities for extending life at the
highest ages — which is likely to continue occur, at least in the near future — will affect both
the pattern of lifespan variability as well as the increase in longevity. The maximum inner
rectangle approach and the life expectancy decomposition method are designed to capture po-
tential changes in lifespan variability. In this context, the maximum inner rectangle approach
offers further extension possibilities beyond the measures presented. Mostly importantly, the
possibility of decomposing the complete maximum living potential into the different kinds of
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person-years lived and lost represents a promising opportunity to gain further insights into the
relationship between the compression and the shifting of mortality, as well as into the poten-
tial expansion of mortality as increasing life expectancy is accompanied by increasing lifes-
pan variability. In addition to the decomposition method, lifetime risk as such is an interesting
measure for anticipating changes in the life expectancy because it expresses the likelihood that
an average individual will contract a disease in the future; a crucial information for anticipat-
ing future changes in life expectancy. It may therefore makes sense to combine information
on survival and diseases incidence in a single index. Lifetime risk provides a unique oppor-
tunity in this context. Further extending this method, which allows us to decompose lifetime
risk differentials into the components of disease-related mortality and case fatality, can help
us better understand the dynamics of two potential drivers of increasing longevity.
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5.1. Cluster objectives
Mortality forecasting approaches aim to predict future levels of life expectancy. Given the
changes in the age patterns of mortality improvement — and perhaps more importantly, the
location of improvements potentials at the highest ages — the accuracy of the approaches used
to predict increases in life expectancy depends to a large extent dependent on their ability to
capture and forecast mortality dynamics at the highest ages. However, these trends have been
divers in the past. Figure 5.1 illustrates this diversity. The figure illustrates the correlation
between life expectancy at birth (x-axis) and average life years lost at birth, e†0 (y-axis) for fe-
males in Denmark, Italy, and Japan. Average life years lost at birth (e†0) – a measure of lifespan
variability – can be interpreted as an indicator of the underlying mortality dynamics, because
the respective pattern of lifespan variability is determined by the distribution and intensity of
age-specific mortality improvements.
Until the three populations reach a life expectancy level of 75 years, there are only marginal
differences in the corresponding levels of average life years lost. However, as soon as the
countries exceeded this level of life expectancy, the corresponding levels of average life years
lost show diverse patterns, with a continuation of the regular decline (the compression of mor-
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tality) for Italian females; an increase and a decrease for Danish females; and a leveling-off
(the shifting of mortality) for Japanese women. These findings illustrate that different under-
lying mortality trajectories can lead to similar levels of life expectancy, but to varying levels of
lifespan variability. Different authors have already discussed this phenomenon in more detail
(Wilmoth and Horiuchi, 1999; Smits and Monden, 2009; Vaupel et al., 2011).
The diversity of mortality dynamics is a challenge for mortality forecasting approaches, be-
cause the future development of life expectancy depends entirely on whether and, if so, how
improvement potentials at the highest ages are exploited. In Figure 5.1, we can see that these
improvements can be realized through multiple dynamics, such as a further compression in
the case of Italy or a shifting of mortality in the case of Japan. To provide robust forecasts of
life expectancy, mortality forecasting approaches should be able to capture and process a va-
riety of mortality dynamics. In this instance, lifespan variability could serve as an indicator of
mortality dynamics, which could be used to evaluate the performance of mortality forecasting
approaches in capturing and forecasting these mortality dynamics.
Basic life table functions, such as life expectancy at birth (a measure of central tendency)
and age-specific mortality (a measure of mortality intensity) are usually applied to evaluate
the performance of forecasting approaches. Accordingly, the more closely a forecast fits the
observed values, the greater the forecasting performance is. Based on these assumptions, the
goodness-of-fit test and other validation procedures are applied to quantify the predictive abil-
ity of mortality forecasting approaches. For the evaluation of the differences between the pre-
dicted and the observed mortality, ex-post quantitative aspects are generally used (Armstrong
and Collopy, 1992; Cairns et al., 2011; Keilman, 1997; Shang, 2015). The quantified forecast
errors can than be expressed in absolute or relative terms, and can be averaged over different
dimensions, such as ages, time periods, or populations (Booth et al., 2006; Keilman and Pham,
2004; Koissi et al., 2006; Shang et al., 2011; Smith et al., 2001). Depending on the respective
error statistic, different dimensions of predictive ability are evaluated, such as accuracy in the
case of absolute errors and bias in the case of positive and negative errors. However, errors
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Figure 5.1.: Scatterplot of life expectancy at birth and average life years lost at birth
due to death, females, Denmark, Italy and Japan, 1950-2012. Life expectancy
at birth and average life years lost at birth due to death are calculated using
the approach presented in Vaupel et al. (2011). Accordingly, the average life
years lost at birth due to death (e†0) are calculated by applying the equation e
†
0 =
1
l0
ω∫
0
exdx dx, with ex being life expectancy at age x, dx being the life table deaths
at age x, and l0 being the life table radix, to discrete data. Both life expectancy
and average life years lost estimates are based on period life tables, using age-
specific data on death counts and exposures provided by the Human Mortality
Database (2017a).
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and test statistics of basic life table functions are useful for specifying precisely how mortality
has been forecast. But small errors in the forecasting of, for instance, average lifespan do not
necessarily indicate that the underlying mortality dynamics are plausible.
The objective of this study is to explore and highlight the question of whether mortality
forecasting approaches can capture and forecast different trends in life expectancy at birth
and lifespan variability. Hence, the aim is to emphasize the benefits of incorporating lifespan
variability as an additional indicator in the toolkit that is used to evaluate the performance of
mortality forecasts.
Paper in this cluster:
Bohk-Ewald, Ebeling, Rau (2017). Lifespan disparity as an additional indicator for
evaluating mortality forecasts. Published in Demography.
5.2. Approaches used to forecast mortality
Three approaches are selected to forecast mortality. They differ in their ability to capture dy-
namic age shifts in survival improvement. These models are the Lee-Carter model (Lee and
Carter, 1992), its rotating variant (Li et al., 2013), and the model developed by Bohk and Rau
(Bohk-Ewald and Rau, 2017). As their levels of modeling flexibility differ, each of these ap-
proaches model the various trends in lifespan variability differently. Many other approaches
are equally appropriate for meeting our research objective. However, the aim of this analysis
is to show the additional information that can be gained when evaluating the forecasted spread
of mortality in the presence of different trends for life expectancy at birth and lifespan vari-
ability. Hence, an extensive evaluation of the performance of different forecasting approaches
is beyond the scope of this study.
The canonical model by Lee and Carter (1992) is undeniably a standard approach in the field
of mortality forecasting. The Lee-Carter model forecasts mortality by age and calendar year
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on the logarithmic scale, while assuming that the relative changes in mortality are constant
across the ages over time. Hence, if the survival improvements were relatively large at young
ages and were small at old ages in the reference years, it was assumed that this proportion
would be unchanged in the forecast years. The absence of a dynamic shift in survival im-
provements to progressively higher ages may induce (1) an underestimation of life expectancy
at birth, as well as (2) a strong compression of deaths, which may in turn be accompanied by
a strong decline in lifespan variability.
Many scholars have refined the Lee-Carter model to address the problem of the inflexibil-
ity in the age profile of mortality change (Booth et al., 2006; Shang et al., 2011; Soneji and
King, 2011). An important step in this direction was taken by Li et al. (2013), hereafter called
Lee-Carter-rotated, who implemented a time-variant age schedule of mortality change that ro-
tates from a present level to an ultimate level. The timing and the pace of the rotation depend
on the average lifespan, which has been forecasted in a previous step using the original Lee-
Carter model. As soon as life expectancy at birth exceeds a certain level, the rotation starts
and proceeds until life expectancy at birth reaches an ultimate level. The rotating age pattern
basically induces a postponement of relatively large survival improvements from younger to
older ages. Given that the average lifespan is forecasted using the original Lee-Carter model,
it is important to note that the rotation only affects the underlying mortality dynamics, not the
average level of mortality. Assuming a regular decline in mortality, we expect to find that like
the original model, the rotated model may (1) underestimate the additional years of life; but
that unlike the original model, it may (2) be able to forecast a mortality compression that is
less strong because of its greater modeling flexibility.
The model of Bohk and Rau (Bohk-Ewald and Rau, 2017) provides an alternative strategy
for forecasting that relatively large rates of mortality improvement proceed from younger to
older ages. The model predicts survival improvements instead of death rates. Moreover, the
Bohk-Rau model has a linear and an exponential core model for forecasting time series of
age-specific mortality change; it uses simulation-based Bayesian inference to run those mod-
89
5. Cluster IV – The role of mortality dynamics for future mortality prospects
els and to estimate coherent changes in mortality among adjacent ages. Although both the
Lee-Carter-rotated and the Bohk-Rau model allow the age profile of the rates of mortality im-
provement to change, the latter model appears to be more flexible, since it does not assume
an approximation of an ultimate schedule. We expect to find that the Bohk-Rau model will
perform similarly to the Lee-Carter-rotated model in forecasting average mortality and lifes-
pan variability for populations with regular mortality declines. But we hypothesize that the
Bohk-Rau model will perform even better in generating forecasts for populations with irregu-
lar mortality developments, because it is more adaptable to different forecasting situations.
5.3. Materials and data
In the evaluation, we examine whether each of the three models is able to generate precise
forecasts of average lifespan and lifespan variability. The examples are designed to indicate
whether the approaches can capture (1) regular and irregular trends of average lifespan, as
well as (2) different dynamics in the age shifts of survival improvements. We have chosen
to compare the forecasts for women in Italy (regular e0 and e
†
0), Japan (regular e0 and ir-
regular e†0), and Denmark (irregular e0 and e
†
0) because in recent decades these groups have
differed substantially in their levels of life expectancy and lifespan dispersion (see Figure 5.1).
We use death counts and exposures by single years of age from age zero to ages 110+,
and by calendar years from 1950 to 2009, from the Human Mortality Database (2015d). To
enable the forecasting approaches to shift deaths to ages beyond 110+, we have extended the
age range to 130+ with the Kannisto model (Thatcher et al., 1998) (see the original paper for
further details).
To generate the mortality forecasts, we implemented all models in the statistical software
R (R Core Team, 2017). We implemented the Bohk-Rau model and the Lee-Carter model
in their original versions, but we made a few adjustments to the original version of the Lee-
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Carter-rotated model. Most importantly, we set the onset of the rotation in the age pattern to
a life expectancy level of 75 because differences in lifespan disparity started to develop for
women in Italy, Japan, and Denmark as the average lifespan exceeded this value (see Figure
5.1). To avoid jump-off bias for the Lee-Carter model and the Lee-Carter-rotated model, we
use the last observed death rates to forecast mortality.
To measure lifespan variability, we take the average number of life years lost at birth (Vaupel
and Romo, 2003; Zhang and Vaupel, 2009), e†0, estimated by
e†0 =
ω∫
0
eada da
l0
, (5.1)
with ea being the remaining life expectancy at age a and da being the life table deaths at age
a, with both integrated from age zero to ω, the highest age at death. l0 is the radix of the life
table. A major reason why we have chosen e†0 is that it is demographically interpretable as the
average life years lost. Since e†0 refers to the lost living potential, it also provides information
about the capacity for further increases in life expectancy. We argue that these key features
mean that e†0 in particular is suitable to be used to evaluate the plausibility of mortality fore-
casts.
5.4. Evaluation results of the mortality forecasts
Our evaluation is based on four different evaluation settings, which vary in terms of their ref-
erence periods and forecast years. In these settings, mortality is always forecasted up to 2009,
but using different reference periods (1965–1990 1960–1985, 1955–1980, and 1950—1975).
Thus, the range of forecast years varies across these settings (the results for the last three
settings can be seen in the original article). Figure 5.2 presents the results of the central vali-
dation setting. The mortality forecasts are based on the reference period 1965–1990. Mortality
is then forecasted from 1991 to 2009. Based on these forecasted death rates, life expectancy
at birth (e0) and lifespan equality (e
†
0) are calculated. Based on this setting, we are able to
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compare the estimations with the actually observed values. The upper, middle, and bottom
panels depict the results for life expectancy (left) and lifespan variability (right) for women
in Italy, Japan, and Denmark. The observed trajectories are in black. The blue, green, and
red solid lines refer to the Bohk-Rau model, the Lee-Carter-rotated model and the Lee-Carter
model, respectively. Moreover, the forecasted years, from 1991 to 2009, are highlighted in
gray; and the reference period, from 1965 to 1990, is highlighted in beige.
Besides employing visualization techniques for the evaluation, we calculated forecast er-
rors to evaluate the forecasting performance of each method. To quantify forecast accuracy in
terms of the mean and the spread of mortality, we use the Absolute Percentage Error (APE).
This is a relative error that relates the absolute difference between forecasted and observed
values to the size of the actual values. Since the APE can deal with measures of different
scales, we use it to compare the forecasting performance (across time and by country) of the
methods using e0 and e
†
0. Table 5.1 lists those MAPEs (Mean Absolute Percentage Errors)
averaged over all four validation settings.
The fits of life expectancy at birth and lifespan variability basically appear to depend on the
regularity of mortality trends and the ability of the approaches to capture them appropriately.
Since the mortality developments among Japanese and Danish women were irregular, making
precise forecasts for these groups is particularly challenging. Thus, the predictive ability of
the approaches declines as the magnitude of the MAPEs increases. This effect appears to be
greater for the Lee-Carter model than for the other two models, and it appears to be more pro-
nounced in forecasts of lifespan variability than of average lifespan. For example, the greatest
overall MAPE, 10.7%, is for e†0 in Japan from the Lee-Carter model; whereas the smallest
overall MAPE, 0.4%, is for e0 in Italy from the Bohk-Rau model (see Table 5.1). The greater
forecast error found for the Lee-Carter model is probably due to the extrapolation of average
trends of the reference period. Hence, if the overall trend in lifespan variability is decreasing
in the reference period, the Lee-Carter model may be expected to predict a decreasing pattern
as well, and vice versa (see Figure 5.2). The structural breaks observed in Danish and Japanese
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Figure 5.2.: Life expectancy at birth (left panels) and life years lost at birth (right panels)
for women in Italy (top), Japan (center), and Denmark (bottom).Observed
data are in black, while forecasted data are in red (Lee-Carter model), green
(Lee-Carter-rotated), and blue (Bohk-Rau model). The forecast years are 1991
to 2009, based on the reference period 1965 to 1990. All estimates are based
on age-specific death counts and exposures provided by the Human Mortality
Database (2015d).
93
5. Cluster IV – The role of mortality dynamics for future mortality prospects
Table 5.1.: Mean of the Absolute Percentage Errors (MAPE) for e0 and e†0 over all valida-
tion settings by country and method. The MAPE is calculated over the APE of
all four validation settings. The reference periods (1965–1990 1960–1985, 1955–
1980, and 1950—1975) and the forecast years of the settings differ. All of the
forecasts range from the year after the end of the reference period until 2009.
The calculations in all of the settings are based on age-specific death counts and
exposures provided by the Human Mortality Database (2015d).
Country Measure LC LC, rotated Bohk-Rau
Average across all validation settings
Italy
e0 0.011 0.011 0.004
e†0 0.027 0.019 0.024
Japan
e0 0.008 0.008 0.005
e†0 0.107 0.086 0.025
Denmark
e0 0.009 0.008 0.022
e†0 0.057 0.045 0.024
lifespan variability are unexpected, and are difficult for all of the models to capture since they
are not designed for this specific task.
By focusing exclusively on lifespan variability, we are able to discern large differences
between the approaches, particularly between the two Lee-Carter models in the forecasts of
Japanese female mortality. The rotating variant appears to capture the flattening decline in
lifespan disparity in the forecast years much better than the original model, and thus sub-
stantially improves forecasting performance with an overall MAPE for e†0 in Japan, which is
substantially lower for the Lee-Carter-rotated (8.6%, Lee-Carter model: 10.7%). This find-
ing demonstrates the need for time-variant survival improvements in order to capture dynamic
trends in the variability of the age at death. It should be noted that we do not expect forecasting
errors to be equal to zero, since they show more signs of overfitting than of displaying high
forecasting performance.
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5.5. Cluster conclusion
The comparative analysis revealed that, irrespective of the reference period, forecasting per-
formance basically depends on the regularity (or continuation) of mortality trends and the
ability of the approaches to capture them appropriately. While the forecasts of life expectancy
at birth generated by the Lee-Carter models are rather conservative, the forecasts generated by
the Bohk-Rau model often have small forecast errors, but also a few upward outliers across
all validation settings. Moreover, the Japanese forecasts were found to be precise when we
looked at average lifespan only, but they turned out to be rather inaccurate when we took lifes-
pan disparity into account as well. Hence, the models were not able to capture the flattening
decline of Japanese lifespan disparity in the forecast years, although the rotating model and
the Bohk-Rau model fared better than the Lee-Carter model due to time-variant survival im-
provements.
However, the remaining deviations from the observed values indicate that the refinement
or the development of forecasting approaches should focus not only on average mortality, but
on lifespan disparity. This may be particularly important given the concentration of mortality
improvement potentials at the highest ages. Improving mortality at those ages would likely
mean that people will be able to live beyond the current maximum ages. Hence, it is crucial
that forecasting approaches are able to capture multiple trends in the (right) tail of the lifespan
distribution (stagnation or expansion). The approaches should therefore be able to forecast
further reductions in mortality not only up to the current maximum ages, but to higher ages
and beyond. Reaching this goal will require a high degree of modeling flexibility, which has
been missing in existing approaches.
To summarize, our analysis illustrates that the joint evaluation of the average lifespan, e0;
and the life years lost, e†0; provide new insights that we believe are needed for a comprehensive
evaluation of the predictive performance of mortality forecasts. We also suggest that these new
insights are used when improving or developing new methods for forecasting mortality. Until
now, these approaches were exclusively designed to capture the almost linear increase in life
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expectancy at birth. Hence, it is not surprising that forecasts of the average lifespan turn out
to be more accurate and yield smaller forecast errors. The incorporation of lifespan disparity
as a quality criterion or even central outcome may substantially improve the methodology.
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6.1. Assessing the consequences and the
implications of the continuous mortality
improvements
The primary aim of both the first cluster, measuring survival progress, and the second cluster,
investigating mortality dynamics at the boundaries of age-specific mortality, was the assess-
ment of mortality change. The initial motivation for undertaking such an assessment was
the persistent continuity of mortality improvements (White, 2002; Oeppen and Vaupel, 2002;
Vallin and Meslé, 2009). The two clusters addressed this issue from different angles. The
first cluster focused on how the advancement of the continuous change is measured, while
the second cluster looked at the implications of the continuous change for the boundaries of
age-specific mortality.
The formulation of the concept of “equivalent time” (ET ) and the classification of reference
types are the two key outcomes of the first cluster. ET combines two common perspectives
on assessing survival progress, gap and slope, into a single index. This index expresses dif-
ferentials in the advancement of survival improvement in calendar years, which is a common
unit for tracking the development of populations. In the study, we showed the benefits of ET
and its advantages when it comes to assessing past progress and to gauging future prospects.
The proposal of the classification of reference trends is preceded by a question: What is
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desirable progress? Is it sufficient to keep up with a reference trend, or should a population
overtake the levels of a reference trend? Obviously, answers to this question can be given on
a case-by-case basis only, and in light of the specific issues to be addressed. However, by
restricting ourselves to overall survival progress, we can use the change in life expectancy as a
basis of evaluation. Thus, the previous question could be reformulated as follows: Is keeping
up with the increase in record life expectancy sufficient progress for a population with much
lower levels of life expectancy? Or should this population be improving more quickly in or-
der to catch up with the record values? Moreover, is record life expectancy an appropriate
point of reference in this context? The proposed breakdown of reference types and compar-
ison settings into intra-, inter-, and supra-groups can help us critically review and select the
appropriate progress benchmark for addressing these questions.
The consequences and implications of the continuous mortality improvements for the lower
boundary of age-specific mortality (minimum mortality) received special attention in the sec-
ond cluster. Past developments of three key characteristics – the level, the gap, and the
sex-specific differences – have been analyzed in order to gain a better understanding of the
consequences and implications of more than a century and a half of continuous survival im-
provements. To my knowledge, this is the first investigation of this kind. The results represent
trends at the population level, and are intended to stimulate follow-up questions for further
investigations. The general findings can be summarized as follows: minimum mortality has
decreased tremendously, and is likely to decline further; the location of minimum mortality
has shifted to younger ages; and the sex-specific differences in minimum mortality changed
from temporary female excess mortality to persistent male excess mortality. Hence, for mini-
mum mortality, the main consequence of the continuous mortality improvement could be the
decline to recent levels of eight females deaths and 10 male deaths per 100,000 person-years
lived among the best practice countries.
What are the implications of the finding for minimum mortality? After one and a half cen-
turies of continuous survival improvements, there is still room for further gains, even in the
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historically lowest death rate across age. This finding alone might not be surprising. However,
evidence of the continuity of the decline in minimum mortality among the most recent cohorts
and of the likelihood of future improvements at the lower boundary are impressive signs of
the ongoing diffusion of advances in various areas of life, and of how these advances continue
to generate further survival improvements, especially in situations in which opportunities for
improvement are arguably very small. This implies not only that the prospects for reducing
mortality at the lower edge are good, it also shows that the opportunities for further mortality
improvements at all ages are enormous; an important implication in particular by recognizing
that it is sometimes assumed that mortality cannot be further reduced, despite the occurrence
of major breakthroughs (Olshansky et al., 1990).
Understanding the implications of the shift in the location of minimum mortality is not
straightforward, as the reasons for this change are unclear. Karapanou and Papadimitriou
(2010) have reported that improvements in socioeconomic conditions in the 20th century re-
sulted in an earlier onset of puberty, which can be seen in the decline in the average age at
first menarche. Given the close association between the location of minimum mortality and
the onset of sexual maturity, the shift may be attributed to similar advances, which are in turn
the drivers of the overall mortality improvements. Thus, on the one hand, we could emphasize
the positive effects of these advances; but one the other, we could focus on the negative con-
sequences of earlier menarche, such as higher rates of cancer mortality, especially of breast
cancer (Karapanou and Papadimitriou, 2010). The shift in the location to younger ages could
therefore also be regarded as a “failure of success” (Gruenberg, 1977). In conclusion, the loca-
tion of minimum mortality is a good example of the ambivalent implications of these general
advances.
The investigation of maximum mortality, or of the level of the late-life mortality plateau,
provided only limited insights. For females, a maximum level of eight deaths per 10 person-
years lived was found, whereas the results for males did not allow us to derive a concrete
empirical value. However, this project shed light on the problems that can arise when study-
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ing mortality in this age range, particularly the lack of appropriate data. Hence, although
mortality has been improving over a long period of time, it seems that we will have to wait
even longer to collect the data we need to gain insights into the upper boundary. Once these
data are available, examining the time trends in the level of the plateau and the ages at which
it is reached could provide important insights into the dynamics of mortality change and the
question of whether the continuous mortality improvements are large enough to alter essential
features of the human mortality trajectory, such as the late-life mortality plateau.
Combining the findings of the two clusters allows us to draw one general conclusion: the
pattern of advancement is often more informative than the actual level of advancement for
understanding the consequences and implications of the continuous mortality improvements.
ET , the different reference types, and the findings for the boundaries of age-specific mortality
all indicate that studying delays in, speeds of, and patterns of improvement are more informa-
tive when accompanied by an exploration of the consequences and implications of continuous
survival improvement.
6.2. Exploring the consequences and implications of
the changing age-pattern of mortality
improvement
The third cluster, mortality dynamics in an era of old-age mortality improvements, aimed to
explore the consequence and implications of the changing age pattern of mortality improve-
ment. The different articles focused on three specific aspects of this field: the rectangular-
ization of the survival curve, the effects of longevity increases on lifetime risk differentials,
and the contributions of different mortality dynamics to the increases in life expectancy. The
objectives of all three studies centered on the sustained decline in old-age mortality, which
generated various kinds of methodological challenges.
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One type of method has been instrumental to providing answers to the different questions:
the decomposition approach. Generally, decomposition methods are used to quantify the con-
tributions of various components to the differences between two or more populations in a
specific measure. The lifetime risk of getting a disease and life expectancy are the two central
measures used in the presented approaches. To my knowledge, the method for the decom-
position of lifetime risk is the first approach of its kind, whereas there are several existing
approaches for the decomposition of life expectancy differences (see, for instance, Andreev
et al., 2002; Pollard, 1982; Vaupel, 1986; Keyfitz, 1977). However, the decomposition method
presented here employs a new perspective. It decomposes life expectancy differentials into
the contributions of different mortality dynamics; more specifically, into the contributions of
a general shift of deaths to higher ages (the shifting of mortality) and of a further compression
of deaths toward the end of the lifespan (the compression of mortality).
Although the use of the maximum inner rectangle approach (MIRA) as a decomposition
method has not been presented, the method can easily be applied in this way. However, the
initial objective of the MIRA was to refine the framework of the rectangularization of the
survival curve, which was established in a seminal article by Fries (1980). In addition to
offering some modifications of the original framework, we proposed a novel type of rectangu-
larization, inner rectangularization, which complements the usual perspective on this process.
Commonly, rectangularization has been understood as the process of a population approach-
ing its maximum living potential, which is given by the current maximum lifespan (see, for
instance, Wilmoth and Horiuchi, 1999; Cheung et al., 2005). However, using the newly devel-
oped maximum shared lifespan as a reference point, inner rectangularization can be defined
as the process of a population approaching its current maximum lifespan equality, which is
given by the current level of life expectancy. Moreover, the inner rectangle ratio, the measure
of inner rectangularization, extends the landscape of alternative lifespan variability measures
by measuring the dispersion among the number of person-years lived, rather than effect or the
size of person-years lost due to death.
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In the MIRA as well as in the life expectancy decomposition, mortality dynamics are cap-
tured through the pattern of lifespan variability. In addition to representing methodological
advances, both approaches provided new insights into the consequences of the old-age mor-
tality decline for mortality dynamics. The application of the life expectancy decomposition to
Swedish females showed that the shifting of mortality has gradually replaced the compression
of mortality as the leading force of life expectancy increase; a process that has been underway
at least since the 1940s. The application of the MIRA to the same population also confirmed
the importance of this dynamic for the overall mortality change. However, the results of the
MIRA also suggest that in recent years, the compression of mortality has been strengthening
among Swedish females. Moreover, the results across all of the countries analyzed with the
MIRA reveal the existence of various patterns of mortality dynamics in recent decades. For in-
stance, an increase in lifespan variability was found among Danish females, which is believed
to be a consequence of tobacco smoking (Lindahl-Jacobsen et al., 2016); while a continuous
process of compression was observed among Italian females, even after the onset of old-age
mortality declines. These findings highlight the country-dependent advancement of old-age
mortality declines. The results also suggest that although life expectancy increases have been
accompanied by a compression pattern over the long term (Colchero et al., 2016), new dynam-
ics have been emerging since the onset of the sustained decline in old-age mortality. It thus
appears that the age pattern of mortality improvement has been changing, as the evidence that
new lifespan variability patterns are accompanying life expectancy increases indicates. The
question of how future mortality change will alter the relationship between life expectancy and
lifespan variability therefore remains open. The MIRA can be a valuable tool for answering
this question.
With regards to the potential for lifespan extension at the highest ages, another closely re-
lated question arises: What are the future prospects for mortality dynamics? It is clear that
old-age mortality improvements will continue to be needed, and that life expectancy will rise
even further in the future. But how will these dynamics be shaped? The answer to this ques-
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tion depends entirely on the plasticity of mortality at the highest ages. Several scenarios are
conceivable, such as a further shifting of mortality in the coming decades. Alternatively, if
mortality at the highest ages is difficult to change, a new era of compression with a further
rectangularization of the survival curve may emerge. We can only speculate about the like-
lihood of either of these scenarios. An important determinant of future trends will be the
development of health and its relationship to mortality. Looking at the current evidence, we
see that even though we have already experienced an era with major innovations (Fogel and
Costa, 1997), these general advances have resulted only in a delay of the aging process, which
Vaupel (2010) called the “postponement of senescence.” Thus, while we have succeeded in
generating extra life years, it so far appears that we have not altered the process of deteriora-
tion with age. This development aligns almost perfectly with the shifting of mortality, which,
given the results of the presented studies, seems to have been the predominant dynamic in
many low-mortality countries since the 1950s. Moreover, the decomposition of lifetime risk
as a measure while combining information on mortality and health has shown that increasing
longevity and improving incidence levels can almost offset each other. Nevertheless, analy-
ses of other populations are needed before we can reach any clear conclusions on this topic.
Although only the lifetime risk decomposition refers to the direct intersection of health and
mortality development, all of the presented methods allow us to investigate these processes and
their consequences. The MIRA and the lifetime risk decomposition are also flexible enough
to capture and analyze patterns beyond the shifting or the compression of mortality.
While the presented methods do not directly indicate how further advances in different
fields, such as medicine or health care, might translate into mortality change, the outcomes
arguably provide a sufficient basis to investigate their relationship. In particular, the MIRA
represents a valuable approach in this context because future mortality dynamics will be de-
termined by the distribution of these advances in the population. Accordingly, from a philo-
sophical and from a future-oriented perspective, the MIRA can be interpreted as a measure of
distributive justice in a population with respect to mortality. While individual lifestyle choices
affect mortality, the provision, the quality, and the advancement of health care in a popula-
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tion have important effects on lifespan variability. In that context, Marchand et al. (1998)
discussed four alternative views that are applicable to equality in person-years lived: first, tar-
geting a maximization of the total sum of health in a population would generate no further
equality increases; second, reducing class inequalities in health would result in more equality;
third, improving health for the lowest socioeconomic group would also increase equality; and,
fourth, priority should be given to the sickest individuals, irrespective of their social class,
which would potentially also increase equality. These third and fourth views are related to
Rawls’ “difference principle,” as outlined in his work of political philosophy, “A Theory of
Justice” (Rawls, 1971). Clearly, the evaluation, assessment, and determination of such strate-
gies are difficult and complex tasks, but the consequences of population aging and increasing
longevity might lead us to focus more on addressing these issues in the future. The presented
methods can provide valuable insights from different angles that can prove helpful in this con-
text. In addition to using the MIRA as a measure for lifespan equality, we could, for example,
apply the lifetime risk decomposition in order to highlight how advancement translates into
the improvement of different aspects, such as case fatality or disease-related mortality.
So far, the main focus of mortality research has been on the consequences of the old-age
mortality decline. Yet the changes observed in the age pattern of mortality improvement show
the decreasing contribution of mortality at younger ages to overall survival improvement. Us-
ing the MIRA to quantify young/premature and old-age mortality has provided intriguing
insights into the importance of premature mortality. Since 1850, survival improvements have
largely resulted in a continuously declining share of premature deaths. Obviously, continued
improvements in old-age mortality are conditional on this development. However, as the age
pattern of improvement changes, the share of the population who die prematurely tends to
level-off. This lead us to formulate the hypothesis that in low-mortality countries, the pro-
portion of premature deaths is going to reach a lower limit in the near future. The MIRA
suggests that this limit could be at around 10%-15% of all deaths. However, the results of the
second cluster challenge this hypothesis, because the past and the future declines in minimum
mortality could be interpreted as signs of further declines in the share of premature deaths.
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Although this is only one specific death rate, it is a death rate that is particularly interesting
for investigating the frontiers of mortality decline, since it is the lowest rate across all ages.
Hence, the falsification of this hypothesis remains a task for future research.
The shift away from saving premature deaths toward extending the premature age range is
also associated with the changing meaning of chronological age: i.e., of who is considered
young and who is considered old. The increase in life expectancy and the related evolution
of new or extended lifespan stages, such as time spent in retirement, have fueled this debate,
and have led to the proposal of some alternatives to the chronological age, such as subjective
age (Kotter-Grühn et al., 2016). Nevertheless, this issue should receive further attention espe-
cially among demographers, since age is central variable in our discipline. Moreover, for the
presented approaches, age remains an instrumental variable. However, the MIRA and the life
expectancy decomposition have the potential to make contributions to this debate.
6.3. The prospects for prolonging life at the highest
ages
Although our results do not provide any specific quantitative outcomes of future mortality
development, the initial objective of the fourth cluster, understand how mortality dynamics af-
fect future mortality trends, is an investigation of the prospects of prolonging life at the highest
ages. The outcomes of the cluster are an evaluation of the capacity of our tools to provide us
with the best possible information on future mortality prospects, or, in other words, with the
best possible approaches for projecting mortality trends. Accordingly, the cluster illustrates
the benefits of using lifespan variability as an indicator for mortality dynamics to evaluate the
performance of mortality forecasting approaches.
The results can briefly be summarized as follows: as long as life expectancy increases were
accompanied by a reduction in lifespan variability, the compared approaches performed well;
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but when life expectancy increases were accompanied by other lifespan variability patterns,
the compared approaches started to show deficiencies. It may be assumed that many mortality
forecasting approaches anticipate the compression of mortality as the predominant force for
further life expectancy change. But this assumption appears to be incorrect, because most
approaches capture past trends that largely support the predominance of compression, and
extrapolate them into the future. Accordingly, if we anticipate that this relationship will no
longer hold in the coming decades, the analysis suggests some ideas that could be used to
improve mortality forecasting approaches. Incorporating a flexible modeling of the dynamic
age shifts of mortality improvements is of particular importance in this context. Lifespan vari-
ability can provide two focal contributions for this task. First, as was already mentioned, it
can serve as a criterion for the evaluation of approaches. Second, and perhaps more important,
lifespan variability could become a quantitative input for mortality forecasting approaches.
For instance, parameters of lifespan variability and their likelihood could serve as priors for
Bayesian mortality forecasting approaches. This is clearly a vague proposal. In fact, it should
be understood as an illustration of the claim that while lifespan variability and, more gener-
ally, the range of mortality dynamics have so far been neglected component by forecasters,
they could be used to increase the precision of mortality forecasts.
The findings of the fourth cluster bring us back to the question we raised previously: What
are the future prospects for mortality dynamics? In the previous chapter, different aspects of
this question were outlined. But for mortality forecasting, one more claim could be made.
Expert opinions have been used as inputs for mortality forecasts (Booth and Tickle, 2008).
Experts from different fields have, for example, been asked for their opinions on the future
of a specific cause of death or on future levels of life expectancy, which have then been used
as target values (Booth and Tickle, 2008). The variety of mortality dynamics since the onset
of the sustained decline in old-age mortality, together with the prospects for lifespan exten-
sion (Sierra et al., 2009) are illustrative of the opportunities for altering human mortality that
emanate from advancements in various fields. Thus, in order to broaden our perspectives,
demographers should ask scholars in other fields about their expectations for future mortality
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trends, and about how these expectations affect the approaches we use and the questions we
ask in researching mortality.
6.4. Measuring trends and dynamics in an era of
continuous mortality decline
The main focus of this thesis is on the consequences and implications of the continuous mor-
tality decline for mortality dynamics. Three key findings – the remarkable continuity of mor-
tality improvement, the changing age pattern of mortality improvement, and the location of
longevity extension potentials at the highest ages – are the basis for the individual articles of
this thesis. The articles explore in particular the various methodological challenges that are
caused by the interplay of the above mentioned developments. Five out of the seven articles
included in the thesis propose new or refined approaches. Three of these approaches use lifes-
pan disparity as an indicator for mortality dynamics, while the two other approaches address
the interplay of disease dynamics and longevity extension, and the measurement of survival
progress in an era of continuous mortality declines. Although the two remaining articles pro-
pose no new methods, they apply existing approaches in a novel way to investigate the effects
of the continuous mortality decline on the boundaries of age-specific mortality.
The application of these novel approaches, as well as the insights offered on mortality
change at the boundaries, shed light on some of the challenges both demographers and the
general public face currently, and will face in the future. In the past, survival progress has
been remarkably stable and regular, especially among the leading western countries. Since the
onset of the change in the age pattern, mortality improvements have continued to proceed rel-
atively continuously, but appear to have slowed in a number of countries. Moreover, the level
as well as the pace of advancement vary greatly across populations. Hence, the challenges
we face are two-fold. First, what factors will drive future longevity increases in the leading
countries, and how will these advancements shape mortality change? Second, what level of
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progress is sufficient for the lagging populations to catch up with the leading populations?
This thesis does not provide concrete answers to these questions, but it offers methodological
opportunities to tackle these issues. Moreover, the development of the lower boundary of age-
specific mortality has not only illustrated the opportunities for further advancements and for
additional reductions in mortality; it points to the value of analyzing the potential failures of
this success.
With the changing age pattern of mortality improvement, different kinds of mortality dy-
namics have emerged. This development and the prospects for further improvements at the
highest ages suggest that the current variety of mortality dynamics will persist into the future,
and may even expand as new patterns emerge. In particular, the evaluation of mortality fore-
casting approaches and the proposed lifespan variability measurements highlight the method-
ological challenges associated with this development. A central question in this context is
how life expectancy and lifespan variability will be related in the future. Again, the proposed
approaches and measure do not provide an instant answer to this question, but the evaluation
of mortality forecasting approaches has demonstrated the need to seek out a range of answers
to the question of how such approaches should be developed and refined. The proposed lifes-
pan variability tools, as well as the lifetime risk decomposition method could be used to help
answer this question. The MIRA refers to a further related question in this context: Namely,
how are future mortality improvements altering lifespan equality? The availability as well as
the distribution of drivers for further survival improvements, such as innovations in medicine
or health care across and within populations, will be important determinants in either reducing
or increasing lifespan equality. Given that resources are limited, this issue might be of partic-
ular interest for future research.
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Abstract
Background: Mortality decline is a central aspect of the advancement in
development. Differences in development are usually assessed based on the gap
between two countries at a single point in time or by comparing rates of
improvement over time. Here, we propose a third approach that combines these
two indicators in a single quantity, which we will call “equivalent time” (ET ).
Methods: ET translates the gap between a country’s population and a reference
population into a time lag. It expresses how many years we need to go back in
time to find the value for the reference group that is equivalent to the value for
the country’s population. The translation from the gap to ET can be performed
with any indicator, given that the values of the reference are changing
monotonically over time. We illustrate the application of ET to US male life
expectancy (LE) using three reference categories that cover different types of
development benchmarks: cancer-free LE of US males (intra-group), LE of
Japanese males (inter-group), and average LE of males in the G7 countries
(supra-group).
Results: Between 1960 and 2015, LE increased almost continuously among the
US male population and the three reference groups. The LE gap between US
males and the inter-group reference category remained fairly stable, at a level of
about three years; while the LE gap between US males and the intra-group
reference category declined from one year higher in 1960 to four years lower in
2015. The LE gap between US males and the supra-group reference category
increased from a small difference in 1960 to about three years in 2015. Thus, ET
suggests that over the study period, US males continuously lost ground relative
to these reference group: by 2015, the life expectancy of US males was lagging
almost 20 calendar years behind that of the intra- and inter-group reference
populations, and almost 15 calendar years behind that of the supra-group
reference population.
Conclusion: ET represents an intuitive indicator for assessing differentials in
survival advances that can be also applied in a broader context of development.
Our illustrative examples demonstrate that ET might be a more sensitive
measure than commonly applied approaches. ET thus has the potential to
become a standard procedure for assessing survival progress and general
development, complementing classical approaches.
Keywords: advances; gap; slope; references; mortality; progress; equivalent time
Background
Humankind has made substantial progress along important dimensions of devel-
opment, including longevity, since the early 19th century, and especially since the
end of World War II [1–3]. Spearheaded by a group of Western countries, progress
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in living conditions diffused through most countries, albeit at varying paces [4].
Monitoring the state of development is crucial for evaluating the success or failure
of past national policies, but also for identifying opportunities for further advance-
ment. This type of monitoring is particularly important in cases in which a country
is failing to keep up with the general trend, or has periods in which its development
is stagnating, or even reversing.
One of the most important dimensions of development is the decline in mortality
rates, which has been occurring almost everywhere in the world [5]. Thus, mea-
suring survival improvements is among the main approaches used for tracking the
general development of populations. For instance, the level of life expectancy is one
of the three dimensions measured in the Human Development Index [6]. Further-
more, global goals and targets based on progress in mortality and health, such as
the Millennium Development Goals and the more recently established Sustainable
Development Goals [7], are instrumental to the development agenda of the United
Nations. While mortality decline is observed in most parts of the world, the pace
of decline varies greatly across regions and across social strata [8–10]. In addition
to having societal relevance, monitoring and analyzing trends in survival progress
are crucial to theory-building and modelling [11].
One of the most popular approaches used to assess and compare the decline in
mortality in different countries is to compute the difference in life expectancy at
a certain point in time, which we refer to here as the gap perspective. Alterna-
tively, researchers can compare country-specific annual changes in life expectancy,
which represent the pace of survival improvement. The goal of our paper is to
(re-)introduce a concept that combines the gaps in and the pace of life expectancy
changes in a more intuitive indicator, which we call “equivalent time” (ET ).
Methods
The concept of equivalent time
In our analysis, survival progress is linked operationally to the level of life ex-
pectancy at birth (LE) over time. Thus, countries with higher levels of LE experi-
ence greater advances in survival progress than countries with lower levels of LE.
Likewise, increases and decreases in LE over time reflect advances and declines in
survival progress, respectively. While the former is expressed by the difference in
LE between two countries at the same point in time (gap), the latter is measured
by computing the absolute change over a given period of time within a country or
a group of countries (slope). Hence, the gap might be understood as a static aspect
of development, and the slope as a dynamic aspect of development.
We propose a third, previously neglected dimension for tracking development that
expresses how far back in time we need to go to find the equivalent level of LE in a
country relative to that of a reference group. This indicator is defined as the length
of time the advancement of a country’s LE lags behind that of a reference popu-
lation (see Fig. 1). We label this quantity “equivalent time” (ET ). An example: If
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we observe that the life expectancy of the comparison population is five years lower
than that of the reference population (∆ = −5), and that LE in the reference pop-
ulation is increasing at an annual rate of 0.1 years (β = 0.1), then ET = ∆/β, and
we observe an equivalent time of -50 years. This value expresses that the progress
of the comparison population lags 50 years behind that of the reference population.
Or, in other words, the comparison population would need 50 calendar years at
the given pace to reach the life expectancy level of the reference population at the
point in time of the comparison. Hence, in cases in which the reference trend is
linearly increasing, ET could be simply computed by dividing the gap by the slope.
Thus, ET combines the static and the dynamic aspects of development in a single
quantity, expressed as the delay in development.
To identify a unique ET , the reference trend must fulfill certain requirements.
To exclude the possibility that there is more than one equivalent value, the ref-
erence time series must change monotonically over time. This could, however, be
viewed as a minor issue, because we see fairly steady improvements in most mea-
sures of survival progress, such as life expectancy and mortality measures like,
age-standardized death rates. Moreover, to provide a straightforward benchmark
for progress, the cases chosen as reference usually have a steady pace of develop-
ment. For the slope, it is not necessary to assume a constant change over time. It
is also possible to directly compare empirical values without calculating a general
slope.
Illustrative examples
Materials
To demonstrate the added value of ET , we compare the trends in life expectancy
among US males to those of three reference groups based on the gap, the slope,
and the ET between 1960 and 2015 (see Fig. 2). Our goal in selecting the refer-
ence groups was to ensure that we were covering the spectrum of reference types
typically used in comparative studies. We label the three main types intra-group,
inter-group, and supra-group. In the intra-group comparison, a counterfactual of
the trends in the country of interest is used as the reference: namely, cancer-free life
expectancy of US males. In the inter-group comparison, a second external group
is used as the reference: namely, Japan the world leader in LE. Finally, in the
supra-group comparison, a more general trend is used as the reference: namely, the
average LE of the G7 countries. Obviously, which references are chosen depends
on the research objective. Even if a specific reference fits the research purpose, it
is important to take into account the specific features of the respective reference
type (see Table 1). The results stemming from an intra-group comparison are not
sufficient to determine whether the measured lags are a peculiarity of the respective
population, or are occurring across several populations. Moreover, the outcomes
of an inter-group comparison do not tell us whether the reference population is a
prime example of the specific gains being evaluated, or is an outlier. Finally, the
results of the supra-comparison do not indicate whether the more general reference
trend is reflective of a common trend across populations.
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Data
The estimates of life expectancy at birth for US males — the comparison group
— are based on death counts and exposures from the Human Mortality Database
[12]. In the intra-group comparison, cancer-eliminated life expectancy is used as the
reference (see, for instance, Preston et al [13] for more details on cause-elimination
life tables). Cause-specific death counts were obtained from the National Center for
Health Statistics [14]. The total time period analyzed encompasses the years 1960
to 2015. Cancer deaths were reconstructed using the International Classification of
Diseases (ICD) codes 140–239 (ICD 7–9) and C00–D48 (ICD 10). The calculation of
Japanese life expectancy in the inter-group comparison and of the life expectancies
for the G7 countries in the supra-group comparison were also based on death count
and exposure data from the Human Mortality Database [12]. To ensure that the
supra-group also covers the years 1960-2015 for countries that were missed in the
most recent life expectancy estimates, values were obtained from the World Bank
[15]. The equivalent time in all three examples was calculated using linear inter-
polation between the time series of the comparison population and the reference
population. The whole analysis was conducted in the language R [16].
Results
Figure 2 shows the results for all three comparisons. The rows display the results
for the intra-, inter-, and supra-group comparisons; while the columns show the life
expectancy, the gaps, the slopes and the equivalent times. The slopes are calculated
as annual increases over five-year periods, assuming a linear change between the
respective time points.
The life expectancy level of US males increased continuously between 1960 and
2015 (panel a). Although an increase can also be observed for all three reference
groups, the level of life expectancy differs across the groups, and compared to
the US pattern (panels a–c). The LE gap between US males and the inter-group
reference-category remained fairly stable at a level of about three years, while the
LE gap between US males and the intra-group reference-category declined from one
year higher in 1960 to four years lower in 2015 (panels d–e). The LE gap between
US males and the supra-group reference-category increased from very small in 1960
to about three years in 2015 (panel f).
An assessment based on the pace of improvement alone provides limited insights.
Both cancer-free and average G7 life expectancy had almost the same slopes as that
of US males life expectancy across the different year groups; whereas Japanese life
expectancy increased more rapidly until 1985-89, but changed at almost the same
pace thereafter (panels g–i). However, in general, the slopes varied greatly over
time, which makes it difficult to derive solid conclusions about the advancement of
survival progress.
Compared to the gap and the slope, the ET shows larger differentials in the de-
velopment levels of the reference groups and larger differences between the groups
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in the advancement of survival progress over time. In the intra-group comparison,
US male life expectancy in 1975 is the first value, which can be located on the
reference trend line. In this year, the survival progress of US males lagged around
13 calendar years behind the level that hypothetically could have been achieved if
cancer had been eradicated. This lag grew consistently over time to reach a magni-
tude of almost 19 calendar years in 2015 (panel j). In the inter-group comparison,
we even see that the survival progress of US males was two calendar years ahead of
that of Japanese males in 1960. But by 2015, this advantage had turned into a lag
of almost 21 calendar years (panel k). In the supra-group comparison, US male life
expectancy in 1970 is the first value, which can be located on the G7 average trend
line. In this year, the survival progress of US males lagged around 10 years behind
the average level of progress of the G7 countries. After a period of improvement,
the lag among US males increased consistently to reach a level of 12 calendar years
by 2015 (panel l).
In sum, the results indicate that the survival progress of US males has been in-
creasingly falling behind that of other groups, as reflected in the large increases in
ET among US males over the study period. This is a remarkable insight given that
US life expectancy increased virtually throughout the whole study time at a pace
that was almost comparable to that of the reference categories. At the same time,
the gap between US life expectancy and that of the reference groups remained fairly
stable, at least compared to that of the intra- and supra-group reference categories.
This means that ET is a more sensitive measure of advances in survival than the
comparison of gaps or slopes.
Discussion
In this paper, we have introduced a measure used to assess survival progress, which
we labeled “equivalent time” (ET ). The measure complements the current practice
of comparing development at a single point in time and of comparing changes in
development over time. It offers a simple, generic, and intuitive way to express in
calendar years the delay in the development of a population in comparison to that
of a reference population. We argue that ET has the potential to become a standard
approach in the toolbox that is used for the assessment of survival progress in both
large-scale cross-country comparisons and case studies, and for the evaluation of
single countries. We used period life expectancy as an example to illustrate ET .
Any other continuous variable that is monotonically increasing or decreasing over
time could be used as well.
The simplicity of ET is, of course, also a shortcoming. Since it is build on a single
variable, critics might see ET as an oversimplified measure that does not capture
the multiple dimensions of development. This criticism is certainly justified. Thus,
in cases in which reliable data on other dimensions are available, the use of more
complex measures might indeed be more appropriate. However, for many countries,
and particularly for longer historical periods, such data are often not available.
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The idea of using lags to assess survival progress was already suggested by Stol-
nitz more than 60 years ago [17]. He applied this approach in studying the delays
in mortality decline in non-western countries relative to those in western countries.
Surprisingly, we are not aware of any other study that has applied this approach.
More recently, Goldstein and Wachter used a comparable concept to study the re-
lationship between cohort and period life expectancy within countries [18]. They
defined the lag as “how far back in time from the current period we have to go
to find a cohort with equivalent life expectancy” [18, pp. 259]. The general idea
of time lags has also been used to evaluate the decline in age-specific mortality by
expressing the improvement in ages with equivalent mortality levels, which are usu-
ally called “equivalent ages” [19, 20]. While these earlier studies focused on detailed
aspects of mortality and survival, our definition of ET is more general and refers
to cross-country comparisons of overall survival progress.
ET adds a dynamic component to research on differentials in survival advances;
or, more generally, of advances in population development. The previous literature
on this topic is dominated by studies examining the gap between specific measures;
i.e., differences between countries at a certain point in time. For example, Drefahl
et al. [21] used the declining ranking of Sweden across countries with the highest
life expectancy as the initial impetus for investigating why Swedish life expectancy
is “losing ground”. By comparing the best- and the worst-performing US counties,
Wang et al. [22] investigated the question of why US life expectancy lags behind
that of other high-income countries, even though health care expenditures in the
US are the highest in the world. Jasilionis and Shkolnikov [23] used life expectancy
differentials between different educational groups to study the relationship between
education and the longevity increase. They suggested that the trajectory of the
highly educated group shows the way to higher levels of life expectancy for other
population groups. The Human Development Index includes a measure based on
the gap between an observed life expectancy and a hypothetical minimum life ex-
pectancy divided by the range between the hypothetical minimum life expectancy
and the highest observed life expectancy in a specific calendar year [6]. The Global
Burden of Disease research program [10] uses a similar approach to assess progress
on a large collection of health and mortality indicators in 188 countries. Similar
to the Human Development Index, the program’s progress benchmark is a scale
bounded by the best- and the worst-performing population for each indicator at a
certain point in time. Since all of these studies target a dynamic research question,
a delay-based measure such as ET could add to their analyses.
Using an illustrative example, we proposed a potential application of ET that
complements classical approaches. The application of ET to the case of US males
life expectancy between 1960 and 2015 revealed that LE in this group was increas-
ingly falling behind, even though it increased almost continuously over the whole
study period; and that the LE gap between US males and the reference groups was
more or less constant over most of the study period. For instance, the application of
ET showed that relative to their Japanese peers, US males experienced a delay in
LE development of two decades. This is an intriguing result, especially given that
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the US has the highest health care expenditures in the world [22]. In this context,
earlier studies have demonstrated that the quality of health care — in the form of
both treatment and the use of more aggressive measures to discourage poor health
behaviors like smoking — plays a crucial role in further lowering death rates [24–26].
In future research, the usefulness of ET as a measure of differentials in survival
progress and in advances in general development should be examined. Among the
promising research settings for measuring these differentials are the countries of
western and eastern Europe before and after the fall of the Iron Curtain in 1990, as
well as eastern and western Germany before and after reunification [27, 28]. Similar
exercises might be carried out by examining the ET of countries during the imple-
mentation of large policy reforms or economic crises. Moreover, ET might be useful
for studying the burden of certain diseases in a population. Since ET allows us to
quantify the delay in development due to a specific disease, it may, for example, be
used to investigate the consequences of eradicating cancer [29].
Conclusion
In addition to introducing another tool for measuring progress and development, we
were able to show in this paper that the assessment of the performance of a specific
country is not straightforward. Rather, we illustrated that such assessments are
sensitive to the selected indicator (e.g., life expectancy), perspective (gap, slope,
lag), and reference (e.g., G7 countries). It is therefore important to use care in
interpreting results that are based on a single measure, perspective, or reference.
If possible, multiple factors should be taken into account for each of these dimen-
sions. The concept of equivalent time represents a new (or rejuvenated) approach
for studying advances in development. Using a single number, the measure reflects
both the differences in development at a certain point in time and the pace of
change over time. ET therefore offers a simple and intuitive way of expressing the
delay in the development of a given population relative to the development of a
reference population.
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Figure 1 Schematic representation of measuring advancements in the decline of mortality.
Tables
Table 1 Classification of different kinds of references for the evaluation of survival progress. The
listed examples are using the reference perspective in at least some part their empirical analysis.
Type Example Pitfall Exemplary Study
Intra-group e0,Country A – e
−i
0,Country A w/o health burden i
peculiarity or commonality? Aburto et al. [30]
Inter-group e0,Country A – e0,Country B prime example or exception? Mesle´ and Vallin [31]
Supra-group e0,Country A – e0,Cross-country average common trend? Bongaarts [32]
e0 –Life Expectancy at Birth
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Figure 2 Life expectancy, gap, slope (annual change over five-year periods), and equivalent
time of US life expectancy compared to that of three references, males, 1960-2015. All
estimates are based on period life tables. The slopes indicate the annual change between the two
years, comprising five-year intervals. The last group, 2010-15, comprises six years. The slope
calculation is based on the assumption of a linear change between the two time points. Equivalent
time is calculated using linear interpolation.
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How has the lower boundary of human mortality
evolved and has it already stopped decreasing?
Marcus Ebeling1,2
Abstract
In contrast to the upper boundary of mortality, the lower boundary has so far
largely been neglected. Based on the three key features location (1), sex-specific
difference (2) and level (3), this paper analyzes past and present trends in the
lower boundary of human mortality. The analysis is based on cohort mortality
data for 38 countries, covering all the cohorts born between 1900 and 1993. Min-
imum mortality is analyzed using observed as well as smoothed estimates. The
results show that the ages at which minimum mortality is reached have shifted to
lower ages. Although the differences have become almost negligible over time,
males are showing higher levels of minimum mortality than females. The level of
minimum mortality was halved more than five times over the analyzed time hori-
zon. The results also suggest that even after more than one and a half centuries of
mortality improvements, minimum mortality has not yet reached a lowest limit,
and is likely to decrease further in the near future. Trends in the three key features
also raise questions about the importance of evolutionary, social, and biological
determinants for the recent and future development of minimum mortality.
1 University of Rostock, Rostock, Germany
2 Max Planck Institute for Demographic Research, Rostock, Germany
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Introduction
Whereas the upper boundary of mortality (maximum mortality) is a topic that has pre-
viously attracted the attention of scholars (e.g., Gampe, 2010; Rau et al., 2017), the topic
of the lower boundary (minimum mortality) has so far largely been neglected. In this
paper, we aim to analyze past and current trends in the ages and levels of minimum
mortality, as well as the sex-specific differences in minimum mortality.
The steady decline in mortality is one of the greatest success stories in human his-
tory (Oeppen and Vaupel, 2002; Riley, 2001). Mortality rates across almost all ages
have been consistently declining to lower and lower levels for more than one and a
half centuries.While the successive improvements have been unprecedented, the mor-
tality trajectory has retained its key features (see Figure 1): For example, levels of in-
fant mortality have been consistently similar to mortality levels between ages 60 to 80.
Moreover, adult mortality has shown a log linear increase over age, and mortality lev-
els between infancy and early adulthood have followed a U-shaped pattern.
As mortality declined in developed countries, the main improvements in life ex-
pectancy shifted from younger to higher ages (Christensen et al., 2009). Today, the con-
tributions of the youngest ages to the increase of the average age at death are almost
negligible. Nevertheless, in almost all countries of the world, mortality at younger
ages has been decreasing continuously (Armour-Marshall et al., 2012; Verguet et al.,
2014). Consequently, the U-shaped mortality trajectory between infancy and juvenile
ages has become more and more pronounced over time (see Figure 1). Minimum mor-
tality represents the inflection point of this pattern; i.e. it marks the lowest mortality
level across ages, and the threshold between mortality decrease and increase over age.
[Figure 1 about here]
Together with the maximum level, minimum mortality embraces the range of age-
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specific mortality. The maximum mortality level has been estimated at a level of
around 7,000 deaths per 10,000 person-years lived, indicating the magnitude of the
late-life mortality plateau (Gampe, 2010). Minimum mortality cannot be assessed to
a specific level. Minimum mortality declined from around 30 per 10,000 to a level of
less than one per 10,000 over the time horizon of 150 years (see Figure 1). The plas-
ticity of the lower boundary compared to the stability of the upper boundary points
to the most important difference between the two. Explanations for the stable upper
boundary are diverse, and range from a more homogeneous population composition
at those ages to physiological and genetic aging processes (Wachter, 1999; Pletcher and
Curtsinger, 1998; Missov and Vaupel, 2015; Vaupel et al., 1998). Minimum mortality, by
contrast, appears to (still) be alterable. Most importantly, improved living standards
(e.g., better sanitation and nutrition) and medical breakthroughs, such as antibiotics
and vaccinations, are the main reasons for the survival gains at childhood and juvenile
ages (Cutler et al., 2006; Blum, 2009; Gore et al., 2011). The major causes of death at
those ages have shifted away from infectious diseases and toward behavioral causes
(Blum, 2009). Today, injuries and non-communicable diseases are the leading causes
of death for people aged 5 to 14 in low-mortality countries (Patton et al., 2009).
After the degree of alterability, the location is the second major difference between
minimum and maximum mortality. Maximum mortality is located at the end of the
lifespan, whereas minimum mortality is reached within a tiny age range at the end of
the first decade of life. It marks a specific point over the life course at which physical
and social development levels are most favorable for withstanding the risk of death.
The explanations of why mortality levels are lowest in this exact age range are mainly
drawn from evolutionary mechanisms, such as high selection pressure prior to the be-
ginning of the reproductive period; i.e. the proximity of these ages to the onset of
sexual maturity (Burger et al., 2012; Chu et al., 2008; Levitis, 2011). However, for both
males and females, scholars have observed over the past century temporal changes in
related processes, such as faster body growth or the earlier onset of puberty (Frisch,
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1978; Tanner, 1973; Goldstein, 2011; Scho¨nbeck et al., 2012). The location of minimum
mortality might be similarly affected by these shifts.
Male-female differences are the third key feature that could reveal further dispar-
ities between maximum and minimum mortality. The question of whether there are
sex-specific differences in maximum mortality cannot be answered clearly. Gampe
(2010) found no relevant differences between the male and female levels, whereas Rau
et al. (2017) documented higher levels for males. Among children and adolescents,
mortality is higher for males, despite the fact that the absolute gap becomes smaller
with decreasing levels of mortality (Gissler et al., 2009). Surprisingly, external causes
of death as an indicator for sex-specific risk-adverse behavior explain only a minor part
of the male-female differences (Gissler et al., 2009). For example, Gissler et al. (2009)
measured a higher rate of non-external causes for boys than for girls. It therefore ap-
pears that additional factors must be responsible for these differences.
An assessment of minimum mortality could have also implications for the develop-
ment of methods and models in mortality research. For instance, mortality forecasting
approaches usually assume that death rates have no lower limit. Instead, the loga-
rithm of death rates is used, which allows rates to decline infinitely, while staying be-
tween zero and one (see, for instance, Hyndman and Ullah, 2007; Lee and Carter, 1992).
A proof seems impossible, as the question of whether mortality rates can decline in-
finitely has yet to be answered. Examining trends in minimum mortality can help us
better understand the dynamics at the lower edge of human mortality. Moreover, at-
tempts were made in previous parametric mortality models, such as the Siler-model
(Siler, 1983) or the Heligman-Pollard model (Heligman and Pollard, 1980), to include
mortality at all ages; and thus the decreasing and increasing parts of age-specific mor-
tality, which are connected by minimum mortality. Mortality modeling could benefit
from an investigation of minimum mortality in, for instance, the refinement of existing
models or the development of new models.
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Based on these considerations, three essential key questions should be asked when
seeking to identify the characteristics of the lower boundary of mortality. First, how
pronounced are the sex differences in the lower boundary of age-specific mortality?
Second, at which ages is minimum mortality located, and how have these ages changed
over time? Third, how has the level of minimum mortality evolved, and is minimum
mortality still decreasing? Given the unprecedented mortality improvements of the
past, it is not far-fetched to hypothesize that minimum mortality might be the first
mortality rate that finally hits a lower (natural) limit; and that therefore indicates the
absolute frontiers of human mortality improvement.
Data
We have chosen a cohort perspective to estimate minimum mortality. Only a cohort
follow-up ensures a life course perspective, and thus the clear identification of the
lowest mortality rate over age. Because the mortality rates of several cohorts are com-
bined in period perspective, period-based estimates could be distorted by peculiarities
across cohorts, such as fluctuating birth cohort sizes or unexpected external shocks
and changes, like political crises or medical breakthroughs. In addition, many forces
shaping minimum mortality such as selection work in cohort direction. Hence, a co-
hort perspective allows to evaluate and discuss the trends in the light of these potential
explanations and determinants. This is not readily possible in a period based compar-
ison. Furthermore, a cohort perspective still covers a sufficient observation time and
provides current values, since minimum mortality is located at an early stage of life.
We use cohort data from the Human Mortality Database (2017). Death counts are
given by Lexis–triangles. Accordingly, the full death counts for one age are the sum
of two consecutive triangles in cohort direction. The two triangles are spread over
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two periods, and thus the end-year/start-year population between them is used as
the exposures-to-risk (see the supplemental information for an illustration). For most
countries, the majority of raw data for death counts in the Human Mortality Database
are given by Lexis–triangles. Especially at the beginning of the 20th century, this num-
ber was growing. For other countries and periods with raw data of a different struc-
ture, a regression approach is applied to split the death counts within a Lexis–square
into counts by a Lexis–triangle (see Wilmoth et al. (2007) for further details). All es-
timates are based on data for ages one to 20. The earliest cohort considered includes
those born in 1900. For some countries, the data start later in time. The last cohort
available also varies by country. Countries with data covering fewer than 20 cohorts
are excluded from the analysis. (see the supplemental information for further details).
Methods
Although data from the Human Mortality Database cover national populations and
can thus be considered complete enumerations, the data are still subject to stochastic
variation (Udry et al., 1979; Kirkby and Currie, 2010; Klotz, 2016). For instance, Udry
et al. (1979) have demonstrated that the smaller a population is, the more unstable
the respective mortality rates are. In addition, it is usually assumed that the underly-
ing mortality process is smooth (see also Kirkby and Currie, 2010). Minimum mortal-
ity could be considered to be especially vulnerable to population size and stochastic
variation because of its low intensity. Hence, around the age of minimum mortality,
mortality could be quite noisy. Minimum mortality contains another, rather technical
and theoretical problem: namely, that mortality rates are bound at zero at the lower
end. In low-mortality countries with a small population size, mortality at some ages
below 20 is already at such low levels that the number of age intervals without any
deaths is consistently increasing over time (see the supplemental information for fur-
ther details). To deal with zero death rates and stochastic variation, we complement
the analysis of observed trends with estimates based on a two-dimensional smooth-
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ing approach. Although using other approaches is also conceivable, we have chosen a
smoothing approach for count data developed by Camarda (2012), and applied it over
age and cohort. The main reason for this choice is that the approach was developed to
capture the data-generating process behind mortality, which is assumed to be Poisson
(Brillinger, 1986). Therefore, the approach can also process intervals with zero death
counts. Furthermore, the approach provides a sufficient fit to both mortality and the
age of minimum mortality (see the supplemental information for further details on
method evaluation and selection). However, model testing and evaluation were nec-
essary to determine the best calibration for the problem at hand.
The approach by Camarda (2012) uses P-splines within a generalized linear array
model. This or a similar approach is widely used in practice to smooth observed mor-
tality rates (see, for instance, Colchero et al., 2016; Bohk-Ewald and Rau, 2017; Cur-
rie et al., 2004). The method relies on the assumption that death counts are Poisson-
distributed over age and time. The Poisson assumption implies that the mean and the
variance are equal. However, for most countries in the dataset, variance is considerably
higher (or lower) than the mean, and the Poisson assumption is therefore violated (see
the supplemental information for further details). This phenomenon is known as ex-
tra Poisson variation, or (under-) overdispersion (Breslow, 1984; Djeundje and Currie,
2011). Data may be overdispersed for a number of reasons. In many cases, popula-
tion heterogeneity and unexpected events, such as period shocks, are responsible for
the overdispersion. Since variance is higher than the mean, incorporating overdisper-
sion is especially important when seeking to generate robust standard errors. The ap-
proach by Camarda (2012) can integrate this specific feature by allowing the variance
to change proportional to the mean. Furthermore, because the Poisson assumption al-
lows for the incorporation of age intervals without any deaths, the approach is able to
utilize this information. The method is readily available via the package “MortalityS-
mooth” for the statistical programing language R (2016).
7
The occurrence of period shocks, such as the Spanish flu or a war, can lead to prob-
lematic estimates when two-dimensional smoothing approaches are applied, because
in such situations the respective mortality rates are subject to more than just stochastic
variation (Kirkby and Currie, 2010; Palloni, 1990). When the two dimensions are co-
hort and age, the situation becomes especially difficult because the period shocks are
located on a backward 45-degree line in the age-cohort surface. Hence, in the model
calibration, we investigated the influence of such ruptures by fitting them with and
without information about ages, which are affected by period shocks. Due to the data
structure, we excluded the 1915–1919 and 1938–1947 periods, which cover the Spanish
flu and World Wars I and II. The P-spline approach we used interpolates the emerging
gaps, which are generated when the mortality of the respective ages is ignored.
Based on the evaluation and model testing, the following settings were used to
obtain smooth minimum mortality estimates (see the supplemental information for
further details). Irrespective of the impact in the specific country, we excluded war
years to ensure a consistent analysis framework. To avoid potential distortions, we
restricted the range of ages to be searched for the minimum mortality to the ages five
to 15; which is theoretically reasonable given the range of observed ages. We also de-
cided to control for overdispersion across all countries to provide consistency. Even
after these restrictions were applied, overdispersion or underdispersion was found in
almost all of the countries (see the supplemental information for further details).
Results
Level of minimum mortality: Figure 2 shows the level of minimum mortality for
males and females in France. The supplemental information contain the minimum
mortality trajectories for all other countries. The graph depicts the level of minimum
mortality per 100,000 person-years lived. Levels are shown on a log-scale, using the
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logarithm of two to emphasize level halving. Accordingly, the horizontal contour lines
mark the consecutive halving of the mortality level. The solid lines are minimum mor-
tality estimates based on the age-cohort smoothing and the colored area around this
line indicates the 95% confidence interval. The plus signs indicate observed minimum
mortality. The squares mark the observed minimum mortality for cohorts who spent
at least one year in the omitted periods (1915–1919, 1938–1947). Females are colored in
red and males in blue.
[Figure 2 about here]
In Figure 2, we can see that minimum mortality declined from almost 250 deaths
per 100,000 person-years lived to around 10 deaths per 100,000 person-years lived over
the cohorts born between 1900 and 1993. Over the course of this decline, the trajecto-
ries for French males and females show four periods with distinct developments (see
tags in Figure 2). Minimum mortality improves only slowly in the first period (I),
which encompasses the cohorts born between 1900 and 1920. The second period (II)
is characterized by rapid improvements. This period spans the cohorts born between
1920 and 1950. In the third period (III), minimum mortality improvements decelerated,
and were close to stagnation at certain points. This trend lasts up to the cohorts born
in the early 1960s. The fourth period (IV), which runs until the most recent cohorts,
again shows steady improvements. The trajectory of France is exemplary of the tra-
jectories observed in the majority of countries analyzed. Variation can only be found
in small temporal differences and in the manifestation of patterns in the four periods
described. Only the minimum mortality levels for a few countries, such as those of
Russia or Belarus, deviate from the general trend. In these countries, the improve-
ments in minimum mortality over the analyzed cohorts are marginal to non-existent.
Figure 3 shows the minimum mortality levels for three recent cohorts (1970, 1980,
and 1990) for all of the countries observed. The countries are ordered based on the
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minimum mortality level of the 1990 cohort, with the lowest to the highest values be-
ing displayed from left to right. To identify the significance of differences in the most
recent estimates (1990), minimum mortality for the 1990 cohort is depicted with the
corresponding 95% confidence interval, which is illustrated by the bar around the re-
spective median estimate. Note that the axes for males and females have different
ranges.
[Figure 3 about here]
Japan currently has the lowest minimum mortality levels at around eight deaths
for females and 10 deaths for males per 100,000 person–years lived. For the females
of the 1990 birth cohort, the three countries with the lowest minimum mortality lev-
els are Japan, Sweden, and Northern Ireland; while for the males of 1990 birth cohort,
the three countries with the lowest minimum mortality levels are Japan, Austria, and
Sweden. Note that the estimates for Luxembourg and Iceland rest on data with many
zero death rates, and should therefore be interpreted with care. The levels among the
best-practice countries are very close to each other, which is reflected in the black solid
trend and the overlapping confidence intervals. This overlapping, which applies to
almost half of the countries, suggests that the differences are marginal, and are not
statistically significant. Therefore, efforts to rank or select clear leaders would be inap-
propriate. However, among the countries with the highest minimum mortality levels,
clear distinctions can be made. Russian males and females have by far the highest
levels. Males and females in other Eastern European and Baltic countries, as well as
in Portugal, also have relatively high minimum mortality levels. Among the G7 or
the countries with the greatest economic power, no uniform pattern can be observed.
These countries are spread over the remaining rankings above the group of the worst
performing countries.
The finding that mortality has declined continuously across almost all countries,
and especially among the most recent cohorts, supports the assumption that minimum
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mortality for both males and females is likely to decrease in the near future. All of the
countries studied showed at least a marginal decline in mortality over time. Moreover,
in the majority of these countries, a stable pattern of improvement could be observed
in the cohorts born since the 1970s; and this trend may be expected to continue.
Age of minimum mortality: The results for the minimum mortality ages can be
seen in Figure 4. The observed mortality rates as well as the smoothed mortality rates
are given by age. Hence, the ages of minimum mortality are also measured in in-
tegers. Due to stochastic fluctuations and the impact of the world wars, minimum
mortality ages based on the smoothed mortality estimates are considered as the basis.
Furthermore, the trends across countries are very homogeneous, and show only small
variations. Therefore, we pooled the ages of minimum mortality across countries and
summarized the results for 10 consecutive cohort groups. Due to the varying length of
the data, the number of ages in each of these 10 groups differs.
[Figure 4 about here]
The age of minimum mortality decreased over the cohorts studied. This trend is
also visible if we look at the ages based on the observed mortality estimates. For the
cohorts up to the cohorts born in 1920–1929, the modal value jumps between ages 11
and 12. The distribution of males and females for the 1930–1939 and 1940–1949 cohorts
are right–skewed, which means that ages higher than the mode are observed more fre-
quently than younger ages. This is, however, likely an effect of World War II. Although
minimum mortality among the cohorts born in 1950–1959 or later has been relatively
consistently located at age 11, the distribution is shifting toward younger ages. The
shift is indicated quite well by the growing frequency of age 10 as the age of minimum
mortality over the respective groups. Accordingly, for the last two cohort groups, the
modal value is already located at age 10, and ages above and below the mode are al-
most evenly observed. However, the growing frequency of age nine over the last two
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cohort groups could suggest that the shift toward younger ages might be continuing.
In addition to the location of minimum mortality, we also analyzed the form of
the U-shape pattern, using the ratio of death rates at ages adjacent to the age of min-
imum mortality (see the supplemental information for more details). However, there
is no clear trend across cohorts, countries or sexes. For some countries, the U-shape
remained almost constant, whereas in other countries considerable difference are visi-
ble. Therefore, the location of minimum mortality is much more clear in some countries
than in others.
Sex–specific differences: The sex-specific differences in the ages of minimum mor-
tality are declining over the cohort groups. For the first three cohort groups, the fre-
quency of the modal value is more pronounced for females than for males. However,
especially for the post-war cohorts, the distributions for both males and females are
almost similar.
[Figure 5 about here]
Figure 5 shows the absolute male–female differences in the levels of minimum mor-
tality for all of the countries analyzed. The trajectories of Japan, Russia, France and
Norway are highlighted. A negative difference expresses higher mortality for females
and vice versa.
The development of sex–specific differences over time shows two distinct patterns:
higher female mortality with a consistently growing male disadvantage followed by a
trend toward convergence. In all of the countries observed from the 1900 birth cohort
onward, the female minimum mortality levels were higher in the first 10 to 20 cohorts;
albeit with vastly differing magnitudes. For instance, in the 1900 birth cohort, the
minimum mortality level of females was around 25 deaths per 100,000 person-years
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higher than that of males in France, whereas the female minimum mortality level was
only around seven deaths higher than that of males in Norway. However, the start-
ing level is also the point at which the female disadvantage was the greatest. The
gender gap decreased steadily, with males and females reaching similar levels of min-
imum mortality somewhere between the 1905 and the 1920 birth cohorts. Thereafter,
these varying developments continued and the sex-specific differences widened once
again. The gender gap in minimum mortality rates peaked among the 1940 birth co-
hort. For example, French males of the cohorts born between 1935 and 1940 had mini-
mum mortality levels that were around 15 deaths per 100,000 person-years higher than
the minimum mortality levels of their female peers. The growing male disadvantage
was mainly driven by the rapid improvements in minimum mortality among females
in the cohorts born between 1920 and 1940. After the male disadvantage reached its
maximum level, the levels converged steadily in almost all of the countries. Russia has,
however, been an exception to this overall pattern. Among the most recent Russian co-
horts analyzed, men have a minimum level that is still around 20 deaths per 100,000
person-years higher than that of females; whereas in, for example, Japan, France, and
Norway, the absolute male-female differences are almost negligible.
Discussion and Conclusion
Whereas the upper boundary of mortality is a topic that has previously attracted the
attention of scholars, the issues surrounding the development and characteristics of
the lower boundary have so far been neglected. The lower boundary, hereafter also
called minimum mortality, is the lowest mortality rate across ages. It is located at the
bottom of the U-shaped pattern, which describes the trajectory of childhood and early
adolescent mortality. This paper addresses the past and the present developments of
three key features of minimum mortality: level, location, and sex-specific differences.
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Our analysis rests on cohort mortality data. The lengths of the available time se-
ries vary by country, with a maximum range covering the cohorts born between 1900
and 1993. In addition to using observed trends, we complemented the analysis with
smoothed mortality estimates using a two-dimensional P-spline approach over age
and cohort (Camarda, 2012). This approach was selected after it was compared with a
locally weighted regression, tested, and assessed under different model specifications
(see the supplemental information for more details). To prevent the distortion of the
minimum mortality estimates by period shocks, we excluded the data for the ages that
were affected by World Wars I and II.
Although we removed the war years, a remaining effect of the two world wars can-
not be ruled out completely. The temporary acceleration in the decline of minimum
mortality for the 1920-1950 cohorts in the smoothed as well as in the observed esti-
mates is visible in almost all of the countries, but the pattern is especially pronounced
in countries such as Italy, France or England and Wales, which experienced war on
their territories. Those estimates probably do not reflect the real minimum mortality,
and are additionally influenced by post-war improvements. Thus, the estimates might
not reflect the minimum mortality levels that would have been observed in the absence
of war. A further problem for small populations with decreasing mortality is the emer-
gence of age intervals without any deaths. Although the P-spline approach is able to
handle this phenomenon, the estimates for Iceland and Luxembourg in particular are
not reliable, and should be interpreted with care. The number of such intervals within
one cohort increases constantly over time, and reaches problematic levels. For exam-
ple, the Icelandic cohorts born between 1975 and 1992 contain an average of 11 such
intervals for males and 12 such intervals for females between ages one and 20. Given
their sudden appearance, the zeroes in Iceland might even be subject to data problems.
The level of minimum mortality decreased continuously over the observed time pe-
riod. Furthermore, the pace of improvement among recent cohorts has been rela-
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tively steady. Therefore, recent trends do not suggest an imminent end to this de-
cline. Among the best-practice countries, the current levels are about eight deaths
per 100,000 person-years for females and about 10 deaths per 100,000 person-years for
males. However, the lower boundary of mortality has not been decreasing constantly.
Especially among the post-war cohorts, improvements slowed temporarily, with some
countries even experiencing stagnating or slightly increasing levels. The reasons of
why minimum mortality stagnated and declined again are open to speculation. The
introduction of mass immunization for several diseases in the 1960s could hint at po-
tential explanations (Riley, 2001). Other factors such as the changing fertility-related
behavior at that time (Billari and Kohler, 2004) or changes in the child care (Vandell
et al., 2010) might also serve as potential explanations. Given that the current levels
are unprecedented, it is even more intriguing that the lower boundary of mortality has
still not reached a lowest limit after almost 170 years of continuous mortality improve-
ments. The question of whether minimum mortality has a lower limit remains open
and continues to present challenges. If such a limit does exist, mortality might follow a
constant force of mortality, whereby simply good or bad luck are the essential mortal-
ity determinants. However, recent developments in childhood health challenge such
optimistic and futuristic thoughts. For instance, Bru¨ne and Hochberg (2013) found that
chronic diseases in childhood such as obesity, diabetes or autoimmune diseases have
been increasing, especially since the late 1980s. They argued that changes in the envi-
ronment favor this development; speculating that evolutionary and medical factors —
such as thrifty genes, hygiene, fetal programming, or the extensive intake of cow’s milk
— might explain this trend. Although rising prevalence of chronic diseases in child-
hood might not have an immediate effect on death, they could potentially increase
the vulnerability, and thus, have an indirect effect on the level of minimum mortality.
However, based on our results, we cannot confirm any negative influence of such a de-
velopment on the improvement of minimum mortality up to the most recent cohorts.
The minimum mortality age shifted toward lower ages. For the oldest birth cohorts
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analyzed, minimum mortality was mainly located at age 12. Over time, however, the
modal value shifted toward lower ages, and the distribution around this modal value
moved to lower ages. In the most recent cohorts, the lower boundary of age-specific
mortality is located at age 10. The location of the lowest mortality across ages is closely
associated with the onset of sexual maturity. Evolutionary theories of aging argue that
evolutionary fitness, defined as the intrinsic rate of natural increase, is most sensitive
to mortality changes around the age of sexual maturity (Hamilton, 1966). Accordingly,
selection pressure on age-specific mortality should be highest around the onset of the
reproductive period, when the respective mortality rates are pushed to their lowest
possible levels. Similarly, the age of maturity itself should be under strong selection
pressure as a key age that defines the onset of reproduction. Other authors have also
argued that intergenerational transfers, such as parental care, shape selection pres-
sure and are an important determinant of the shape of human life history, and thus
of, mortality (Gurven et al., 2012). Consequently, the investments of older generations
in younger generations lead to a concave shape of selection pressure, which may push
mortality down even further at the onset of the reproductive period, when such invest-
ments start to pay off (Chu et al., 2008; Lee, 2003; Bogin, 1997). As a result of the close
relationship between the location of minimum mortality and sexual maturity, it could
be hypothesized that the earlier occurrence of minimum mortality might be related to
temporal changes in different aspects of childhood development such body growth,
and perhaps as a consequence, the earlier occurrence of puberty and sexual maturity,
which has been reported by a number of authors (Goldstein, 2011; Tanner, 1973; Frisch,
1978; Scho¨nbeck et al., 2012). However, the similar locations of minimum mortality of
males and females could be seen as a sign against this idea because different stud-
ies provide evidence for a slightly earlier onset of the puberty of females, which also
holds for the transition through the different development stages of sexual maturity
(Susman et al., 2010; Lee, 1980). In addition to these factors, Levitis and Martı´nez
(2013) have offered further hypothesis for why juvenile mortality is U-shaped, and for
why we therefore see an inflection point between the decreasing and the increasing
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parts of mortality over age. However, the plasticity of minimum mortality challenges
all of these concepts. Given the enormous gains that have been made over a short pe-
riod of time, it is possible to speculate about whether human progress has decoupled
minimum mortality from evolutionary mechanisms — or has, at least, weakened the
relationship between them.
The development of absolute sex-specific differences in the lower boundary of mor-
tality shows two distinct patterns: higher female mortality with a consistently growing
male disadvantage, followed by a trend toward convergence. In the oldest cohort an-
alyzed, females had higher minimum mortality levels. Tuberculosis could be one po-
tential explanation for this female excess mortality. Different authors document higher
tuberculosis death rates of females in the respective age range (10-14) for similar co-
horts as well as for calendar years, in which the respective cohorts reached their mini-
mum mortality (Frost, 1995; Springett, 1952b,a). Further reason such as discrimination
related to sex or birth order (Modin, 2002) are conceivable but remain as vague specu-
lations. The female disadvantage turned relatively rapidly into a male disadvantage,
which reached its maximum level at some point among the interwar cohorts. Since
then, a continuous trend toward convergence can be observed. The male disadvantage
is the result of slower improvements in the minimum mortality levels of males than of
females. These pace differentials are striking because the usual determinants of sex-
specific differences, such as lifestyle and behavioral factors, should be less relevant at
these ages. We can speculate that excess mortality, caused by environmental condi-
tions is decreasing more quickly among females than among males. Furthermore, it
is possible that after this type of excess mortality is no longer relevant the gender gap
will be primarily driven by biological factors. Currently, communicable diseases can
be excluded as a potential driver and external causes of death explain only a small
part of the gender gap (Gissler et al., 2009). Accordingly, non-behavioral causes and
non-communicable diseases could be emerging as the potential drivers. Studies that
used cancer — a leading cause of death in childhood in the developed countries —
17
to illustrate this development found that boys are more likely than girls to develop a
childhood cancer (Kaatsch, 2010; Dorak and Karpuzoglu, 2012).
It is clear that at the minimum mortality age, the physiological and social consti-
tutions of humans are most capable of withstanding death. Following Belsky et al.
(2015), we argue that aging research should focus on the age groups that are still in the
very early stages of the aging process. In their study, they focused on individuals aged
26–38. Minimum mortality as such marks the inflection point between decreasing and
increasing mortality, and could thus be interpreted as the point at which aging begins.
Hence, investigating the aging process starting from the age of minimum mortality
might prove to be even more intriguing. We could then ask the following questions:
Are there some lessons we can learn from the findings on minimum mortality about
how aging and mortality might be postponed to or altered at later ages? Are we able to
extend minimum mortality levels to the point of developing a second mortality plateau
at younger ages? Or does minimum mortality reflect the baseline level of mortality if
humans did not age? These are all non-trivial questions for which there may be no
clear answers. However, they all invite further investigation into the lower boundary
of human mortality.
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Figure 1. Age-specific mortality, France, females, years 1850,1900, 1950, and 2000.
Mortality rates are smoothed. Source: Own illustration using age-specific death counts and
exposures-to-risk from the Human Mortality Database (2017).
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Figure 2. Minimum mortality, France, females and males, birth cohorts 1900–1993.
The graph depicts the observed (squares and crosses) as well as the smoothed (solid line)
minimum mortality. The observed rates marked with a square indicate the cohorts who spent
at least one year in the omitted periods (World Wars I and II). The colored area around the
smoothed minimum mortality estimates depict the 95% confidence interval as calculated by
the approach of Camarda (2012). Minimum mortality rates are illustrated using the logarithm
with basis two. The solid gray grid lines and the Roman numerals mark the different periods of
development. Source: Own illustration using age- and cohort-specific death counts and
exposure-to-risk from the Human Mortality Database (2017).
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Figure 3. Minimum mortality, females and males, birth cohorts 1970, 1980 and 1990.
The graph depicts the levels of minimum mortality for the 1970, 1980 and 1990 birth cohorts
for all countries analyzed. Note that for Bulgaria, the last available cohort was born in 1989.
Countries are ordered according to the minimum mortality level for the cohort born in 1990,
with the lowest to the highest levels displayed from left to right. The bars around the median
estimate of the 1990 birth cohort depict the 95% confidence interval, as calculated by the
approach of Camarda (2012). Note that the vertical axis has different ranges for males and
females. Source: Own illustration using age- and cohort-specific death counts and
exposure-to-risk from the Human Mortality Database (2017).
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Figure 5. Absolute male–female minimum mortality differences, Japan, Russia,
France and Norway, birth cohorts 1900-1994. The gray lines depict all of the other
countries included in the analysis. The sex–differences are calculated based on the smoothed
minimum mortality estimates. Source: Own illustration using age- and cohort-specific death
counts and exposure-to-risk from the Human Mortality Database (2017).
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1
1 Country-specific details
Table 1. Overview of the country-specific details. An overdispersion parameter close to
one indicates that there is no overdispersion. A parameter (smaller) bigger than one indicates
(under-) overdispersion. Zero death depicts the number of age intervals without any death
over the entire cohort range. Data: Human Mortality Database (2017)
Males Females
Overdispersion Parameter Overdispersion Parameter
Country Cohort Range w Shocks w/o Shocks zero Death w Shocks w/o Shocks zero Death
Australia 1920–1990 1.1096 0.9590 0 1.0598 0.8942 2
Austria 1946–1993 1.0959 1.0959 0 0.9977 0.9946 1
Belgium 1918–1994 2.2458 1.0370 0 1.6513 1.1506 1
Bulgaria 1946–1989 1.7444 1.7356 0 1.7718 1.7626 0
Belarus 1958–1993 1.0168 1.0168 0 0.7194 0.7194 0
Canada 1920–1990 1.5618 1.2300 0 1.4573 1.1523 0
Switzerland 1900–1993 1.6633 1.0885 0 1.7624 1.0983 4
Czech 1949–1993 1.1055 1.1055 0 1.0871 1.0871 0
East Germany 1955–1992 1.4714 1.4714 0 1.2217 1.2217 0
West Germany 1955–1992 1.8816 1.8816 0 1.3631 1.3631 0
Denmark 1900–1993 1.4443 0.9926 1 1.3514 0.9759 2
Spain 1907–1993 10.8917 4.8185 0 9.1480 3.8431 0
Estonia 1958–1992 0.8162 0.8162 4 0.8716 0.8716 19
Finland 1900–1994 5.1371 1.3763 3 2.9506 1.2812 3
France 1900–1993 18.8175 2.0831 0 11.8500 1.7096 0
Northern Ireland 1921–1992 0.5730 0.5031 1 0.5735 0.5108 5
United Kingdom 1921–1992 2.5081 1.3913 0 2.1009 1.0925 0
Scotland 1900–1992 1.1885 0.6947 0 1.3090 0.6730 0
England and Wales 1900–1992 13.8741 2.1381 0 7.5534 1.9456 0
Hungary 1949–1993 1.2149 1.2149 0 1.1390 1.1390 0
Ireland 1949–1993 0.5220 0.5220 0 0.6297 0.6297 0
Iceland 1900–1992 0.5678 0.5226 232 0.4639 0.4214 299
Italy 1900–1991 41.6297 4.7319 0 37.7099 4.4166 0
Japan 1946–1993 4.9041 3.9621 0 3.1759 2.1095 0
Lithuania 1958–1992 0.7205 0.7205 0 0.5350 0.5350 0
Luxembourg 1959–1993 0.6319 0.6319 113 0.6211 0.6211 208
Latvia 1958–1992 0.6645 0.6645 0 0.6046 0.6046 0
Netherlands 1900–1991 6.0515 1.0800 0 5.2064 0.9995 0
Norway 1900–1993 1.1325 0.7643 2 1.0105 0.6839 6
New Zealand 1947–1992 0.8661 0.8661 0 0.9191 0.9191 2
Poland 1957–1993 1.3319 1.3319 0 1.0967 1.0967 0
Portugal 1939–1991 1.3432 1.2131 0 1.2641 1.0713 0
Russia 1958–1993 6.2416 6.2416 0 1.8984 1.8984 0
Slovakia 1949–1993 1.0929 1.0929 0 1.1056 1.1056 1
Sweden 1900–1993 2.5450 1.2409 0 2.5207 1.1638 1
Taiwan 1969–1993 1.5302 1.5302 0 0.7381 0.7381 0
Ukraine 1958–1992 2.3891 2.3891 0 1.0001 1.0001 0
U.S.A. 1932–1993 2.7886 2.3596 0 2.0869 1.7153 0
2
2 Illustration of death rate construction
Year
A
ge
t t+1 t+2
x
x+1
x+2
x+3
Average Person−Years
Deaths
Deaths
Figure 1. Illustration of the death rates used for the analysis.
3
3 Method evaluation
To identify an appropriate method, we compared a smoothing approach for count data
developed by Camarda (2012) and a local regression model (LOESS) (Cleveland and
Devlin, 1988; Chambers and Hastie, 1991), both applied over age and cohort. The use
of other approaches, such as GAMs with an appropriate specification of the smooth-
ing function and the distribution of the response (see Wood (2006)), is, of course, also
conceivable (Kafadar, 1994; Currie et al., 2004). However, it is beyond the scope of the
paper to either develop an appropriate approach or to provide an exhaustive method
comparison of several approaches. Thus, availability, practicability, and accuracy are
paramount considerations.
Note that the approach by Camarda (2012) has been described in more detail in the
main text.
In the LOESS, logarithmic mortality rates over age and cohort are required as an
input. Cohort and age are then used as the predictors in the model. To obtain the fit
of a specific point, a weighted least squares regression model is fitted by minimizing
for a set of observations within a pre-specified span around the specific observation.
Weights are distributed so that observations closer to the central point have a higher
weight than observation with a larger distance. Accordingly, a small span results in a
high degree of adaptation to the data and a big span in a rough fit (for more details, see
Cleveland and Devlin (1988) or Chambers and Hastie (1991)). To get the fit of a new
point, a new regression model for a new set of respective observations and weights
must be fitted. We determined the optimal span by using the value that minimizes the
Akaike information criterion (AIC).
Although this approach has advantages over other two-dimensional smoothers
(Kafadar, 1994), the LOESS rests on linear regression. It can also be applied using non-
linear regression with additional quadratic terms for the two predictors. But consider-
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Figure 2. Minimum mortality and minimum Mortality Age estimation under
different model specifications, Italy, males, cohorts 1900–1991. Data: Human
Mortality Database (2017)
5
ing the results of Kafadar (1994), the linear LOESS seems to outperform the quadratic
version. However, the use of linear regression to fit age-specific mortality has been
criticized for several reasons (Pletcher, 1999; Promislow et al., 1999). First, the tech-
nique does not capture the data-generating process, and is thus theoretically wrong.
Accordingly, in the LOESS, errors are assumed to be normally distributed with a con-
stant variance (Cleveland and Devlin, 1988), which is a problematic assumption for
age-specific mortality rates. An additional drawback resulting from the application of
linear regression is that the logarithm of death rates is required as a response to keep
the rates within the range of zero and one. For this reason, the LOESS –in opposite to
the approach by Camarda (2012)– is not able to include zero mortality rates as infor-
mation in the model fit. The respective death rates have to be considered as missing.
These rates are then interpolated by borrowing information from neighboring cohorts
and ages. All of these disadvantages are reasons to reject the LOESS as a potential
method, but we still chose to test it as an alternative to the P-spline approach because
of its great practicability.
As was mentioned in the main text, we excluded the 1915–1919 and 1938–1947 pe-
riods, which cover the Spanish flu and World Wars I and II. Both the LOESS and the
P-spline approach interpolate the emerging gaps, which are generated when the mor-
tality levels of the respective ages are ignored.
We chose Italian males as a comparison basis because even after omitting the war
years, they were affected by the two World Wars and had a large amount of overdisper-
sion, as indicated by their overdispersion parameter (see Table 1 in the main article).
We complemented this assessment by evaluating Swedish males, a small population
among whom the influence of period shocks was weak. The results for Swedish males
can be found in Figure 3.
Figure 2 presents the results of the different models and the respective model spec-
6
Table 2. Model accurracy, residual standard error (RSE), males, Italy, ages 1–20,
cohorts 1900–1991. The RSE is based on the data used to fit the model. RSE in
brackets for models with war years is based on comparing only non-war years. Data:
Human Mortality Database (2017)
Control
Model War Year Overdispersion RSE
P-spline Yes No 0.1434 (0.1172)
P-spline Yes Yes 0.1462 (0.1197)
P-spline No No 0.0866
P-spline No Yes 0.0900
LOESS Yes – 0.2589 (0.1651)
LOESS No – 0.1287
ifications for Italian males. The two upper panels show the results of the P-spline ap-
proach, including the war years, with (left) and without (right) accounting for overdis-
persion. The two middle panels depict the outcomes of the P-splines approach exclud-
ing the wars years, with (left) and without (right) accounting for overdispersion. The
two lower panels illustrate the outcomes of the LOESS with (left) and without (right)
the war years. In addition to the observed minimum rates (squares), the estimated
minimum rate (black solid line) with the 95% confidence intervals (colored area) and
the estimated ages of minimum mortality are shown (solid blue line). Observed ages
are depicted with circles. The left axis depicts mortality per 100,000 person-years lived
on a log scale. The right axis depicts the minimum mortality age. In addition to the
visual inspection, we calculated the residual standard error (RSE) for all ages and co-
horts considered in the model fit. Table 2 shows the values for all six models. The RSE
in brackets is based on comparing only fitted and observed values of non-war years
for approaches that include the war years in the model fit.
The RSE across the considered ages and cohorts is lower when the war years are
7
omitted. Hence, for both the LOESS and the P-spline approach, the fit of the models
is increased. In comparison, however, the P-spline approach shows a higher degree
of accuracy, which is expressed by a lower RSE. The minimum mortality trajectories
of both approaches are affected differently by the war years. The LOESS consistently
overestimates the level of minimum mortality up to the first post-war cohorts, whereas
the P-spline approach even reveals implausible spikes up to that point. In general, the
minimum mortality estimates of the LOESS are rougher than those of the P-spline ap-
proach. For Swedish males and for both approaches, the smoothed minimum mortal-
ity estimates are not as close to the observed rates as they are for Italian males; and
they are generally above the observed minimum. These more conservative estimates
are acceptable for countries with a small population size because, due to higher fluc-
tuations, the observed minimum mortality rates could represent more outliers than in
countries with a bigger population size.
The exclusion of the war years provides a more stable trajectory for the minimum
mortality age. In general, the observed ages fluctuate considerably, but they change
even more for the cohorts affected by war. The impact of war is especially visible for
the 1931 cohort, who had a minimum mortality age of 20; which is six years after the
end of WW II (see also Figure 4). Given the age trajectories of the adjacent cohorts,
it is highly unlikely that age 20 would have been the minimum mortality age for this
cohort in the absence of war. Only the LOESS and the spline approach without the war
years are able to provide such stable minimum mortality age patterns over time.
Allowing for overdispersion in the P-spline approach has only a small effect on
the accuracy of the model, but a big impact on the standard errors. Regarding the
median estimates, Camarda (2012) stated that by controlling for overdispersion, the
trajectories are smoother. This is visible in the slightly higher RSE for both models
with overdispersion. However, the standard errors of minimum mortality for the most
recent cohorts in particular increase when the relationship between the mean and the
8
variance is relaxed. The confidence intervals in the LOESS approaches are generally
narrower. For both approaches, it should be noted that in the figures, the confidence
bounds seem smaller because of the logarithmic axis for mortality rates.
9
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Figure 3. Minimum Mortality and Minimum Mortality Age Estimation under
different Model Specifications, Sweden, Males, Cohorts 1900–1993. Data: Human
Mortality Database (2017)
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4 Influence of war on age-specific mortality pattern
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Figure 4. Observed and fitted age-specific mortality trajectory, Italy, males, cohort
1931. Data: Human Mortality Database (2017)
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5 Minimum Mortality All Other Countries
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Figure 5. Minimum mortality, all other countries, females and males. Data: Human
Mortality Database (2017)
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Figure 6. Minimum mortality, all other countries, females and males. Data: Human
Mortality Database (2017)
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Figure 7. Minimum mortality, all other countries, females and males. Data: Human
Mortality Database (2017)
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Figure 8. Minimum mortality, all other countries, females and males. Data: Human
Mortality Database (2017)
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6 Development of the U-shaped mortality pattern
Figure 9 shows the ratio of age-specific death rates adjacent to the minimum mortality
and minimum mortality for various countries and four different cohorts. The trajecto-
ries do not reveal a shared trend for both perspective across cohorts and across coun-
tries. For instance, with the exception of the birth cohort 1900, Italian females show
an approximately stable U-shape across cohorts with marginal convergence towards
minimum mortality for younger ages and marginal divergence at ages higher than the
minimum mortality age. An almost similar pattern can be seen for Danish females.
However, French females show a different trend. For this population, the U-shaped
pattern became flatter over time, which is especially visible for ages younger than the
minimum mortality age. For French males, in opposite, it seems that the U-shaped
pattern became more pronounced over time. Generally, the difference of minimum
mortality and adjacent death rates varies also across countries.
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Figure 9. Ratio of death rates at adjacent ages to the location at minimum mortality
and minimum mortality, cohorts 1900, 1930, 1960, 1990, males and females, various
countries. Standardized age-specific death rates are shown for the age range: minimum
mortality age ± two years of age. The shown estimates are based on the smoothed age-specific
death rates. Source: Own illustration using age- and cohort-specific death counts and
exposure-to-risk from the Human Mortality Database (2017).
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Introduction
Rectangularization of the survival curve is one of the
key analytical frameworks in mortality research. We
argue that the canonical understanding of rectangu-
larization is outdated. Instead of abolishing the
concept completely, we suggest extending the frame-
work to accommodate recent developments in
mortality.
While the process of rectangularization had been
recognized earlier (e.g., Pearl and Miner 1935;
Comfort 1956), Fries’ (1980) interpretation of the
concept has arguably become the commonly
accepted view. Mortality developments in high-
income countries over recent decades have,
however, rendered several of Fries’ assumptions
obsolete. Most importantly, potential reductions in
mortality among the oldest old were not anticipated
in the classical rectangularization framework. Mor-
tality for people aged 80 and above has been declin-
ing in a number of countries since the 1960s (see, e.g.,
Kannisto 1994; Kannisto et al. 1994; Vaupel 1997;
Rau et al. 2008). This trend in turn has invalidated
several (partly implicit) assumptions of Fries’
theory: the idea that life expectancy has ‘looming
limits’ has been rejected (Oeppen and Vaupel
2002; Vallin and Meslé 2009), the contributions
of improvements in premature mortality to
increases in life expectancy have become negligible
(Christensen et al. 2009), and Fries’ (1980, p. 130)
assessment that ‘[…] there has been no detectable
change in the number of people living longer than
100 years […]’ has been disproven (e.g., Vaupel and
Jeune 1995; Vaupel 2010). Although we have not
witnessed any increase in maximum observed life-
span since the death of Jeanne Calment at age 122
in 1997 (Robine and Allard 1998), Fries’ (1980,
p. 133) prediction that ‘human life span may not be
fixed but may be slowly increasing, perhaps a
month or so each century’ had already been
exceeded by more than an order of magnitude with
the increases that occurred between 1980 and 1997
(Wilmoth et al. 2000).
Furthermore, in Fries’ framework, life expectancy
gains can only be generated by a decrease in lifespan
variability (see, e.g., Nagnur 1986; Nusselder and
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Mackenbach 1996). This compression would be com-
pleted when, ‘under ideal conditions’ (Fries 1980,
p. 132), lifespans were scattered in a normal distri-
bution around a mean of 85.6 years, with a standard
deviation of about four years. Later, Fries (1989)
assumed wider intervals. But since the second half
of the twentieth century, both stagnating variability
and increasing life expectancy have been observed
simultaneously (Kannisto 1996; Bongaarts 2005;
Canudas-Romo 2008; Bergeron-Boucher et al.
2015). This phenomenon is commonly labelled the
‘shifting of mortality’. Some authors go one step
further and discuss the possibility of life expectancy
gains in the presence of increasing variability in life-
spans; this is called the ‘expansion of mortality’
(Myers and Manton 1984; Rothenberg et al. 1991;
Cheung et al. 2005; Engelman et al. 2010, 2014). It
is, however, clear that the almost constant difference
between the mean and the modal age at death
(Canudas-Romo 2010) are not compatible with nor-
mally distributed deaths across age, even with histori-
cally low levels of premature mortality.
It may come as a surprise that we do not suggest
entirely discarding the concept of rectangularization.
Indeed, we find the simplicity and intuitiveness of the
concept appealing, and recognize that rectangulari-
zation is one of the few theoretical frameworks that
incorporates the relationship between (average)
length of life and lifespan variability. Thus, rather
than rejecting the concept, we wish to extend it to
incorporate recent mortality changes, as well as
future developments.
The first step in extending rectangularization is to
detach the framework from its static perspective. It
needs to capture mortality changes dynamically at
all ages, and not just in the premature age range. It
would also be beneficial if a measurement approach
could differentiate between and quantify changes in
premature and old-age mortality. Furthermore, it
would be desirable if an extension of Fries’ frame-
work still allowed us to assess the potentially impend-
ing limits to lifespan.
The framework we propose, which we call the
‘maximum inner rectangle approach’ (MIRA), is
designed to address these issues. Our approach uses
two dimensions of rectangularization. We call the
classical perspective ‘outer rectangularization’
because it relates the survival curve, and, accordingly,
life expectancy, to the ‘maximum living potential’.
Hence, it compares the current experience with the
current theoretical maximum, if everyone survived
to and then died at the actual maximum lifespan.
There is, however, another perspective that has so
far largely been neglected, which we call ‘inner
rectangularization’. Defined as the rectangle under
the survival curve with the largest possible area,
this perspective relates the current inequality in life-
span to current life expectancy. The basic idea is illus-
trated in Figure 1. The bold solid line denotes a
hypothetical survival curve starting from a radix of
one and reaching zero at the highest attainable age,
ω. The dotted line denotes the classic reference
used to estimate the advancement of rectangulariza-
tion—the outer rectangle—which also expresses the
maximum living potential. The dashed line depicts
our newly proposed concept: the maximum inner
rectangle.
Maximum inner rectangle approach (MIRA)
The MIRA is based on different areas and specific
ages that will be introduced in the following
section. Table 1 provides an overview of all MIRA
quantities.
In the MIRA, we distinguish between inner and
outer rectangularization. Outer rectangularization is
the standard perspective of rectangularization, and
captures progress in mean lifespan relative to pro-
gress in maximum lifespan. Hence, the outer frame
of the survival curve serves as a reference point.
We denote the area of the outer rectangle as ω,
because it is determined by the maximum attainable
age (ω) and the radix of the survival function (l0),
which we set to one. The maximum age should be
able to move forwards or backwards depending on
the underlying mortality development. In the empiri-
cal application we link ω to a specific survival pro-
portion, k—such as the age at which 1 per cent of
the population is still alive—so that lv = k.
In a population, ω can be interpreted as the
maximum living potential. It counts the hypothetical
number of person-years that could be lived in a popu-
lation if everyone survived to the maximum age and
then died. In comparison, the actual number of
person-years lived in a population corresponds to
the area under the survival curve, and determines
mean lifespan. The ratio of mean to maximum life-
span serves to capture the degree of outer rectangu-
larization of the survival curve. Thus, we define the
outer rectangle ratio (ORR) as
ORR =
NameMev
0 lada
v
= e0
v
, (1)
with e0 denoting life expectancy (or mean lifespan)
and ω maximum age. By definition, 0 ≤ ORR ≤ 1.
The ratio relates the observed number of person-
years lived in a population to the maximum person-
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years possible. For example, if ORR = 0.8, then
current living conditions are allowing the population
to exploit 80 per cent of its current maximum living
potential.
Inner rectangularization adds a new perspective. In
contrast to the outer rectangle, we seek the largest
rectangle under the survival curve. Any inner rec-
tangle (IR) under the survival curve is defined hori-
zontally by age, x, and defined vertically by survival
to that age, lx. Consequently, the corresponding
area is IRx = x× lx. The first age derivative of IRx
then identifies the age, x∗, that corresponds to the
maximum inner rectangle (MIR) with an area of
MIR = x∗ × lx∗ (2)
as the solution to
d IRx
d x
= 0 (3)
which simplifies to
x∗ = 1
mx∗
. (4)
Although there is no closed form solution, x∗ can be
found numerically, given that
mx . 0 ∀ x [ [0, v], (5)
where mx denotes the force of mortality. A proof for a
unique maximum in the case of increasing mortality
with age is included in the supplementary material
(section A).
MIR counts the ‘maximum uniformly shared
person-years’. It is determined by the maximum
shared lifespan (x∗) and the survival proportion up
to this lifespan (lx∗). At ages below x∗, the share of
the population living for x years (lx) would be
larger than lx∗ , but the number of years lived per indi-
vidual would be smaller than x∗. Likewise, at ages
above x∗, the number of years lived per individual
would be larger than x∗, but the share of the popu-
lation living for x years (lx) would be smaller than
lx∗ . In either case, the total number of uniformly
shared person-years, as indicated by MIR, would be
reduced.
Using this definition of MIR allows us to add an
inner perspective to the process of rectangulariza-
tion. In an analogy to the maximum living potential
(ω), we can interpret life expectancy (e0) as a popu-
lation’s current theoretical maximum number of life
years that could be shared uniformly. Accordingly,
with perfectly uniform lifespans, 100 per cent of indi-
viduals in a population would share a lifespan of
length e0. With actual lifespan inequality as measured
by MIR, however, a maximum survival fraction of
lx∗ , 100 per cent shares a uniform lifetime of at
most x∗ years. Thus, by relating MIR to e0, we
define inner rectangularization as the process of a
population approaching its current lifespan equality
potential. It is measured by the inner rectangle
ratio (IRR), which is given by
IRR = MIR
e0
. (6)
The IRR captures a trend that differs from that of the
ORR, because changes in the MIR do not require a
change in the mean or the maximum lifespan.
Indeed, the trend could be characterized by a con-
stant mean and a falling maximum lifespan, or by
an increasing mean but a constant maximum lifespan,
or even by a falling mean and a falling maximum life-
span. Though closely related, the IRR differs from
Figure 1 The survival curve and its maximum inner rectangle and outer rectangle
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the ORR because it is essentially an index of lifespan
equality, while the ORR is an index of exploiting
maximum living potential. Accordingly, if
IRR = 0.8, then current living conditions are allow-
ing the population to exploit 80 per cent of its
current lifetime equality potential.
The two indices can be combined into a single
index to measure total rectangularization. We
define the total rectangle ratio (TRR) as
TRR = IRR ×ORR = MIR
v
. (7)
The TRR measures achieved lifespan equality in
relation to maximum possible equality. Accordingly,
if TRR = 0.8, then current living conditions are
allowing the population to achieve 80 per cent of its
maximum possible lifespan equality at present.
Data and estimation procedure
We computed MIRA quantities using period life
tables, which we estimated from death counts and
corresponding exposures from the Human Mortality
Database (2015). In this paper, we choose to high-
light the trajectories of Swedish, Danish, and Italian
females because these countries provide three
exemplary mortality developments. Furthermore,
all three countries have sufficient data coverage
over time. In estimating x∗ and lx∗ , a key challenge
we faced was that the data are only available in dis-
crete integer units, but x and lx need to be continuous.
Therefore, we estimated x∗ in two steps. First, we
smoothed the product of x and lx with cubic splines
using R’s splinefun() function (R Core Team 2015),
which allowed us to evaluate the function value
with arbitrary precision. Second, we used R’s
general-purpose univariate optimization function
optimize() to find the maximum. A similar two-step
approach with splines has been used previously in
mortality research to estimate the modal age at
death (Ouellette and Bourbeau 2011). We calculated
other age estimates, such as ω and the threshold ages
discussed in the next section, using the same
procedure.
In several empirical studies on rectangularization,
the maximum age (ω) is not set at the actual age at
which there are no survivors left in the life table
population. Wilmoth and Horiuchi (1999), for
instance, set the cut-off age at the point at which
0.1 per cent of the population were still alive. Rossi
et al. (2013) used the 10 per cent threshold and,
most recently, Schalkwijk et al. (2016) used the 0.1,
1, and 10 per cent thresholds. In our study, we
opted for a threshold of 1 per cent. Sensitivity analy-
sis revealed that the actual choice of value for lv had
only minor effects on the results. As the maximum
age changes with varying survival fractions, the esti-
mates of TRR and ORR change quantitatively.
However, the patterns of the ratios remain stable
over time.
Illustration of the inner, the outer, and the
total rectangle ratio
Figure 2 shows the three ratios for females in Italy
(upper left panel), Denmark (upper right), and
Sweden (lower). It depicts the IRR (black line), the
ORR (light grey), and the TRR (dark grey). Figure 2
illustrates the following key points:
(1) The TRR and the ORR have been develop-
ing almost in parallel for about 160 years.
This suggests that Fries’ concept of rectangu-
larization needs to be revised. If Fries’ ideas
were correct, we would have expected to
witness a ‘catching-up period’ of the TRR
to the ORR until his ‘ideal conditions’ with
Table 1 Quantities of the maximum inner rectangle approach (MIRA)
Name Acronym Expression Interpretation
Inner rectangle IRx x× lx Age-specific uniformly shared person-years (PY)
Maximum shared
lifespan
x∗ max[x × lx] Maximum number of uniformly shared life years by largest number of
survivors
Maximum proportion lx∗ lx∗ Largest proportion alive at the maximum shared lifespan
Maximum inner
rectangle
MIR x∗ × lx∗ Population’s current maximum number of uniformly shared PY
Life expectancy e0
NameMev
0 lada Population’s current number of PY, i.e., mean lifespan
Outer rectangle v v× l0 Maximum possible PY
Outer rectangle ratio ORR e0/v Proportion of PY lived from maximum possible PY
Inner rectangle ratio IRR MIR/e0 Proportion of uniformly shared PY from all PY lived
Total rectangle ratio TRR MIR/v Proportion of uniformly shared PY lived of maximum possible PY
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life expectancy of about 85 years were
reached. None of the selected countries has
reached this level of life expectancy yet. Con-
sequently, we should see a continued narrow-
ing of the gap, but this is not the case.
(2) Inner rectangularization describes a different
dimension of mortality progress. Its trajec-
tory is decoupled from those of the ORR
and the TRR, mainly because its frame of
reference is not maximum lifespan, but life
expectancy. In each of the examples we can
see an increase over time, with a trend
change occurring sometime during the
1950s when the slope becomes shallower.
This break can likely be attributed to the
shift in survival improvements from
younger to older ages (e.g., Christensen
et al. 2009).
(3) We can see that the IRR in each of these
three countries has followed a different tra-
jectory over the last half century, with a
steady increase in Italy, a slow increase in
Sweden, and a slight dip in Denmark during
the 1970s and 1980s. Even though the IRR
has generally increased over time, the
country-specific patterns suggest that the
Figure 2 Inner rectangle ratio, outer rectangle ratio, and total rectangle ratio for females, Italy (1872–2012),
Denmark (1850–2011), and Sweden (1850–2014)
Note: All calculations are based on period life tables in the respective year.
Source: Human Mortality Database (2015).
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forces behind this development vary. For
instance, the steady increase in Italy suggests
that a rise in life expectancy accompanies a
faster growth of the MIR. The almost stag-
nating IRR in Sweden between 1960 and
1990 suggests that life expectancy has
increased similarly to the MIR. Denmark’s
unusual dynamics suggest a declining MIR
while life expectancy stagnated.
(4) The IRR highlights how evenly the magni-
tude of and trends in age-specific mortality
changes are spread over age. We claim
that this provides a new perspective on life-
span variability. Our suggestion is strength-
ened by the correlation between the IRR
and other summary measures of lifespan
variability. Table 1 in the supplementary
material (section B) shows that the IRR is
less correlated with common measures of
lifespan variability (shown in Table 2 in
the supplementary material) than those
measures are correlated with each other.
This pattern is especially pronounced for
the time period when gains in premature
survival were instrumental for the increase
in life expectancy (the period 1850–1950 in
our analysis).
Applying the MIRA to separate premature
from old-age mortality
Premature and old-age mortality are terms that are
frequently used in mortality research, but they are
loosely defined, which may be sufficient for many
applications. However, in analysing rectangulariza-
tion, these definitions are a crucial issue. In Fries’
description, premature mortality plays a central
role. He argues that declines in premature mortality
drive the process of rectangularization, and implicitly
assumes that only these improvements are generat-
ing life expectancy increases. Although, Fries
remains unclear in his definition of premature ages,
his descriptions most evidently suggest that he is
referring to life expectancy as a threshold. We
argue that x∗ can be interpreted as an age that
allows us to separate premature from old-age mor-
tality. With x∗, we provide an approach that is
embedded within our rectangularization framework,
and which quantifies the threshold. Accordingly, the
threshold in MIRA is based on the longest lifespan
that is shared by the largest fraction of the
population.
Even though existing approaches, such as those by
Zhang and Vaupel (2009) and Gillespie et al. (2014),
rest on different lifespan variability measures, their
respective threshold ages result from a proportional
perturbation of age-specific mortality and, hence,
they rely on the same perturbation/definition. In
both approaches, the threshold refers to a specific
age, such that proportional mortality reductions
before this age would result in a decrease in lifespan
variability, whereas reductions at higher ages would
lead to an increase in lifespan variability (see
section F of the supplementary material for more
details). Hence, x∗ could serve as an alternative defi-
nition of a threshold age separating premature and
old-age mortality, based on the maximum shared
lifespan.
Figure 3(a) illustrates the relationship between x∗
(horizontal axis) and lx∗ (vertical axis); that is, the
coordinates to measure the number of maximum uni-
formly shared person-years; again, this is shown for
females in Italy, Denmark, and Sweden. The grey
contour lines depict the number of life years lived
in the MIR. The two time periods 1850–1950 and
1951–2014 are illustrated by dashed and solid lines,
respectively. Generally, two trends can be distin-
guished in Figure 3(a): a ‘vertical’ development
(until 1950) and a ‘horizontal’ development (after
1950).
The share of the life table population dying at
older ages is denoted by lx∗. Consequently, 1− lx∗
equals the proportion dying prematurely. Premature
mortality improvements drove progress until 1950, as
illustrated by the increasing share of survivors (lx∗).
With improving old-age mortality, x∗ shows an accel-
erated movement towards higher ages; whereas the
corresponding survival fraction at x∗ (lx∗) shows
only small gains. This pattern is similar to that of
the modal age at death, which is also robust to mor-
tality changes at lower ages, but sensitive to
changes at higher ages (Canudas-Romo 2010).
To compare the trajectories resulting from our
approach with alternative approaches, we also plot
the relationship between the threshold ages pro-
posed by Gillespie et al. (2014; Figure 3(b)) and
Zhang and Vaupel (2009; Figure 3(c)), which are
based on the variance and the number of life years
lost, respectively, and the corresponding survival pro-
portions. These estimates show similar shifts in the
trend. The slopes of the curves in each of the three
parts of Figure 3 have become shallower in recent
decades. This development could point to the exist-
ence of a limit to premature mortality that cannot
be lowered any further. Fries (1980) argued that pre-
mature mortality would be almost eliminated,
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declining to a maximum share of 2–5 per cent of all
deaths. The three measures presented here suggest
that there is a limit of at least 10–15 per cent (the
minimum is from the MIRA measure).
It should, however, be noted that we use different
vertical scales within Figure 3. If we instead used the
scale from our measure in Figure 3(a) for the other
two measures, we would obtain almost horizontal
lines for those measures. Within the 160 years of
life expectancy development contained in the
figure, the proportion dying at old age has changed
relatively little under the threshold ages suggested
by Zhang and Vaupel (2009) and Gillespie et al.
(2014). In both cases, the change amounts to less
than 15 percentage points; a shift we consider to be
rather small. In contrast, our measure shows a shift
of about 65 percentage points, from 20 per cent
dying at old age in 1850 to about 85 per cent dying
Figure 3 Scatterplot of the threshold age and survival proportion at the threshold age according to: (a) MIRA;
(b) Gillespie et al. (2014); and (c) Zhang and Vaupel (2009), women, Italy (1872–2012), Denmark (1850–2011),
and Sweden (1850–2014)
Notes: The trend lines are based on a locally weighted smoothing to highlight the patterns only. Additionally, contour lines in
panel (a) visualize the corresponding number of person-years lived in equality (MIR), since this is determined by the product
of both. The approaches of Zhang and Vaupel (2009) and Gillespie et al. (2014) and their calculation are explained in more
detail in the supplementary material.
Source: As for Figure 2.
Rectangularization reconsidered 7
at old age in the most recent years. These numbers
seem to be more in line with the findings of, for
example, Christensen et al. (2009), who estimated
that almost 80 per cent of recent gains in life expect-
ancy for Japanese women were caused by survival
improvements among older people.
Discussion and conclusion
Rectangularization is one of the established analyti-
cal frameworks in mortality research. We propose
refining the classical concept to adjust for recent
changes in survival improvements, and to allow for
the incorporation of anticipated mortality trajec-
tories in the near future. This new framework,
which we call the maximum inner rectangle approach
(MIRA), rests on two theoretically distinct types of
rectangularization: inner rectangularization and
outer rectangularization.
Outer rectangularization relates the number of life
years that are currently lived (i.e., life expectancy) to
a theoretical maximum where everyone dies at the
same (maximum) age. We extend this standard defi-
nition of rectangularization by introducing the
concept of inner rectangularization. This novel
concept corresponds to the largest rectangle under
the survival curve. This rectangle captures the
largest number of life years lived by the largest pro-
portion of the population. Thus, it measures the pro-
portion of lifespan equality at the current level of life
expectancy. By contrast, outer rectangularization
measures the degree of living potential exploited,
using maximum lifespan as a reference point.
The measurement of both constituent parts of the
MIRA rests on simple ratios. To measure outer rec-
tangularization, we use the well-known concept of
the moving rectangle (Wilmoth and Horiuchi 1999;
Rossi et al. 2013; Schalkwijk et al. 2016). As far as
we know, there are no demographic predecessors to
our concept of inner rectangularization. Thus, the
age that maximizes the IR provides a novel point of
reference, indicating maximum shared lifespan. This
point represents the optimal trade-off between past
lifetime and number of survivors in terms of lived
person-years. Hence, the principle of inner rectangu-
larization rests on identifying the optimal combi-
nation of two (inversely related) inputs—age and
survival—which unify the biggest area under a
curve representing their respective relationship.
Such measures have previously been applied else-
where. For instance, the Hirsch index (or h-index)
measures the productivity and citation impact of
scientists (Hirsch 2005). It depicts that x publications
of a scientist have been cited at least x times. The geo-
metric equivalent is a list of all publications by a
scientist (y-axis) sorted by the number of citations
(x-axis). This approach is similar to our application,
where the survival curves could be interpreted as a
sorted list of life lengths (x-axis) of the population
(y-axis). Another example of such a maximum rec-
tangle can be found in physics: the ‘maximum
power point’ indicates the maximum power of a
photovoltaic module, with a given current–voltage
curve (Wasynezuk 1983). Our approach is also
related to Cohen’s (2015) decomposition of life
expectancy model, which derives Markov’s inequal-
ity and Chebyshev’s inequality for tail probabilities
in a novel way. In this approach, Cohen decomposes
life expectancy into three parts, one of these parts
being a non-maximized version of the IR.
Our most important empirical findings are as
follows. First, we found that outer rectangularization
has shown continuous gains over time (see also
Figures 1 and 2 in sections C and D of the supplemen-
tary material). This is a consequence of the straight
linear increases in life expectancy (Oeppen and
Vaupel 2002), which have been faster than the
increase in the longest lifespans, as measured by ω.
However, we also detected a considerably slower
pace of outer rectangularization since the middle of
the twentieth century. Second, we found that inner
rectangularization also increased rather uniformly
until around 1950; and that the patterns thereafter
could not be summarized with a general trend
because they are rather country-specific (see also
Figures 1 and 2 in sections C and D of the supplemen-
tary material). These country-specific patterns
appear to be attributable to differences in the onset
of sustained mortality declines among the oldest
old (Kannisto 1994), as well as by other factors,
such as smoking among Danish women (e.g., Juel
et al. 2000; Jacobsen et al. 2002; Lindahl-Jacobsen
et al. 2016), and postponed reforms of the healthcare
system in the Netherlands (Mackenbach et al. 2011;
Peters et al. 2015).
If we interpret x∗, the age maximizing the IR, as a
threshold age separating premature from old-age
mortality, then the rises in x∗ (see also Figure 3 in
section E of the supplementary material) and in cor-
responding survival, lx∗ , switched in around 1950,
from a reduction in premature deaths to an extension
of the premature age range. This dynamic also points
to a potential minimum proportion of individuals
dying prematurely. Depending on the underlying
definition of threshold age, the share dying prema-
turely varies between 10–15 per cent (MIRA),
15–20 per cent (Gillespie et al. 2014), and 30–35 per
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cent (Zhang and Vaupel 2009) under current mor-
tality conditions. Hence, Fries’ prediction that prema-
ture mortality would be almost completely
eradicated seems rather unlikely. We can, however,
see that the definition and measurement of prema-
ture mortality are issues that have been unresolved
at least since Lexis (1877).
Using x∗ as a reference point also would enable us
to extend the MIRA beyond the areas and ratios pre-
sented here. These areas above and below the survi-
val curve would allow us to decompose life
expectancy and maximum living potential because
they capture all person-years apart from those
included in the MIR. An application of the decompo-
sition could provide a basis for a more detailed analy-
sis of past and potential future developments of
rectangularization. For instance, the non-uniform
number of person-years lived of life expectancy
(e0 −MIR) could be subdivided into the numbers
for those dying prematurely and for those living
longer than x∗. Such an analysis can show to what
extent changes in life expectancy, and thus rectangu-
larization, are determined by lifespan equality
increases, premature mortality reductions, and long-
evity extensions. Generally, we would expect to see
continuous gains in life expectancy if large shares of
the population benefit from mortality improvements.
This would result in rising lifespan equality. Indeed,
the absolute number of uniformly shared person-
years (MIR) has increased in almost all countries
with continuously rising life expectancy (see Figure
3(a), for example). But relative to life expectancy,
the country-specific patterns of the IRR after 1950
question this relationship (as shown in Figure 2).
The rise in uniformity of person-years lived seems
to be more detached from overall gains in life expect-
ancy in some countries than in others. In the selected
countries, for instance, Italian females were shown to
be closest to the described scenario; whereas Danish
females, with their convex IRR trend, were found to
have a stronger degree of detachment. The extension
opportunities offered by the MIRA should help us to
gain deeper insights into these dynamics.
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A Second Derivative of MIRA Equation
In general, the relationship between hazard (µ(x)), density ( f (x)) and survival function (l(x)) is
given by
f (x) = l(x)µ(x) (1)
Hence, the derivative with respect to x of equation 1 is
d f (x)
d x
=
d l(x)
d x
µ(x) +
d µ(x)
d x
l(x) (2)
Dividing equation 2 by f (x) results in
d f (x)
d x
f (x)
= −µ(x) +
d µ(x)
d x
µ(x)
. (3)
The general equation for calculating x∗ is given by
A(x) = xl(x). (4)
Deriving equation 4 with respect to x results in
d A(x)
d x
= A′ = l(x)− x f (x). (5)
For an extremum x∗, it is required that
A′(x∗) = l(x∗)− x∗ f (x∗) = 0. (6)
Rewriting equation 6 gives
x∗ =
1
µ(x∗)
. (7)
The second derivative of equation 4 is equal to
d2 A(x)
d2 x
= A′′(x) = − f (x)− f (x)− x · d f (x)
d x
= −2 f (x)− x · d f (x)
d x
. (8)
For a maximum, it has to hold that
−2 f (x)− x · d f (x)
d x
< 0 ∀ x = x∗. (9)
This can also be expressed by
−2
x
<
d f (x)
d x
f (x)
∀ x = x∗. (10)
2
Inserting equations 7 and 3 in equation 10 results in
−2µ(x) <
d µ(x)
d x
µ(x)
− µ(x) ∀ x = x∗. (11)
Simplifying equation 11 reduces the problem to
−µ(x)2 < d µ(x)
d x
∀ x = x∗, (12)
which is always true for an increasing force of mortality over age, representing the adult human
pattern.
3
B Correlation Analysis of Common Lifespan Variability Measures and
MIRA Ratios
Table 1: Kendall’s correlation coefficient τ for measures of variability and MIRA indices for
period data available in the Human Mortality Database, both sexes combined. The lower left
triangle refers to the years 1850–1950, the upper right triangle refers to the years 1951–2014. We
selected Kendall’s τ because it does not rely on a linear relationship like Pearson’s r, or a monotonic
relationship like Spearman’s ρ. For New Zealand, data for the entire population are included. For
Germany, separate data for the eastern and the western regions are included. England and Wales,
Scotland, and Northern Ireland are included separately. Measures are calculated based on period
life tables in the respective years. The measures in continuous notation and examples of their usage
can be found in Table 2. (G - Gini-coefficient, CV - coefficient of variation, H - Keyfitz’ entropy,
IQR - inter quartile range, SD - standard deviation, VAR - variance, S10 - standard deviation above
age 10, e† - average life years lost)
IRR ORR TRR IQR e† H G CV SD VAR S10
IRR 0.73 0.84 -0.88 -0.81 -0.79 -0.69 -0.60 -0.53 -0.53 -0.78
ORR 0.78 0.89 -0.77 -0.85 -0.92 -0.88 -0.82 -0.73 -0.73 -0.67
TRR 0.83 0.94 -0.85 -0.89 -0.93 -0.83 -0.75 -0.66 -0.66 -0.74
IQR -0.64 -0.80 -0.77 0.86 0.82 0.73 0.65 0.59 0.59 0.80
e† -0.69 -0.74 -0.75 0.76 0.90 0.81 0.74 0.68 0.68 0.81
H -0.78 -0.92 -0.91 0.81 0.81 0.88 0.80 0.71 0.71 0.73
G -0.74 -0.94 -0.90 0.84 0.75 0.91 0.91 0.82 0.82 0.65
CV -0.72 -0.93 -0.88 0.84 0.74 0.90 0.98 0.89 0.89 0.58
SD -0.50 -0.68 -0.64 0.81 0.71 0.69 0.73 0.74 1.00 0.54
VAR -0.50 -0.68 -0.64 0.81 0.71 0.69 0.73 0.74 1.00 0.54
S10 -0.60 -0.54 -0.57 0.54 0.71 0.60 0.54 0.53 0.52 0.52
4
Table 2: Overview of common measures of variability. All measures are used in the correlation
analysis. Not all mentioned examples apply the measure according to the mentioned notation.
Measure Expression Example
Gini-Coefficient G = 1− 1e0
ω∫
0
l2a da Shkolnikov et al. (2003); Smits and
Monden (2009)
Average Life Years Lost e† =
ω∫
0
eada da Vaupel et al. (2011)
Keyfitz’ Entropy H =
ω∫
0
eada da
e0
Nagnur (1986); Nusselder and
Mackenbach (1996)
Standard Deviation SD =
√
ω∫
0
(a− e0)2da da Myers and Manton (1984); Ed-
wards and Tuljapurkar (2005);
Thatcher et al. (2010); Kannisto
(2000)
Variance VAR =
ω∫
0
(a− e0)2da da Edwards and Tuljapurkar (2005);
Gillespie et al. (2014)
Coefficient of Variation CV =
√
ω∫
0
(a−e0)2da da
e0
Anand et al. (2001)
Standard Deviation above
Age 10
S10 =
√
ω∫
10
([a−10]−e10)2da da
l10
Edwards and Tuljapurkar (2005);
Gillespie et al. (2014)
Inter Quartile Range IQR = Xl0.75 − Xl0.25 Wilmoth and Horiuchi (1999)
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Figure 1: Inner rectangle ratio, outer rectan-
gle ratio and total rectangle ratio, all Human
Mortality Database countries with data be-
tween 1850 and 2014, females. All calculations
are based on period life tables in the respec-
tive year. Source: Human Mortality Database
(2015)
6
D MIRA Ratios for all HMD Countries: Males
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Figure 2: Inner rectangle ratio, outer rectan-
gle ratio and total rectangle ratio, all Human
Mortality Database countries with data be-
tween 1850 and 2014, males. All calculations
are based on period life tables in the respec-
tive year. Source: Human Mortality Database
(2015)
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E Maximum shared lifespan x∗ for all HMD Countries
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Figure 3: Maximum shared lifespan x∗, all Human Mortality Database countries with data be-
tween 1850 and 2014, males and females. All calculations are based on period life tables in the
respective year. Source: Human Mortality Database (2015)
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F The threshold ages used to separate early and late mortality
The term “threshold age” is commonly used to describe a specific age, which represents the cut-off
age between premature and old-age mortality. Existing approaches commonly define this bor-
der such that mortality reductions before this age would result in a decrease of lifespan variability,
whereas mortality reduction at higher ages would lead to an increase of lifespan variability. Zhang
and Vaupel (2009) and Gillespie et al. (2014) derive threshold ages using average life years lost (e†)
and variance of the age at death (VAR), respectively. Van Raalte and Caswell (2013) provide results
for a range of lifespan variability measures using matrix calculus.
The approaches by Zhang and Vaupel (2009) rests on a proportional change in age-specific
mortality, expressed by the derivative of the respective measures with respect to the logarithm of
the force of mortality (µx). Accordingly, the age separating early and late mortality in the approach
by Zhang and Vaupel (2009) is given by the root of equation 13,
kx = e†x + ex(Hx − 1) (13)
where e†x denotes average person years lost above age x, ex is the remaining life expectancy at age
x, and Hx denotes the cumulative hazard at age x.
In their applications, Gillespie et al. (2014) use different starting ages for the calculation of their
threshold age. For comparison reasons, we choose the variant which starts directly at birth. Similar
to the application by Zhang and Vaupel (2009), Gillespie et al. (2014) base their threshold age also
on a proportional change in age-specific mortality. Accordingly, equation 14 results from deriving
the variance of the age at death with respect to ln µx.
kx = −2µx
ω∫
x
la(a− e0) da (14)
In equation 14, la denotes the survival fraction at age a and e0 is life expectancy at birth. The thresh-
old age is then given by the root.
We calculated these ages by estimating the respective function empirically and searching for
the root numerically. The procedure is similar to those applied for calculating MIRA quantities
and the endpoint of the survival curve.
9
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Abstract
Increasing longevity can distort time trends in summary measures of health and mortality,
such as the lifetime risk of getting diseased. If not observing a cohort, this lifetime risk is cal-
culated with cross-sectional data on age-specific incidence and survival. In those instances,
incidence and survival may work in opposite directions resulting in lifetime risk estimates
where, reductions in incidence might be offset by a simultaneous longevity increase. The
proposed method decomposes the difference between two lifetime risks into contributions
of changing incidence and changing survival. The approach can be extended to measure
the contributions of changes in disease related mortality and even case fatality. We illustrate
the method with hypothetical examples as well as remaining lifetime risk at age 60 of
experiencing a myocardial infarction, colorectal cancer and hip fractures for Swedish males.
The empirical examples show that the influence of increasing longevity on the development
of lifetime risk depends on the respective age profile of occurrence. In the cases of myocar-
dial infarction and hip fracture, longevity increases of the general population counterbal-
anced or even exceeded the substantial gains in disease incidence, while for colorectal
cancer, the lifetime risk was almost unaffected by the longevity improvement. This was
because colorectal cancer has an on average earlier onset than myocardial infarction and
hip fracture.
Introduction
Lifetime risk expresses the probability to develop a certain disease throughout lifetime or from
a certain age onward (remaining lifetime risk). This makes it a useful indicator for monitoring
the burden of a disease in a population. It is, for instance, widely applied in cancer research
[1–4].
There is no common procedure for the calculation of lifetime risk. In many studies, it rests
on longitudinal data for cohorts, such as the Rotterdam study, the Framingham Heart Study
or population register data [5, 6]. Lifetime risk in these approaches refers to observed lifetimes
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of individuals. However, lifetime risk has also been calculated based on cross-sectional data [1,
4, 7]. This approach is sometimes called “current probability method” [8]. In such a context,
lifetime risk is based on observed disease and death patterns at a certain point in time. For at
least two practical reasons, the use of cross-sectional lifetime risks are a valuable alternative to
estimates based on longitudinal data. First, the data requirements are much lower for such a
lifetime risk since no data with a sufficiently long follow-up time are necessary. Second, a
cross-sectional lifetime risk summarizes the current burden in the population, whereas a life-
time risk based on longitudinal data summarizes past trends.
For the calculation of lifetime risk based on cross-sectional data, death and incidence rates
for the respective period and population are required. Essentially by using standard life table
techniques, these death and incidence rates are assumed to apply as if a real cohort would pass
through time. The necessary assumption of time-invariant mortality and incidence are obvi-
ously false but since we are aiming to depict the current situation, this is, nevertheless, accept-
able. Let us assume we have age-specific death and incidence rates of myocardial infarction for
males aged 60 and older in a certain period. For this example, an interpretation of a lifetime
risk would be: a 60 year-old male at the specific point in time has on average a remaining life-
time risk of, for instance, 30% to experience a myocardial infarction, if mortality and incidence
stay constant over time.
The underlying risk population for a cross-sectional lifetime risk is usually drawn from a
life table [1, 4, 8]. Accordingly, the two exit possibilities are the disease of interest and death as
competing risk. The resulting lifetime risk estimate is based on the population age-structure of
the life table, which can be regarded as a closed and stationary population, and which, solely
depends on age-specific incidence and survival. Hence, differences in lifetime risk over time or
between populations can arise from differences in incidence or in general survival. However,
changes in just one of the two are unlikely in reality. In this instance, the interplay of survival
and disease incidence can distort lifetime risk estimates and complicates meaningful compari-
sons of cross-sectional lifetime risks over time or between populations [1]. For example, a
recent study has shown that the lifetime risk of hip fracture increased over time, despite declin-
ing age-specific incidence rates [7]. But how much of the change in lifetime risk can be attrib-
uted to each of the two factors?
In this paper, we aim to present a simple method to disentangle the two factors, allowing us
to quantify how much of the change in lifetime risk is due to 1) changes in age-specific inci-
dence and 2) changes in age-specific survival in the general population. We illustrate the
method with an example based on artificial data and an application to empirical estimates of
lifetime risk of myocardial infarction, hip fracture and colorectal cancer, using incidence and
mortality of Swedish males.
Methods
Decomposing lifetime risk
Assuming that our incidence rates depict the first occurrence of the disease of interest, the rate
of either dying or getting diagnosed at age x, μx, can be written as
mx ¼ mx þ Ix ð1Þ
where mx is the death rate at age x and Ix is the incidence rate of getting diseased at age [1, 9].
For these estimation, death rates ideally refer to the disease-free population because they are
the exit rate for those who die before getting diseased, whereas incidence covers the exit rate
for those who get diseased before they die. In empirical application, however, these data
requirements can not always be fulfilled and alternative death rates must be used (see data and
Decomposing lifetime risk
PLOS ONE | https://doi.org/10.1371/journal.pone.0195307 April 19, 2018 2 / 9
located in a secure server at the institution the
authors are affiliated with. This dataset that the
authors used is available upon request from the
corresponding author, given that the person that is
interested to use it can obtain approval from the
data owners, the National Board of Health and
Welfare in Sweden and Statistics Sweden.
Interested researchers may also contact the data
owners directly for access to the dataset. The used
mortality data for the entire Swedish population
can be downloaded from the Human Mortality
Database(www.mortality.org).
Funding: Financial support for Anders Ahlbom has
been provided by Forte (Grant no.: 2014-0231).
The funding institution had no influence on the
design, analysis and interpretation of the outcomes
of this study.
Competing interests: The authors have declared
that no competing interests exist.
materials for further discussion). Note that death and incidence rates are referring to age inter-
vals, which can also be bigger than one year of age. However, the length of the age-groups does
not change the basic derivation of the decomposition method. To improve readability, we
therefore excluded the notation of intervals throughout the manuscript. Moreover, the whole
approach assumes constant rates within age intervals and also independence of age-specific
death and incidence rates.
The probability of staying alive and healthy within one age interval x can be expressed by
exp[−μx]. Hence, the fraction alive and healthy at age x can be calculated by exp½ 
X
0xi<x
mxi ,
where xi denotes the running index of the sum, which is age. The lifetime risk of becoming dis-
eased from age x onward, lrx, can then be calculated by
lrx ¼
X
xxio
Ixi exp½ 
X
0xi<x
mxi ; ð2Þ
where ω denotes the highest age attained. Eq 2 can be rewritten as
lrx ¼
X
xxio
Ixi exp½ 
X
0xi<x
Ixi  exp½ 
X
0xi<x
mxi : ð3Þ
For simplicity, we will write xi for Ixi exp½ 
X
0xi<x
Ixi  and lxi for exp½ 
X
0xi<x
mxi . Hence, Eq 3
changes to
lrx ¼
X
xxio
xi lxi : ð4Þ
We are interested in decomposing the change in lifetime risk to experience a given disease,
denoted with Δ, between two time points A and B or, more generally, the difference between
two populations:
D ¼ lrx;A   lrx;B: ð5Þ
The following methodological outline and derivation of the decomposition is based on previ-
ous studies, which provide general results for mathematical problems of such kind [10, 11].
Given the general definition of lifetime risk of Eq 4, we can rewrite Eq 5 to
D ¼
X
xxio
xi;Alxi ;A  
X
xxio
xi;Blxi ;B: ð6Þ
Rearranging Eq 6 leads to
D ¼
X
xxio
lxi ;A   lxi ;B
h ixi;A þ xi ;B
2
|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}
Contribution of Changing Survival Conditions
þ
X
xxio
xi;A   xi ;B
h i lxi ;A þ lxi ;B
2
|fflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl{zfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflfflffl}
Contribution of Changes in Incidence
:
ð7Þ
The omitted steps for deriving the expression in Eq 7 are listed in the S1 Appendix. Eq 7 pro-
vides now two distinct interpretable terms. The left term expresses the contribution of chang-
ing survival conditions to the difference in the lifetime risk between populations A and B. The
right term expresses the contributions of changes in disease incidence to the difference in the
lifetime risk between populations A and B. For both left and right term, age-specific differences
in incidence and survival are standardized by average age-specific survival and incidence
between both populations, respectively. This could be interpreted as if mortality or,
Decomposing lifetime risk
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respectively, incidence would have been the same for both populations. Note in the S2 Appen-
dix you find an extension of this decomposition, which additionally includes the mortality of
the specific disease.
Hypothetical example
Table 1 presents three hypothetical examples to illustrate the decomposition as presented
in Eq 7. In the first example (I), survival improves as reflected in the lx–columns, while the
incidence proportions are unchanged. The lifetime risk rose by 12 percentage points from
lrA = 0.24 to lrB = 0.36. Because we subtracted B from A we obtained a negative value. The con-
tribution to the increase in the lifetime risk from changes in incidence proportions (last col-
umn) is obviously zero since iA,x and iB,x do not differ at any age. As expected, the difference in
lifetime risk can be completely attributed to improvements in survival.
The complementary picture is provided by the second example (II). Age-specific survival
does not differ between time points A and B. Instead, the age-specific incidence proportions
changed over time. The overall reduction in lifetime risk of 0.07 is therefore equivalent to the
sum of the contributions from the different age categories.
Although all examples are hypothetical, the third example (III) is probably closest to reality
because contributions to lifetime risk differences originate from changes in age-specific sur-
vival as well as from changes in age-specific incidence proportions. The lifetime risk increased
by 15 percentage points from 0.33 to 0.48. Our decomposition method allows us to disentangle
the overall effect into contributions due to varying mortality conditions and varying age-spe-
cific incidence. It turns out that the increase in lifetime risk is due to a combination of higher
incidence proportions and higher survival. In addition to this qualitative assessment, we can
also state that improved survival contributed almost three times more (0.11) to the increase in
lifetime risk than the actual incidence risk (0.04).
Table 1. Illustration of the decomposition method with hypothetical examples. (I) Changes in age-specific survival. (II) Changes in age-specific incidence. (III)
Changes in age-specific survival and incidence. In all three examples, we decomposed the change from A to B (A − B).
Contribution of Change in Age-
Specific
Scenario Age x lA,x lB,x ϕA,x ϕB,x Survival† Incidence‡
(I) Change in Survival 1 1.0 1.0 0.0 0.0 0.00 0
2 0.7 0.8 0.2 0.2 -0.02 0
3 0.2 0.4 0.3 0.3 -0.06 0
4 0.1 0.2 0.4 0.4 -0.04 0
lrA = 0.24 lrB = 0.36 Δ = −0.12 ∑ -0.12 0
(II) Change in Incidence 1 1.0 1.0 0.0 0.0 0 0.00
2 0.7 0.7 0.2 0.1 0 0.07
3 0.2 0.2 0.3 0.4 0 -0.02
4 0.1 0.1 0.4 0.2 0 0.02
lrA = 0.24 lrB = 0.17 Δ = 0.07 ∑ 0 0.07
(III) Changes in Survival and Incidence 1 1.0 1.0 0.1 0.2 0.000 -0.100
2 0.5 0.8 0.2 0.1 -0.045 0.065
3 0.3 0.4 0.3 0.4 -0.035 -0.035
4 0.1 0.2 0.4 0.2 -0.030 0.030
lrA = 0.33 lrB = 0.48 Δ = −0.15 ∑ -0.11 -0.04
† Estimated by first part of Eq 7.
‡ Estimated by second part of Eq 7.
https://doi.org/10.1371/journal.pone.0195307.t001
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Empirical examples
Material and data
We applied the method to remaining lifetime risk of getting diagnosed with myocardial infarc-
tion, colorectal cancer and hip fracture for Swedish males at age 60. Note, however, that the
decomposition can be applied to lifetime risk starting at any age. For the different diseases, we
compared the lifetime risk between two different time points. These are 1987 and 1994 for
colorectal cancer, 1994 and 2014 for hip fractures and 1994 and 2004 for myocardial
infarction.
The incidence estimates for the three disease outcomes were obtained from Swedish regis-
try data maintained by Statistics Sweden and the National Board of Health and Welfare [12].
For myocardial infarction and hip fracture, the first event occurring after age 60 after a seven
year disease free period was identified from the National Patient Register. For colorectal can-
cer, the date of the diagnosis of the cancer was collected from the Swedish Cancer Register.
The incidence counts have been smoothed across age and time to reduce random fluctuations,
using the MortalitySmooth package in R [13, 14].
Death—the competing risk of getting diseased— should ideally be measured by the death
rates of the disease-free population. This requires sufficiently detailed data sources, which
allow to follow individuals over time, in order to determine whether they can be considered
disease-free or not. In most cases, however, such detailed data are not available, and therefore,
alternative data sources must be used. In our example, death rates are based on death counts
and population data of the total Swedish male population, provided by the Human Mortality
Database [15]. For two reasons, these death rates are very likely overestimating mortality in a
cross-sectional setting. First, persons who get diseased and die in the same year are considered
in the incidence as well as in the death rate and are therefore counted as two separate exits. Sec-
ond, in our quasi-cohort perspective, death rates at consecutive ages are also potentially too
high because total population death rates still contain the diseased population. It is very likely
that this population suffers from higher mortality than the disease-free population. For practi-
cal reasons, however, the use of such death rates is acceptable because this misclassification
likely overestimates mortality, and thus, leads to upper bound estimates of lifetime risk and the
contribution of increased survival. Note that the bias of using such death rates depends on the
respective relationship between mortality and the disease of interest.
The left panel of Fig 1 depicts the time trends of lifetime risk for the respective diseases. The
dots mark the time points, which are selected for the decomposition. The selection is based on
the pattern of the respective lifetime risks. Accordingly, for myocardial infarction, we choose
the end points of a period with almost stagnating levels of lifetime risk. For hip fracture, both
time points comprise a period of slight increases and for colorectal cancer, the time points are
the boundaries of a period of increasing lifetime risk. The right panel illustrates the results of
the decomposition. The bars show the contribution of changing survival and of changing inci-
dence as well as the total change in lifetime risk.
Results
In the case of myocardial infarction, the lifetime risks are almost similar at the two time points,
which could lead to the conclusion that there have been no improvements in incidence above
age 60. By applying the decomposition, however, it becomes clear that declining incidence
would have generated a decrease in lifetime risk by more than three percentage points but
increasing longevity prevented this decline. If only mortality would have changed between the
two time points, the mortality improvements and, hence, the higher number of survivors to
Decomposing lifetime risk
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older ages would have resulted in an increase of lifetime risk by more than 2.5 percentage
points. In sum, the counteracting factors resulted in an overall change of lifetime risk by less
than a half percentage point.
For hip fracture, we observe a slight but steady increase in remaining lifetime risk above age
60 over time. This rise, however, is entirely driven by increasing longevity. The declining inci-
dence, given the same mortality at both time points, would have contributed to a decrease of
lifetime risk by more than 1.5 percentage points, whereas the survival improvements, given the
same incidence at both time points, would have generated an increase by more than 3 percent-
age points. Accordingly, the total change sums up to an increase by almost 1.5 percentage
points.
Colorectal cancer is an example, where lifetime risk increases relatively steeply in a short
period of time. In contrast to the other two examples, incidence contributes to a rise in the
remaining lifetime risk at age 60. Consequently, the incidence between 1987 and 1994 has
increased. Rising incidence alone would have generated an increase of lifetime risk by more
than 2.5 percentage points. Also the role of improving survival for changes in the lifetime risk
are different compared to the other two examples. The on average earlier occurrence of colo-
rectal cancer lowered the impact of the longevity advancement. Hence, the contribution of
increasing survival, given the same incidence at both time points, would have resulted in an
increase by slightly more than 0.25 percentage points. The total change, thus, sums up to a rise
of lifetime risk by almost 3 percentage points.
Discussion and conclusion
In this paper, we presented a decomposition method, which allows to separate the contribution
of changing incidence and changing survival on the difference between two lifetime risks. The
Fig 1. Remaining lifetime risk at age 60 and lifetime risk decomposition for myocardial infarction, hip fracture and colorectal cancer, Sweden, males.
https://doi.org/10.1371/journal.pone.0195307.g001
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method can be applied to compare lifetime risks over time or between different populations.
We illustrated the method and the interpretation of its estimates using hypothetical as well as
empirical data for three different diseases, which differ in their development of lifetime risk
over time.
In the analysis of time trends of the incidence of a certain disease, lifetime risk may be a
suitable summary measure across age categories or lifespan. In such an application, it is con-
ceivable that the incidence decreases with time in parallel with a reduction in death risks,
which in turn determines survival. This is the situation in which the change in incidence forces
lifetime risk to go down, while the change in survival forces lifetime risk to go up. Thus, the
two forces work in opposite directions and a positive development of the risk of getting a dis-
ease may be hidden but can be excavated by a decomposition method. Of course, other
approaches such as age-standardization are conceivable to investigate the change in incidence
but such methods would ignore the quantification of the influence of improved survival. In
this context, lifetime risk provides a valuable, perhaps unique, opportunity to combine infor-
mation on survival and incidence within one single index. The presented decomposition
method allows to investigate incidence change and additionally survival change at the same
time by comparing directly the observed age-specific incidence and death rates, thereby omit-
ting the use of some arbitrary standard population.
As we have seen from the empirical examples, whether increasing longevity influences the
development of lifetime risk or not, depends on the timing of the respective disease. In recent
decades, mortality improvements have been especially prevalent at higher ages [16]. Accord-
ingly, especially lifetime risks of diseases, which tend to occur at higher ages, are influenced by
increasing survival. This is because improved survival causes a higher number of survivors to
the ages where disease incidence is highest and, hence, even when incidence is going down,
the declines at those ages are at least compensated by the higher number of persons under risk.
In turn, for disease which tend to occur at ages with only marginal survival improvements,
incidence declines of the same magnitude would have a stronger effect on lifetime risk. That is
because of the number of survivors at that ages, which differs only marginally between the two
populations.
Furthermore, it is worth noting that for fatal diseases there is a certain degree of depen-
dency between the disease risks and the death risks. However, as we show in the appendix the
method could easily be extended to capture this dependency. In this case, it is a three factor
decomposition, which separates, besides the contributions of survival and incidence, the con-
tribution of changes in disease related mortality to incorporate the interrelation of declining
incidence as a potential driver of increasing longevity over time. In fact, the approach could
even be extended to a four factor decomposition, which could additionally provide the contri-
bution of changing case fatality.
Many common summary measures of population health and mortality are distorted by the
increase in longevity, or more generally by the change of the age-structure of the underlying
population. The general procedure presented here can add to our understanding of the influ-
ences of these factors on such measures. Practically, these decompositions could also be impor-
tant in forecasting and planning health care resources in the future.
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The effects of increasing longevity and changing
incidence on lifetime risk differentials: A
decomposition approach
(Appendix 1)
Marcus Ebeling∗, Karin Modig†, Anders Ahlbom‡and Roland Rau§
Mathematical derivation of the method: omitted steps
In the main text, we have not shown the full derivation of the decomposition method. The steps
to derive the final decomposition formula are shown below. Starting from the equation
Δ =
∑
푥≤푥푖≤휔
휙푥푖,퐴푙푥푖,퐴 −
∑
푥≤푥푖≤휔
휙푥푖,퐵푙푥푖,퐵. (1)
we split the two components in the first line of Eq 2 in halves, and add and subtract identical
terms in the second line of Eq 2. We do this in order to end up with easily interpretable terms.
Δ =
∑
푥≤푥푖≤휔
푙푥푖,퐴휙푥푖,퐴
2
+
∑
푥≤푥푖≤휔
푙푥푖,퐴휙푥푖,퐴
2
−
∑
푥≤푥푖≤휔
푙푥푖,퐵휙푥푖,퐵
2
−
∑
푥≤푥푖≤휔
푙푥푖,퐵휙푥푖,퐵
2
+
∑
푥≤푥푖≤휔
푙푥푖,퐴휙푥푖,퐵
2
−
∑
푥≤푥푖≤휔
푙푥푖,퐴휙푥푖,퐵
2
+
∑
푥≤푥푖≤휔
푙푥푖,퐵휙푥푖,퐴
2
−
∑
푥≤푥푖≤휔
푙푥푖,퐵휙푥푖,퐴
2
.
(2)
By grouping, we can reduce Eq 2 to four terms:
Δ =
∑
푥≤푥푖≤휔
푙푥푖,퐴
휙푥푖,퐴 + 휙푥푖,퐵
2
+
∑
푥≤푥푖≤휔
휙푥푖,퐴
푙푥푖,퐴 + 푙푥푖,퐵
2
−
∑
푥≤푥푖≤휔
푙푥푖,퐵
휙푥푖,퐴 + 휙푥푖,퐵
2
−
∑
푥≤푥푖≤휔
휙푥푖,퐵
푙푥푖,퐴 + 푙푥푖,퐵
2
.
(3)
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Eq 3 can now be rewritten to get the decomposition formula
Δ =
∑
푥≤푥푖≤휔
[
푙푥푖,퐴 − 푙푥푖,퐵
] 휙푥푖,퐴 + 휙푥푖,퐵
2
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟
Contribution of Changing Survival Conditions
+
∑
푥≤푥푖≤휔
[
휙푥푖,퐴 − 휙푥푖,퐵
] 푙푥푖,퐴 + 푙푥푖,퐵
2
⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏞⏟
Contribution of Changes in Incidence
. (4)
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Extending the decomposition by the disease related mortality
rate: equations and illustrative example
To investigate and illustrate the relationship between declining incidence of the respective dis-
ease and its role as a potential driver of increasing longevity over time, we incorporate disease-
related mortality as a third factor to the decomposition. If we are including the death rate of the
respective disease at age x, 푑푥, the rate of either dying or getting diagnosed at age x changes to
휇푥 = 푚푥 + 퐼푥 + 푑푥, (1)
where, for interpretation reasons, 푚푥 now depicts the death rate for all other causes than the
disease in question. By applying this modification, the calculation of lifetime risk changes to
푙푟푥 =
∑
푥≤푥푖≤휔
퐼푥푖 푒푥푝[−
∑
푥≤푦<푥푖
퐼푦] 푒푥푝[−
∑
푥≤푦<푥푖
푚푦] 푒푥푝[−
∑
푥≤푦<푥푖
푑푦]. (2)
For simplicity, we will write again 휙푥푖 for 퐼푥푖 푒푥푝[−
∑
푥≤푦<푥푖
퐼푦] and 푙푥푖 for 푒푥푝[−
∑
푥≤푦<푥푖
푚푦] and,
furthermore, 휆푥,푖 for 푒푥푝[− ∑
푥≤푦<푥푖
푑푦]. Given these changes, the original decomposition formula
is extended by a third term, which indicates the contribution of changes in disease-specific
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mortality between both populations. Accordingly, the formula writes as follows∑
푥≤푥푖≤휔
휙푥푖,퐴푙푥푖,퐴휆푥푖,퐴 −
∑
푥≤푥푖≤휔
휙푥푖,퐵푙푥푖,퐵휆푥푖,퐵 =∑
푥≤푥푖≤휔
(휙푥푖,퐴 − 휙푥푖,퐵)
[ 푙푥푖,퐴휆푥푖,퐴 + 푙푥푖,퐵휆푥푖,퐵
3
+
푙푥푖,퐴휆푥푖,퐵 + 푙푥푖,퐵휆푥푖,퐴
6
]
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Contribution of Changing Incidence Risks
+
∑
푥≤푥푖≤휔
(푙푥푖,퐴 − 푙푥푖,퐵)
[휙푥푖,퐴휆푥푖,퐴 + 휙푥푖,퐵휆푥푖,퐵
3
+
휙푥푖,퐴휆푥푖,퐵 + 휙푥푖,퐵휆푥푖,퐴
6
]
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Contribution of Changing Survival Conditions (except Disease)
+
∑
푥≤푥푖≤휔
(휆푥푖,퐴 − 휆푥푖,퐵)
[휙푥푖,퐴푙푥푖,퐴 + 휙푥푖,퐵푙푥푖,퐵
3
+
휙푥푖,퐴푙푥푖,퐵 + 휙푥푖,퐵푙푥푖,퐴
6
]
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Contribution of Changing Disease Related Survival
(3)
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Figure 1: Decomposition of Lifetime Risk at Age 60 for Myocardial Infarction, Sweden,
Males, 1994-2004.
Fig. 1 shows an application of the three factor decomposition to the example of lifetime
risk for myocardial infarction for Swedish males, comparing the years 1994 and 2004. During
2
this period, lifetime risk almost stagnated, which could lead to the presumption that there has
been no improvement in the incidence of getting a myocardial infarction. By applying the three
factor decomposition, however, we see that the opposite is true. Not only incidence declined,
also the mortality of myocardial infarction improved. Given the same mortality for myocardial
infarction and all other causes, the contribution of changing incidence between both time points
would have resulted in a decrease of lifetime risk by more than 3 percentage points. However,
the improved survival for both myocardial infarction and all other causes prevented this decline.
Hence, given the same incidences and mortality of myocardial infarction at both time points, the
contribution of increased survival for all other causes would have resulted in a rise of lifetime
risk by more than 1.25 percentage points. Additionally, improved mortality for myocardial
infarction would have resulted in an increase by almost 1.5 percentage points. In sum, the three
factors add up to a total change of less than -0.5 percentage points.
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The effects of increasing longevity and changing incidence on
lifetime risk differentials: A decomposition approach
—
Correction
We noticed an incorrect summation index that appears in some equations. This error has no
effect on the content of the article. By recalculating our empirical examples with the revised for-
mulas, we noticed only minor changes in the empirical outcomes of our decomposition method.
The magnitude of the changes does not require any adjustments of the text. In fact, they even
strengthen the message of our paper. In conclusion, the incorrect summation index requires the
following corrections:
1. revise the respective formulas in the original paper
2. upload a revised S2 Appendix
3. exchange Figure 1 with a revised figure
1. revise the respective formulas in the original paper
Original text (page 3 in the original manuscript):
Hence, the fraction alive and healthy at age 푥 can be calculated by 푒푥푝[− ∑
0≤푥푖<푥
휇푥푖],
where 푥푖 denotes the running index of the sum, which is age. The lifetime risk of
becoming diseased from age x onward, 푙푟푥, can then be calculated by
푙푟푥 =
∑
푥≤푥푖≤휔
퐼푥푖 푒푥푝[−
∑
0≤푥푖<푥
휇푥푖], (2)
where 휔 denotes the highest age attained. Eq 2 can be rewritten as
푙푟푥 =
∑
푥≤푥푖≤휔
퐼푥푖 푒푥푝[−
∑
0≤푥푖<푥
퐼푥푖] 푒푥푝[−
∑
0≤푥푖<푥
푚푥푖]. (3)
For simplicity, we will write 휙푥푖 for 퐼푥푖 푒푥푝[−
∑
0≤푥푖<푥
퐼푥푖] and 푙푥푖 for 푒푥푝[−
∑
0≤푥푖<푥
푚푥푖].
Corrections/track changes of the respective part (changes are highlighted in blue):
Hence, the fraction alive and healthy at age 푥푖 can be calculated by 푒푥푝[− ∑
푥≤푦<푥푖
휇푦],
where 푥푖 denotes the running index of the sum, which is age. The lifetime risk of
becoming diseased from age x onward, 푙푟푥, can then be calculated by
푙푟푥 =
∑
푥≤푥푖≤휔
퐼푥푖 푒푥푝[−
∑
푥≤푦<푥푖
휇푦], (2)
where 휔 denotes the highest age attained. Eq 2 can be rewritten as
푙푟푥 =
∑
푥≤푥푖≤휔
퐼푥푖 푒푥푝[−
∑
푥≤푦<푥푖
퐼푦] 푒푥푝[−
∑
푥≤푦<푥푖
푚푦]. (3)
For simplicity, we will write 휙푥푖 for 퐼푥푖 푒푥푝[−
∑
푥≤푦<푥푖
퐼푦] and 푙푥푖 for 푒푥푝[−
∑
푥≤푦<푥푖
푚푦].
2. upload a revised S2 Appendix
The incorrect summation index appears also in the S2 appendix. Therefore, this document
requires also minor revisions. Please see the attached document.
3. exchange Figure 1 with a revised figure
Figure 1 shows the graph as printed in the published article. Figure 2 depicts the revised
version of the graph after adjusting for the incorrect summation index.
The following changes occurred after the adjustment for the incorrect summation index:
• myocardial infarction
– slight increase in the lifetime risk estimates
• colorectal cancer
– slight increase in the lifetime risk estimates, the total change between the two lifetime
risks compared, and the contributions of changes in disease incidence
• hip fracture
– slight increase in the lifetime risk estimates, the total change in the two lifetime risks
compared, and the contribution of changes in survival
– slight decline in the contribution of changes in disease incidence
2
The outlined changes do not influence the outcomes of the article and do not require any editing
of the text in the manuscript.
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Although these parameters are useful for specifying precisely how mortality
has been forecasted, they cannot be used to assess whether the underlying
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looking at average lifespan, we should examine whether the forecasted vari-
ability of the age at death is a plausible continuation of past trends. The
validation of mortality forecasts for Italy, Japan, and Denmark demonstrates
that their predictive performance can be evaluated more comprehensively by
analyzing both the average lifespan and lifespan disparity—that is, by jointly
analyzing the mean and the dispersion of mortality. Approaches that account
for dynamic age shifts in survival improvements appear to perform better than
others that enforce relatively invariant patterns. However, because forecasting
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Introduction
The aim of most mortality forecasts is to predict how many additional years of life
people will gain in the future. Basic life table functions—such as life expectancy at
birth (a measure of central tendency) and age-specific death rates (measures of
mortality intensity) are usually applied to evaluate the precision of such fore-
casts. The closer a forecast is to the observed development, the greater is its
forecasting performance—or, interchangeably, its predictive ability. Goodness-of-fit
tests as well as validation procedures are typically used to evaluate the predictive ability
of mortality forecasts. Placing particular emphasis on ex post quantitative aspects
(Armstrong and Collopy 1992; Cairns et al. 2011b; Keilman 1997; Shang 2015),
conventional evaluation measures quantify the difference between predicted and
observed mortality. It is commonly considered that the greater such forecast
errors, the poorer is the forecasting performance. However, although deviations
are supposed to be small, zero deviations would indicate overfitting rather than
a good forecasting performance. Forecast errors can be expressed in absolute or
relative terms, and they can be averaged over dimensions such as age, time,
and population (Booth et al. 2006; Keilman and Pham 2004; Koissi et al. 2006;
Shang et al. 2011; Smith et al. 2001). The meaning of these errors changes in
each case. For example, means of absolute errors measure accuracy, whereas
means of positive and negative errors measure bias—that is, systematic over- or
underestimation. Relative errors deal with scale dependency and therefore allow
comparison of errors across measures and methods. Dowd et al. (2010); Koissi
et al. (2006), and Lee and Miller (2001) analyzed how errors or (standardized)
residuals are distributed. In addition to employing visualization techniques,
these authors used statistical tests such as chi-squared, Levene’s test, the
variance ratio test, or the Jarque-Bera normality test. Moreover, Shang (2015)
recently proposed using test statistics to reveal significant differences in the forecast
accuracy of point and interval estimates as well as differences between the forecasts of
multiple approaches.
Errors and test statistics of basic life table functions are useful for specifying
precisely how mortality has been forecasted. However, small errors in the forecasts
of average lifespan do not necessarily indicate that the forecasted underlying mortality
developments are plausible. Figure 1 illustrates this issue in more detail with a
scatterplot that displays the negative correlation between life expectancy at birth and
lifespan disparity measured by average life years lost at birth, e†0 (e.g., Vaupel and
Canudas-Romo 2003), for women in Italy, Denmark, and Japan from 1950 to 2012. In
contrast to basic life table measures, e†0 provides information about the underlying
mortality developments. Although life expectancy at birth has increased in recent
decades because of reductions in mortality at progressively higher ages, e†0 has de-
creased mainly as a result of survival improvements at premature ages, which shifted
deaths toward the end of the lifespan. Figure 1 shows a striking pattern: the average
lifespan of Italian, Danish, and Japanese women has been similar in recent decades,
whereas the decline in the variability of the age at death differed considerably among
these groups of women as soon as their average lifespan exceeded 75 years. Specifi-
cally, lifespan dispersion (1) declined regularly for Italian women, (2) leveled off for
Japanese women, and (3) increased and decreased for Danish women.
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These findings illustrate that different underlying mortality trajectories can
lead to similar average lifespans and lifespan disparities. Other researchers
have discussed this relationship in detail (e.g., Smits and Monden 2009;
Vaupel et al. 2011; Wilmoth and Horiuchi 1999). For example, Wilmoth and
Horiuchi (1999) showed that different levels of life expectancy at birth can
come across with different levels of lifespan dispersion. Goldstein and Cassidy
(2012) and Bergeron-Boucher et al. (2015) analyzed the impact of changing
slopes in the mortality age profile on life expectancy at birth and lifespan
dispersion. For instance, Goldstein and Cassidy concluded that changes in the
slope have a relatively larger effect on life expectancy at birth than changes in
the level of mortality. To ensure that we take these underlying trajectories into
account, we propose expanding the toolkit of conventional evaluation
procedures. Basic life table functions should be complemented by measures
of lifespan dispersion to improve the assessment of ex post quantitative
aspects and to evaluate the plausibility of underlying mortality trends. To the
best of our knowledge, only Cairns et al. (2006, 2011b) have taken a similar
approach. They added an ex ante evaluation with qualitative criteria to ex post
measures; that is, they examined the forecasting performance using qualitative
criteria, such as the biological validity of the age schedule of mortality, and
investigated the consistency of the forecasts using historical data. However, as
far as we know, no existing studies have used lifespan disparity as an evalu-
ation measure for the plausibility of mortality forecasts. The objective of this
article is to highlight the necessity to assess whether mortality forecasting
methods can capture and forecast different trends of life expectancy at birth
and lifespan disparity—that is, expose the benefits of incorporating lifespan
disparity as an additional indicator in the toolkit that is used to evaluate the
performance of mortality forecasts.
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Fig. 1 Scatterplot of life expectancy at birth and average life years lost at birth due to death for women in
Denmark, Italy, and Japan from 1950 to 2012
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Lifespan Disparity: Measures and Concepts
Lifespan disparity describes the variation in the lifespan distribution—that is, the
differences in the length of life across members of a population. A wide range of
approaches can be used to measure lifespan disparity, including (1) classic statistical
variability measures, such as the standard deviation or the interquartile range; (2)
equality measures, such as the Gini coefficient; or (3) geometric approaches, such as
the Prolate index (Cheung et al. 2005; Eakin andWitten 1995; Kannisto 2000; Wilmoth
and Horiuchi 1999). However, because all these measures are highly correlated
(Vaupel et al. 2011; Wilmoth and Horiuchi 1999), we can expect that their
impact on the results would be minor. Although those measures are highly
correlated, however, their trends may differ. For example, if equality were
rising, measures of variability would decrease, whereas measures of rectangularity
would increase (Wilmoth and Horiuchi 1999).
To measure lifespan dispersion,1 we take the average number of life years lost at birth
(Vaupel and Canudas-Romo 2003; Zhang and Vaupel 2009), e†0, estimated by
e†0 ¼
∫
0
ω
eadada
l0
; ð1Þ
with ea being remaining life expectancy at age a, and da being life table deaths at age a,
with both integrated from age 0 toω, the highest age at death. l0 is the radix of the life
table. A major reason why we chose e†0 is that it is demographically interpretable as the
average life years lost. Because e†0 refers to the lost living potential, it also provides
information about the capacity for further increases in life expectancy. We argue that
these key features enable e†0 in particular to be used to evaluate the plausibility of
mortality forecasts.
Measuring lifespan disparity may reveal one of three general patterns: the compres-
sion, shifting, or expansion of mortality. Although these patterns are not mutually
exclusive in the real world, they are useful for explaining trends in lifespan disparity.
Fries (1980) established the concept of mortality compression, originally describing a
postponement of mortality to some fixed upper lifespan limit, which in turn induces a
reduction in lifespan disparity. Although the expected levels of lifespan disparity have
not been reached and the proposed levels of average lifespan have been exceeded, the
concept of mortality compression is typically used to describe the massive reductions in
lifespan variability since the mid-nineteenth century (Kannisto 2000; Nagnur 1986;
Nusselder and Mackenbach 1996). The concept of shifting mortality describes a
postponement of the old-age death bulk toward higher ages with an approximately
constant level of lifespan variability. Empirical studies have provided evidence that
shifting mortality may occur following mortality compression (e.g., Bongaarts 2005;
Canudas-Romo 2008; Kannisto 1996). The concept of mortality expansion refers to
progressive improvements in survival to very old ages that have not previously been
1 We use the terms “lifespan disparity,” “lifespan dispersion,” and “lifespan variability” interchangeably. Some
scholars also call e†0 “life disparity” (Vaupel et al. 2011). However, we use the term “lifespan disparity” to
describe the general concept of lifespan variability that we measure using average life years lost.
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reached by many people. Mortality expansion to very old ages induces temporarily
increasing lifespan variability, although its impact on total variability of the age at death
has not been evident until recently. However, increasing lifespan dispersion has been
observed in multiple populations at approximately age 60 (Engelman et al. 2010, 2014;
Rothenberg et al. 1991).
A (positive or negative) change in life expectancy at birth, along with a compression,
a shifting, and/or an expansion of mortality, are possible developments that should be
captured in a mortality forecast. Because these developments are closely related and
occur at different times in different populations, mortality forecasting approaches may
need to be adjusted to ensure that they are captured appropriately.
Mortality Forecasting Approaches That Tackle Variability of the Age
at Death
Concise Overview
Many approaches, like the canonical Lee-Carter model (1992), extrapolate past trends
while assuming that the relative progress in mortality made among people of different
ages has been time-invariant. This assumption is, however, implausible, given that
survival improvements differ considerably by age over time. In the first half of the
twentieth century, large reductions in mortality occurred among infants and young
children in many highly developed countries. More recently, most of the survival
improvements have been among adults and the elderly. In the coming decades,
mortality is expected to decline mainly among the very old. Hence, the assumption
of time-invariant changes in mortality by age may induce forecasts that are prone to
errors. Recently developed approaches respond to this problem in different ways. For
example, Janssen and de Beer (2016) accounted for the distribution of the age at death;
Li et al. (2013) rotated the age pattern of mortality change with time; and Haberman
and Renshaw (2012), Mitchell et al. (2013), and Bohk-Ewald and Rau (2017) used
rates of mortality improvement instead of death rates to forecast dynamic age shifts in
mortality decline. Moreover, Li and Lee (2005), Cairns et al. (2011a), Hyndman et al.
(2013), and others used coherent approaches to jointly forecast mortality among
multiple populations, allowing populations to adapt their below- or above-
average increases in life expectancy to a shared trend among multiple popula-
tions. Capturing ruptures in long-term trends that emerge from irregular patterns of
mortality change is also challenging. For example, Coelho and Nunes (2011) dealt with
long-term trend changes in mortality forecasts, Janssen et al. (2013) included exogenous
variables such as tobacco smoking, and Renshaw and Haberman (2006) considered
cohort mortality to account for this issue.
We select three of these approaches, which differ in their ability to capture dynamic
age shifts in survival improvement, to forecast mortality exemplarily for women in Italy,
Japan, and Denmark up to 2009 (see the next section). These models are the Lee-Carter
model, its rotating variant developed by Li et al., and the model developed by Bohk-
Ewald and Rau. Given that their levels of modeling flexibility differ, each approach
models the various trends in lifespan disparity in the three populations differently (see
Fig. 1). All the approaches mentioned in the concise overview are equally qualified to be
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selected for the case studies to show the advantages when evaluating the forecasting
performance using the mean—and, as an extra criterion, the spread of mortality. Hence,
this analysis is designed to show the additional information that can be gained when
evaluating the forecasted spread of mortality in the presence of different trends for life
expectancy at birth and lifespan dispersion. Although the case studies provide some
results for comparing the forecasting performance of the three approaches, this should be
considered preliminary and rather a byproduct than an incentive to conduct this analysis;
a valid model comparison would instead require a systematic evaluation of the forecast-
ing performance using extensive mortality data of multiple countries and periods, which
is beyond the scope of this work. Hence, for the case studies, we select three forecasting
models that cover the range of available approaches andmodeling strategies quite well. In
addition to describing the method-based assumptions of the selected approaches for
capturing dynamic age shifts in survival improvement, as well as some details on
implementation, we offer hypotheses regarding the effect that each approach might have
on the forecasted mean lifespan and lifespan disparity.
Impact of Model-Based Assumptions on Lifespan Disparity
Lee-Carter Model
Although the Lee-Carter model has been used and revised extensively since it was first
developed in 1992 (Booth and Tickle 2008; Booth et al. 2006; Butt and Haberman
2010; Shang 2012; Shang et al. 2011), we use its original version as a benchmark in our
case studies. The Lee-Carter model forecasts mortality by age and calendar year on the
logarithmic scale while assuming that the relative changes in mortality were constant
between the ages over time. Hence, if the survival improvements were relatively large
at young ages and small at old ages in the reference years, this proportion would
assumedly be unchanged in the forecast years. Yet, given the shifts by age in survival
improvements over time, we hypothesize that the inflexibility in the age profile of
mortality change would have affected the Lee-Carter forecasts up to 2009. The
extrapolation of declining mortality at infant, child, adult, and old ages based solely
on the mortality trends observed in the reference period may result in a reliable forecast
for the near future given that the prevalence of mortality reductions at very old ages will
still be low. However, if mortality continues to decline at progressively higher ages in
the coming decades, the Lee-Carter model may produce forecasts that fail to capture
correctly both the average lifespan and lifespan disparity. The absence of a dynamic
shift in survival improvements to progressively higher ages may then induce (1) an
underestimation of life expectancy at birth as well as (2) a strong compression of
deaths, which may in turn be accompanied by a strong decline in the lifespan
dispersion. To generate the mortality forecasts with the Lee-Carter model, we
implemented the model in the statistical software R (R Core Team 2015).
Li et al. Model
Many scholars have refined the Lee-Carter model to address the problem of the
inflexibility in the age profile of mortality change (Booth et al. 2006; Shang et al.
2011; Soneji and King 2011). Li et al. (2013) took an important step in this direction by
1564 C. Bohk-Ewald et al.
implementing a time-variant age schedule of mortality change that rotates from a
present level to an ultimate level. The timing and the pace of the rotation depend on
the average lifespan, which has been forecasted in a previous step with the original
Lee-Carter model. As soon as life expectancy at birth exceeds a value of 80
years, the rotation starts; it then proceeds until life expectancy at birth reaches
an ultimate level of 102 years. The greater the number of forecasted additional
years of life is, the faster the ultimate schedule is achieved, and the rotation
stops. The ultimate schedule of mortality change is constant for ages 0 to 64,
and it gradually declines thereafter. The rotation basically induces a postponement
of relatively large survival improvements from younger to older ages. Given that the
average lifespan is forecasted using the original Lee-Carter model, the rotation affects
only the underlying mortality dynamics—not the average level of mortality. Assuming a
regular decline in mortality, we expect to find that (1) like the original model, the rotated
model may underestimate additional years of life; but (2) unlike the original model, it
may be able to forecast a mortality compression that is less strong because of its greater
modeling flexibility. To take these dynamic mortality changes into account, Ševčíková
et al. (2016) implemented the rotation in Raftery et al.’s (2013) model, which has been
used in the UN World Population Prospects (2014, 2015). To derive the age profiles of
mortality using the rotated Lee-Carter model, we implement this model in R with a few
adjustments. Because we allow approaches to shift deaths beyond the maximum age of
the data (see the upcoming section, “Estimation and Evaluation Procedure”), we set the
ultimate schedule of mortality change constant until age 80, and as gradually declining
thereafter. Moreover, for the rotation, we change the recommended bounds of the
forecasted lifespan, which are 80 years and 102 years. We set the lower bound at 75
because differences in lifespan disparity started to develop for women in Italy, Japan,
and Denmark as the average lifespan exceeded this value (see Fig. 1). Finally, to avoid
jump-off bias, we use the last observed death rates to forecast mortality.
Bohk and Rau Model
The model of Bohk-Ewald and Rau (2017) provides an alternative strategy for fore-
casting that relatively large rates of mortality improvement proceed from younger to
older ages. This model predicts survival improvements instead of death rates, and it
optionally combines the mortality trends of multiple populations to account for
(anticipated) trend changes in the forecast years. Although this model allows us to
assume mortality convergence between a country of interest and reference countries,
we do not use this feature in the case studies in order to enable a fair comparison with
the model of Li et al. (2013). Moreover, the Bohk and Rau model has a linear and an
exponential core model to forecast time series of age-specific mortality change, using
simulation-based Bayesian inference to run those models and to estimate coherent
changes of mortality among adjacent ages. The model has been applied to forecast
mortality for some European countries (Bohk and Rau 2014; Bohk-Ewald and Rau
2017) as well as for the United States (Bohk and Rau 2016). Although both the rotating
Lee-Carter model and the Bohk and Rau model allow the age profile of the rates of
mortality improvement to change, the latter model appears to be more flexible because
it does not assume an approximation of an ultimate schedule. If mortality declines
regularly, we expect that the Bohk and Rau model will perform as well as the rotating
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Lee-Carter model in forecasting average mortality and lifespan disparity and that it will
perform even better in generating forecasts for populations with irregular mortality
developments because it is more adaptable to different forecasting situations. To
generate the forecasts with the Bohk and Rau model, we use its implementation in R,
which is described in detail in Bohk-Ewald and Rau (2017).
Illustrative Examples
In this section, we validate the forecasting performance of the Lee-Carter model, its
rotating variant, and the model of Bohk-Ewald and Rau. Using illustrative examples,
we examine whether each model is able to generate precise forecasts of average
mortality and lifespan disparity. These illustrative examples are designed to indicate
whether the approaches can capture (1) regular and irregular trends of average lifespan
and (2) dynamic age shifts in survival improvements.
Estimation and Evaluation Procedure
The mortality forecasts up to 2009 rely on four reference periods (1965–1990, 1960–
1985, 1955–1980, and 1950–1975). We compare the estimations with the observed
values. Besides e0, which is a common indicator in evaluations, we also compare the
forecasted e†0 values with the observed values to assess the ability of the forecasting
approaches to predict average mortality and lifespan disparity. We focus our main
analysis on e0 and e
†
0, but we also provide results for e65 and e
†
65 in Online Resource 1 in
order to show how sensitive (or robust) our findings are.
We employ visualization techniques as well as forecast errors to evaluate the
forecasting performance of each method. To quantify forecast accuracy in terms of
the mean and spread of mortality, we use the absolute percentage error (APE) because it
is a relative error that relates the absolute difference between forecasted and observed
values to the size of the actual values. Because the APE can, therefore, deal with
measures of different scales, we use it to compare the forecasting performance (across
time and by country) between the methods using e0 and e
†
0. Given that the chosen
approaches provide probabilistic mortality forecasts, we focus not only on the evalu-
ation of median point estimates but also on the calibration of prediction intervals. We
use empirical frequencies to evaluate the uncertainty estimates of probabilistic fore-
casts; empirical frequencies give the proportion of observed values that actually fall
within the prediction intervals. For instance, a 95 % prediction interval should capture
95 % of all observations. If it captures more or fewer observations, it is too wide or too
narrow, respectively (e.g., Raftery et al. 2013; Schmertmann et al. 2014).
We generate forecasts of mortality for women in Italy (regular e0 and e
†
0), Japan
(regular e0 and irregular e
†
0), and Denmark (irregular e0 and e
†
0) because these groups
have differed substantially in recent decades in their levels of life expectancy and
lifespan dispersion (see Fig. 1). As input data, we use deaths and exposures by single
age from 0 to 110+, and by calendar year from 1950 to 2009, from the Human
Mortality Database (n.d.). To enable the forecasting approaches to shift deaths to ages
beyond 110+, we extend the age range to 130+ with the Kannisto model (Thatcher et al.
1998), the details of which we explain in Online Resource 1 (section A). This approach
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is similar to Ševčíková et al.’s (2016) revised UN approach. The estimation of e0 and e
†
0
(and of e65 and e
†
65) is based on life tables produced from the forecasted and observed
age-specific death rates.
Results
Visualize Forecast Performance Figure 2 displays the average lifespan, e0, and
the average number of life years lost, e†0, for women in Italy, Japan, and
Denmark. The observed data are in black, and the forecasted data are in red (Lee-
Carter model), green (rotating variant proposed by Li et al. 2013), and blue (Bohk and
Rau model). Moreover, the forecasted years (1991–2009) are highlighted in gray, and
the reference period (1965–1990), is highlighted in beige. Given the technical construc-
tion of the Lee-Carter models, it is not surprising that the forecasts of average lifespan
are almost identical: both models use the forecasted life expectancy at birth of the
original model. The rotated variant deviates no more than +/– 0.1 years, which we used
as a tolerance level when adjusting the age profile of mortality change with the rotation
to fit the average lifespan of the original Lee-Carter model. By contrast, the forecasts of
the Lee-Carter models differ in terms of lifespan disparity. The effect shown here is
greater than it would have been with Li et al.’s (2013) original implementation because
we let the rotation start when the average lifespan exceeded the value of 75 years, not of
80 years.
Quantify Forecast Performance Table 1 lists the mean of the APEs for e0 and e
†
0
over the forecast years by country and forecasting method for each validation setting,
and Table 2 lists those mean absolute percentage errors (MAPEs) averaged over all four
validation settings. Strikingly, the MAPEs appear to be greater for e†0 than for e0 for
almost any country, validation setting, and method. The overall mean of all MAPEs is
approximately 0.01 for e0 and 0.046 for e
†
0; that is, the forecasts deviate on average by
1 % from life expectancy at birth and by 4.6 % from lifespan dispersion. As a
consequence, the forecasting performance is depreciated for all methods when
we consider e†0 in addition to e0. Furthermore, the MAPEs for e65 and e
†
65 are
listed in Tables S1 and S2 in Online Resource 1. In contrast with mortality over the
entire lifespan, errors often appear to be smaller for e†65 than for e65. An exception is
Japan; in the validation settings 1 and 2, the errors appear to be larger for e†65 than for e65.
The empirical frequencies for e0 and e
†
0 in Table S3 and for e65 and e
†
65 in Table S4
(Online Resource 1) confirm our findings for the median forecasts and show even more
clearly that current approaches struggle to forecast lifespan disparity. The 95 % pre-
diction intervals capture, on average, a fairly large number of observations for life
expectancy at birth and, albeit slightly fewer, for remaining life expectancy at age 65.
By contrast, many fewer observations are captured by the 95 % prediction intervals for
lifespan disparity; empirical frequencies range from 0 % to 96.5 %, with the average
being only approximately 26 %.
Case of Italy: Regular Trends for Mean Lifespan and Lifespan Disparity
If mortality develops regularly without any trend changes in the forecast years, the
predictions of all three approaches appear to be close to the observed values. In Italy,
we detect a regular increase in the average lifespan as well as a regular decline in
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Fig. 2 Life expectancy at birth (left panels) and life years lost at birth (right panels) for women in Italy, Japan,
and Denmark: Observed data, forecasted data using the Lee-Carter model, the Lee-Carter rotating variant
(proposed by Li et al. 2013), and the Bohk and Rau model. Forecast years are 1991–2009. Reference period is
1965–1990
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Table 1 Mean of the absolute percentage errors (MAPE) fore0 and e
†
0 over the forecast years by country andmethod
Country and
Measure
Method
Lee-Carter
Lee-Carter,
Rotated
(Li et al.) Bohk and Rau
Validation 1 (ref. years: 1965–1990; forecast years: 1991–2009)
Italy
e0 0.003 0.003 0.005
e†0 0.019 0.015 0.014
Japan
e0 0.002 0.003 0.002
e†0 0.087 0.080 0.034
Denmark
e0 0.008 0.007 0.006
e†0 0.065 0.054 0.009
Validation 2 (ref. years: 1960–1985; forecast years: 1986–2009)
Italy
e0 0.010 0.010 0.002
e†0 0.029 0.021 0.018
Japan
e0 0.002 0.002 0.004
e†0 0.092 0.076 0.014
Denmark
e0 0.005 0.004 0.017
e†0 0.094 0.077 0.021
Validation 3 (ref. years: 1955–1980; forecast years: 1981–2009)
Italy
e0 0.014 0.014 0.002
e†0 0.027 0.019 0.012
Japan
e0 0.009 0.009 0.003
e†0 0.118 0.092 0.022
Denmark
e0 0.007 0.008 0.029
e†0 0.048 0.033 0.023
Validation 4 (ref. years: 1950–1975; forecast years: 1976–2009)
Italy
e0 0.018 0.018 0.008
e†0 0.032 0.023 0.053
Japan
e0 0.018 0.018 0.012
e†0 0.131 0.094 0.032
Denmark
e0 0.015 0.014 0.035
e†0 0.020 0.018 0.043
Note:MAPEs are shown for four validating settings that all forecast mortality until 2009, but they use different
historical periods.
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lifespan disparity in the entire 1965–2009 period. Hence, Italian women experienced no
trend changes, and their additional years of life were probably due to a compression of
mortality that lasted (without any interruptions) in the reference and forecast years.
Given these regular trends, the forecasts of all the approaches capture mean lifespan
and its disparity with only negligible deviations. However, the MAPEs are smaller for
e0 (0.3 % to 0.5 %) than for e
†
0 (1.9 % for the Lee-Carter model and 1.5 % for the other
two models).
Case of Japan: Regular Trend for Mean Lifespan and Irregular Trend for Lifespan
Disparity
If the average lifespan trend is regular but the lifespan disparity trend is not, differences
in the predictive ability of the three approaches are present but become visible only if
we complement the evaluation with a measure of dispersion. In Japan, we observe a
strong increase in the average lifespan from 1965 to 2009 as well as a decline in
lifespan disparity that levels off in the forecast years. Hence, among Japanese women
there was a trend change in the forecast years, and their additional years of life were
probably due to a compression of mortality in the reference period and a shifting of
mortality in the forecast years. Given the partial instability of mortality trends among
Japanese women, the forecasts of the three models are close to the observed mean
lifespan. The MAPEs for e0 range between 0.2 % and 0.3 %, suggesting that the
forecasts were precise. However, the analysis of lifespan disparity shows that all the
approaches overestimate the observed decline in the variability of the age at death. The
deviations are greater for the Lee-Carter models (MAPEs for e†0 are 8.7 % for the
original model and 8.0 % for its rotated variant) than for the Bohk and Rau model
(MAPE for e†0 is 3.4 %). As a consequence, all three approaches predict a continuation
of mortality compression while assuming that the concentration of deaths at higher ages
will be greater than it actually was.
Table 2 Mean of the absolute
percentage errors (MAPE) for e0
and e†0 over all validation settings
by country and method
Country
and Measure
Method
Lee-Carter
Lee-Carter,
Rotated
(Li et al.) Bohk and Rau
Italy
e0 0.011 0.011 0.004
e†0 0.027 0.019 0.024
Japan
e0 0.008 0.008 0.005
e†0 0.107 0.086 0.025
Denmark
e0 0.009 0.008 0.022
e†0 0.057 0.045 0.024
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Case of Denmark: Irregular Trends for Mean Lifespan and Lifespan Disparity
If the trends of the mean lifespan and lifespan disparity are irregular, both evaluation
measures indicate forecast errors. In Denmark, we observe an increase in the average
lifespan in the forecast years after a period of stagnation in the 1980s and the early
1990s. We also observe a slight increase in lifespan disparity in the reference years that
turns into a sharp decline in the forecast years. Hence, Danish women experienced
trend changes in the forecast years. Their additional years of life were probably due to a
mixture of a shifting and a worsening of mortality at different ages in the reference
years as well as mortality compression in the forecast years. This result indicates
that since the early 1990s, the mortality trends of Danish women have been catching
up to those of vanguard populations, such as women in Italy and in Japan. Given these
unstable mortality trends among Danish women, the forecasts of the three models
capture the increasing trend of the average lifespan quite well. The MAPEs for e0,
0.6 % to 0.8 %, are only slightly higher than for Italy and Japan. However, the situation
is different for lifespan disparity: the Lee-Carter models (more so the original model than
the rotating variant) predict an increase in the forecast years despite an actual decline.
This outcome not only deviates substantially from the observed values yieldingMAPEs
for e†0 of 6.5 % and 5.4 %, but it also appears to be rather implausible given the general
negative correlation between rising life expectancy at birth and declining lifespan
disparity (see Fig. 1). In contrast, the Bohk and Rau model appears to capture
the changing trend in lifespan disparity in the forecast years quite well, resulting
in a more plausible forecast with only small deviations from the realized values
(a MAPE for e†0 of only 0.9 %).
Model Comparison
The illustrative examples suggest that the Lee-Carter model is less flexible than the
other two models. This shortcoming is particularly noticeable when we look at the
changing mortality trends in the forecast years, especially among women in Japan and
Denmark. By contrast, the rotating variant and the Bohk and Rau model appear to be
more capable of adapting to changing trends because unlike the original Lee-Carter
model, which assumes that the relative changes are time-invariant across ages, these
models assume that survival improvements will change over time. Analyzing the
forecast errors, the rotated Lee-Carter model appears to perform on average better than
the other two models because its MAPEs for e0 and e
†
0 are relatively small for all
countries and validation settings. By contrast, the original Lee-Carter model often has
the largest MAPEs; and although the Bohk and Rau model often has the smallest
MAPEs for life expectancy at birth and lifespan dispersion, it also has a few upward
outliers that reduce its overall forecasting performance.
Sensitivity of the Results to the Reference Period
To examine the sensitivity of the above results to the choice of the reference period, we
look at mortality forecasts up to 2009 that rely on different reference periods: 1960–
1985, 1955–1980, and 1950–1975. The analyses are shown in Figs. S2–S4 in Online
Resource 1, and have the same color scheme as in Fig. 2. Although the key message of
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the results presented is not affected by changing the reference period, a comparative
analysis helps to identify method-based differences.
The fits of life expectancy at birth and lifespan disparity basically appear to depend
on the regularity of mortality trends and the ability of the approaches to capture them
appropriately. Because Japanese and Danish women experienced irregular mortality
developments, making precise forecasts for them is particularly challenging. Thus, the
predictive ability of the approaches declines as the magnitude of the MAPEs increases.
This effect appears to be greater for the Lee-Carter model than for the other two
models, and it appears to be more pronounced in forecasts of lifespan disparity than
of average lifespan. For example, the greatest overall MAPE (10.7 %) is for e†0 in Japan
from the Lee-Carter model, whereas the smallest overall MAPE (0.4 %) is for e0 in Italy
from the Bohk and Rau model (Table 2). The greater forecast error for the Lee-Carter
model is probably due to the extrapolation of average trends of the reference period.
Hence, if the overall trend of lifespan disparity is decreasing in the reference period, the
Lee-Carter model tends to predict a decreasing pattern as well, and vice versa.
However, the structural breaks in Danish and Japanese lifespan disparity appear to be
unexpected and are therefore difficult to capture in a forecast generated by any model
that has not been designed for this specific task. If we look instead at the more regular
mortality trends in Italy, for example, we can see that the Lee-Carter models tend to
generate rather conservative forecasts of progress in the average lifespan; that is, they
tend to systematically underestimate the observed trajectories and yield overall MAPEs
for e0 of 1.1 %. By contrast, the forecasts of the Bohk and Rau model yield a smaller
overall MAPE for e0 (0.4 %) than the forecasts of the other two models, and they
sometimes systematically overestimate the additional years of life. Examining lifespan
disparity reveals even more differences between the approaches, particularly between
the two Lee-Carter models in the forecasts of Japanese female mortality. The rotating
variant appears to capture the flattening decline of lifespan disparity in the forecast
years much better than the original model, and thus substantially improves forecasting
performance: the overall MAPE for e†0 in Japan is substantially lower for the rotated
Lee-Carter variant (8.6 %) than for the original model (10.7 %). Also clearly visible for
lifespan dispersion in Japan is that the further in time the reference period is, the more
forecasts of the rotating variant diverge from those of the original model and converge
with those of the Bohk and Rau model. Given that the rotation starts when life
expectancy exceeds 75 years and that Japanese women reached this point in the early
1970s, this finding is not really surprising. As a consequence, the forecast that relies on
data from 1950 to 1975 is also the forecast in which the rotation has the largest effect on
the results. This finding demonstrates the need for time-variant survival improvements
in order to capture dynamic trends in the variability of the age at death. The remaining
deviations from the real values indicate that refining (or developing) forecasting
approaches may help to account for patterns in lifespan disparity, such as the
compression, shifting, and expansion of mortality. However, we do not expect
forecasting errors to be equal to 0 because they showmore signs of overfitting than of
high forecasting performance.
Also of note is that the predictive ability of forecasts that rely on data from 1950 to
1975 appears to be lower than that of forecasts based on more recent mortality trends.
Because this effect can be seen for the average lifespan and also partly for lifespan
disparity, we speculate that it may be attributable to the delayed onset of the old-age
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mortality decline in the 1970s, which was crucial for future mortality develop-
ments in all three populations. Hence, if a major driving trend of mortality in
the forecast years is missing in the reference period, the forecasting performance may
be substantially reduced.
If we restrict our analysis to ages above 65, the relation of errors (MAPEs) for
remaining years of life and lifespan disparity reverses. An exception is Japan, which
shows larger errors for lifespan disparity than for remaining years of life at age 65, but
only in the validation settings 1 and 2. Most likely, the onset of old-age mortality
decline (Kannisto 1994) causes the reversal in the error pattern. Analyzing the magni-
tude of errors across all four validation settings provides evidence that the more years
that are included in the reference period since the onset of the old-age mortality decline,
the more accurate are the forecasts of remaining life expectancy at age 65. Given that
the survival improvements at older ages primarily induced a parallel downward shift of
the force of mortality on the log scale, the effects were large for e65 but only marginal
for e†65. This development is widely known as shifting mortality and has been described
in detail by, for example, Bongaarts (2005) and Canudas-Romo (2008). Japan is the
world record leader in terms of life expectancy thanks to exceptionally large old-age
mortality improvements; we assume that these deviant/special trends in mortality
may have caused larger changes in the variability at death that have not been
captured in the forecasts and thus lead to larger errors for e†65 in the last two validation
settings (Cheung and Robine 2007; Wilmoth and Robine 2003).
Summary and Concluding Remarks
Our analysis has shown that some methods—among them, the original Lee-Carter
model, which is considered a golden standard in mortality forecasting—struggle to
account for trends in lifespan disparity. This shortcoming, often caused by rather time-
invariant survival improvements, has not been shown so clearly yet because the toolkit
for evaluating the forecast performance focused on, for example, life expectancy at
birth and age-specific death rates. These measures of central tendency are typically
used to analyze ex post to what extent forecasts deviate from their realized values.
Although these parameters of central tendency are useful for assessing how precisely
average mortality has been forecasted, they cannot be used to determine whether the
forecasted underlying mortality developments are plausible. This may be a serious
drawback because similar average lifespans can result from different underlying mor-
tality developments, which describe a dynamic age shift of survival improvement from
younger to older ages in many highly developed countries in the last decades. As a
consequence, small forecast errors of average lifespan do not necessarily indicate
plausible trends in the forecasted underlying mortality dynamics. To assess whether
the forecasts of the underlying developments are also plausible, we propose to
use measures of lifespan disparity in the evaluation procedure. Despite many
suitable measures of lifespan dispersion, we employed e†0 as a measure of
spread to tackle this problem.
In illustrative mortality forecasts for women in Italy, Japan, and Denmark—three
populations who differ substantially in terms of lifespan disparity (see Fig. 1)—e†0 was
a useful addition to the common toolkit for evaluating the predictive ability of
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forecasting approaches. We used the original Lee-Carter model (Lee and Carter 1992),
its rotating variant proposed by Li et al. (2013), and the model of Bohk-Ewald and Rau
(2017) to predict mortality up to 2009. Because the three approaches differ primarily in
their ability to capture dynamic age shifts in the distribution of deaths, they are
particularly suitable for evaluating how well they are able to forecast actual develop-
ments in average lifespan and lifespan disparity. To examine the sensitivity of our
results, we chose four reference periods instead of just one: 1965–1990, 1960–1985,
1955–1980, and 1950–1970. We then compared the forecasted values of the average
lifespan and lifespan disparity with the actual values.
The comparative analysis revealed that irrespective of the reference period, fore-
casting performance basically depends on the regularity (or continuation) of mortality
trends and the ability of the approaches to capture them appropriately. Although the
forecasts of life expectancy at birth generated by the Lee-Carter models are rather
conservative, the forecasts generated by the Bohk and Rau model often have small
forecast errors but also a few upward outliers. Moreover, the Japanese forecasts were
found to be precise when we looked at average lifespan only, but they turned out
to be rather inaccurate when we took lifespan disparity into account as well.
Hence, the models were not able to capture the flattening decline of Japanese
lifespan disparity in the forecast years, although the rotating model and the
Bohk and Rau model fared better than the original Lee-Carter model because of
time-variant survival improvements.
However, the remaining deviations from the observed values indicate that the
refinement or the development of forecasting approaches should focus not only on
average mortality but also on lifespan disparity. This indication may be particularly
important given the concentration of mortality improvement potentials at the highest
ages. Improving mortality at those ages could imply that people will probably live
beyond current maximum ages. Hence, it will be crucial for forecasting approaches to
be able to capture multiple trends in the (right) tail of the lifespan distribution
(stagnation or expansion). As a consequence, the approaches should be able to forecast
further reductions in mortality not only up to the current maximum ages but also to
higher ages beyond. Doing so requires a high degree of modeling flexibility, which has
been missing in existing approaches.
To summarize, our analysis illustrates that the joint evaluation of the average
lifespan (e0) and the life years lost (e
†
0) provide new insights that we believe are needed
for a comprehensive evaluation of the predictive performance of mortality forecasts.
We also suggest that these new insights should be used when improving or developing
new methods for forecasting mortality. Until now, these approaches were exclusively
designed to capture the almost linear increase in life expectancy at birth. Hence, it is not
surprising that forecasts of the average lifespan turn out to be more accurate and yield
smaller forecast errors. The incorporation of lifespan disparity as a quality criterion or
even central outcome may substantially improve the methodology.
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Lifespan Disparity as an Additional Indicator for Evaluating Mortality Forecasts
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A Extending the age range beyond 110+
The data used are death counts and exposures by single age, 0 to 110+, from the Human Mortality Database
(2015). To enable forecasting approaches to shift deaths to ages beyond 110+, we extend the age range of
mortality data, like Sˇevcˇı´kova´ et al. (2016), with the model of Kannisto:
µx =
αeβx
1 + αeβx
(2)
as it is described in Thatcher et al. (1998, p. 16). We fit the model with the function optim in R (2015) to 
mortality at ages 80 to 110 using a Poisson log-likelihood for women in Italy, Denmark, and Japan for each 
year between 1950 and 2009. We then use the fitted Kannisto models to smooth mortality for ages 80 to 110, 
and to predict mortality for the ages above 110 in each year. Figure S1 depicts such mortality data for ages 
80 to 130 for Italian, Danish, and Japanese women in the year 1950. The model of Kannisto is particularly 
suitable for populations with low mortality. It is also applied by, e.g., the Human Mortality Database and 
the United Nations (2014) to fit old-age mortality.
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Fig. S1 Extended age range of mortality data of Italian (left), Danish (center), and 
Japanese (right) women in 1950. We used the model of Kannisto to fit (gray line) 
observed mortality (black circles) at ages 80 to 110, and to predict it at ages 111 to 130 
(gray dots).
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B Forecasts until 2009 with reference periods 1960-1985, 1955-1980, and 1950-1975
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Fig. S2 Life expectancy at birth (left panels) and life years lost at birth (right panels) for 
women in Italy (top), Japan (center), and Denmark (bottom); observed data are in black, 
forecasted data are in red (Lee-Carter model), green (rotating variant), and blue
(Bohk-Rau model); reference period: 1960-1985.
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Fig. S3 Life expectancy at birth (left panels) and life years lost at birth (right panels) for 
women in Italy (top), Japan (center), and Denmark (bottom); observed data are in black, 
forecasted data are in red (Lee-Carter model), green (rotating variant), and blue
(Bohk-Rau model); reference period: 1955-1980.
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C MAPE estimates for e65 and e†65
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Country Measure LC LC, rotated Bohk–Rau
Validation 1 (Ref.years: 1965–1990; Forecast years: 1991–2009)
Italy
e65 0.016 0.013 0.014
e†65 0.009 0.008 0.021
Japan
e65 0.015 0.012 0.008
e†65 0.056 0.050 0.012
Denmark
e65 0.020 0.018 0.026
e†65 0.016 0.013 0.010
Validation 2 (Ref.years: 1960–1985; Forecast years: 1986–2009)
Italy
e65 0.046 0.040 0.008
e†65 0.016 0.012 0.034
Japan
e65 0.025 0.018 0.007
e†65 0.050 0.041 0.020
Denmark
e65 0.054 0.046 0.062
e†65 0.051 0.045 0.044
Validation 3 (Ref.years: 1955–1980; Forecast years: 1981–2009)
Italy
e65 0.055 0.049 0.006
e†65 0.027 0.022 0.020
Japan
e65 0.068 0.056 0.018
e†65 0.067 0.055 0.008
Denmark
e65 0.063 0.057 0.099
e†65 0.009 0.010 0.012
Validation 4 (Ref.years: 1950–1975; Forecast years: 1976–2009)
Italy
e65 0.065 0.057 0.041
e†65 0.026 0.020 0.076
Japan
e65 0.105 0.085 0.050
e†65 0.071 0.054 0.029
Denmark
e65 0.066 0.060 0.102
e†65 0.011 0.011 0.009
Table S1 Mean of the Absolute Percentage Errors (MAPE) for e65 and e†65 over the 
forecast years by country and method. MAPEs are shown for four validating settings 
that all forecast mortality until 2009, but use different historical periods.
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Country Measure LC LC, rotated Bohk-Rau
Average across all validation settings
Italy
e65 0.046 0.040 0.017
e†65 0.020 0.016 0.038
Japan
e65 0.053 0.043 0.021
e†65 0.061 0.050 0.017
Denmark
e65 0.051 0.045 0.072
e†65 0.021 0.019 0.019
Table S2 Mean of the Absolute Percentage Errors (MAPE) for e65 and e†65 over 
all validation settings by country and method.
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D Empirical frequencies for e0 and e†0
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Country Measure LC LC, rotated Bohk–Rau
Validaton 1 (Ref.years: 1965–1990; Forecast years: 1991–2009)
Italy
e0 100.00 100.00 94.74
e†0 10.53 31.58 36.84
Japan
e0 100.00 100.00 94.74
e†0 0.00 0.00 0.00
Denmark
e0 100.00 100.00 89.47
e†0 0.00 0.00 42.11
Validation 2 (Ref.years: 1960–1985; Forecast years: 1986–2009)
Italy
e0 79.17 91.67 91.67
e†0 0.00 20.83 41.67
Japan
e0 100.00 100.00 87.50
e†0 0.00 0.00 50.00
Denmark
e0 100.00 100.00 54.17
e†0 0.00 0.00 37.50
Validation 3 (Ref.years: 1955–1980; Forecast years: 1981–2009)
Italy
e0 55.17 72.41 89.66
e†0 13.79 34.48 48.28
Japan
e0 100.00 100.00 48.28
e†0 0.00 0.00 96.55
Denmark
e0 100.00 100.00 55.17
e†0 13.79 13.79 37.93
Validation 4 (Ref.years: 1950–1975; Forecast years: 1976–2009)
Italy
e0 64.71 79.41 88.24
e†0 5.88 26.47 2.94
Japan
e0 64.71 100.00 26.47
e†0 2.94 2.94 82.35
Denmark
e0 100.00 100.00 41.18
e†0 20.59 17.65 32.35
Table S3 Empirical frequencies, in %, for the 95% prediction intervals of e0 and e0
† over 
the forecast years by country and method. The empirical frequencies are shown for four 
validating settings that all forecast mortality until 2009, but use different historical 
periods.
42
E Empirical frequencies for e65 and e†65
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Country Measure LC LC, rotated Bohk–Rau
Validaton 1 (Ref.years: 1965–1990; Forecast years: 1991–2009)
Italy
e65 94.74 100.00 100.00
e†65 21.05 10.53 57.89
Japan
e65 100.00 100.00 47.37
e†65 0.00 0.00 63.16
Denmark
e65 100.00 100.00 57.89
e†65 31.58 36.84 73.68
Validation 2 (Ref.years: 1960–1985; Forecast years: 1986–2009)
Italy
e65 4.17 29.17 83.33
e†65 4.17 12.50 66.67
Japan
e65 70.83 95.83 50.00
e†65 4.17 4.17 91.67
Denmark
e65 100.00 100.00 45.83
e†65 0.00 0.00 8.33
Validation 3 (Ref.years: 1955–1980; Forecast years: 1981–2009)
Italy
e65 13.79 20.69 93.10
e†65 0.00 0.00 75.86
Japan
e65 6.90 41.38 24.14
e†65 0.00 0.00 93.10
Denmark
e65 100.00 100.00 55.17
e†65 48.28 41.38 89.66
Validation 4 (Ref.years: 1950–1975; Forecast years: 1976–2009)
Italy
e65 20.59 35.29 94.12
e†65 2.94 2.94 61.76
Japan
e65 5.88 38.24 23.53
e†65 2.94 0.00 94.12
Denmark
e65 100.00 100.00 61.76
e†65 35.29 41.18 88.24
Table S4 Empirical frequencies, in %, for the 95% prediction intervals of e65 and e†65 over 
the forecast years by country and method. The empirical frequencies are shown for four 
validating settings that all forecast mortality until 2009, but use different historical 
periods.
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Decomposing changes in life expectancy:
Compression versus shifting mortality
Marie-Pier Bergeron-Boucher 1
Marcus Ebeling 2
Vladimir Canudas-Romo 1
Abstract
BACKGROUND
In most developed countries, mortality reductions in the first half of the 20th century
were highly associated with changes in lifespan disparities. In the second half of the 20th
century, changes in mortality are best described by a shift in the mortality schedule, with
lifespan variability remaining nearly constant. These successive mortality dynamics are
known as compression and shifting mortality, respectively.
OBJECTIVE
To understand the effect of compression and shifting dynamics on mortality changes, we
quantify the gains in life expectancy due to changes in lifespan variability and changes in
the mortality schedule, respectively.
METHODS
We introduce a decomposition method using newly developed parametric expressions of
the force of mortality that include the modal age at death as one of their parameters. Our
approach allows us to differentiate between the two underlying processes in mortality and
their dynamics.
RESULTS
An application of our methodology to the mortality of Swedish females shows that, since
the mid-1960s, shifts in the mortality schedule were responsible for more than 70% of
the increase in life expectancy.
CONCLUSIONS
The decomposition method allows differentiation between both underlying mortality pro-
cesses and their respective impact on life expectancy, and also determines when and how
one process has replaced the other.
1 Max-Planck Odense Center on the Biodemography of Aging, University of Southern Denmark, Odense,
Denmark.
2 Max Planck Institute for Demographic Research, Rostock, Germany. University of Rostock, Institute of
Sociology and Demography, Rostock, Germany.
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1. Background
Human mortality has undergone remarkable declines over the years. The increase in life
expectancy is probably the best expression for the dramatic mortality decline in the last
170 years (Oeppen and Vaupel 2002). Improvements in living conditions, nutrition and
medicine are among the main reasons for this development (Riley 2001; Oeppen and
Vaupel 2002). These changes in economic, social, and sanitary conditions first triggered
an important decline in infant, child, and early adult mortality, which contributed to the
reduction in lifespan disparities (Wilmoth and Horiuchi 1999; Edwards and Tuljapurkar
2005; Vaupel, Zhang, and van Raalte 2011). As individuals became more homogeneous
in their ages at death, a compression of the distribution of deaths in a more narrow age-
interval was observed in many low-mortality countries in the first half of the twentieth
century (Fries 1980; Wilmoth and Horiuchi 1999; Kannisto 2000, 2001; Cheung et al.
2009). Fries (1980) hypothesized that this dynamic can be interpreted as a compression
of deaths against the upper limit of the human lifespan. Assuming a nearly negligible
role for premature mortality, he stated the limit of the average age at death as approxi-
mately 85 years, with 95% of all deaths occurring in an age range of 4 years deviation
(Fries 1980). The “compression of mortality hypothesis” motivated a rich discussion on
the occurrence and interpretation of this development. Several studies provided evidence
for a compression, but emphasized that the achieved mortality levels differ substantially
from Fries’ predictions (Nusselder and Mackenbach 1996; Wilmoth and Horiuchi 1999;
Cheung et al. 2005).
After the period of strong compression, low-mortality countries entered a new era
of change. Since the second half of the twentieth century, the main contributions to the
increase in average age at death shifted from infant and early adult ages to old and very
old-ages (Christensen et al. 2009). This generated changes in the mechanisms behind
the increase in life expectancy (Wilmoth and Horiuchi 1999; Edwards and Tuljapurkar
2005; Smits and Monden 2009). The new mechanism behind improvement in life ex-
pectancy is best illustrated by a shift in the distribution of death toward older ages with a
shape remaining nearly constant (Yashin et al. 2001; Bongaarts 2005; Cheung et al. 2005;
Cheung and Robine 2007; Canudas-Romo 2008). Vaupel (1986), Vaupel and Gowan
(1986) and Bongaarts (2005) were among the first to articulate the idea of shifting mor-
tality. Canudas-Romo (2008) deepens this idea by studying the variability around and the
change of the modal age at death. He finds that over time mortality shifts to higher ages,
with approximately constant variability in age at death. He concludes that the shifting
mortality pattern might be the new dynamic behind mortality improvements, subsequent
to the compression process.
The ages at which mortality reductions occur tend to determine the dominating mor-
tality dynamic: compression or shift. Compression is more pronounced when mortal-
ity reductions occur at very young and adult ages (Nusselder and Mackenbach 1996;
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Wilmoth and Horiuchi 1999; Kannisto 2000; Cheung et al. 2005). On the other hand,
shifting mortality requires changes at old and very old-ages (Canudas-Romo 2008). Vau-
pel, Zhang, and van Raalte (2011) report relatively stable variability patterns for survivors
beyond age 50 in the last 100 years. Engelman, Caswell, and Agree (2014) and Engelman,
Canudas-Romo, and Agree (2010), however, provide evidence for a modest expansion of
lifespan variability for survivors at older ages, resulting from mortality improvement at
these same ages.
The measurement of compression and shifting mortality is an important issue, as both
dynamics translate differently into survival, mortality density and hazard distributions
(Wilmoth and Horiuchi 1999). Alterations are, however, visible in all three functions due
to their interrelation. For instance, in a mortality compression context, the survival curve
becomes more rectangular with increasing concentration of deaths at old-age, which is
a well-known phenomenon called rectangularization (Nusselder and Mackenbach 1996;
Wilmoth and Horiuchi 1999; Cheung et al. 2005). Simultaneously, the old-age bulk of
deaths in the distribution of death becomes more pronounced, thereby reducing variability
of the age at death. In the hazard distribution, the slope becomes steeper, with mortality
reductions being more pronounced at younger ages (Wilmoth and Horiuchi 1999; Robine
2001).
In a shifting mortality context, these three functions also undergo transformations.
The downward slope of the survival curve will shift to higher ages with an equal shape.
Similarly, the density distribution will shift towards older ages with a shape also remain-
ing constant. In the hazard distribution, the same pattern requires a constant slope de-
picted by a parallel shift of the logarithmic force of mortality toward higher ages (Bon-
gaarts 2005; Canudas-Romo 2008). In this context, Bongaarts (2005) suggested fixing
the shape parameter of mortality models and assumed that only scale and background pa-
rameters can vary over time. Vaupel (2010) also describes a postponement of senescence
rather than a fundamental change of the age-pattern of mortality for the period starting
around 1950.
In the assessment of the shifting mortality period, the modal age at death has been
an extensively used indicator. By shifting the modal age at death towards older ages, the
deaths around this age move along with it (Canudas-Romo 2008). This indicator also
has several advantages in the investigation of survival at old-ages. First, it is nonsensi-
tive to mortality changes at younger ages. Second, it reflects the most common lifespan.
Third, a change of the modal age can only be realized if there are pulling forces, mean-
ing mortality improvement at ages older than the mode (Kannisto 2000; Canudas-Romo
2010). In fact, the modal age at death has shown an accelerated pace of increase since
the onset of the old-age mortality decline (Kannisto 2000; Wilmoth and Robine 2003;
Canudas-Romo 2008). Since the beginning of the 21st century, this indicator has re-
ceived increasing attention and has become a key indicator of lifespan, especially since
longevity extension became determined by adult and old-age mortality (Kannisto 2000,
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2001; Bongaarts 2005; Cheung and Robine 2007; Canudas-Romo 2008, 2010; Ouellette
and Bourbeau 2011; Horiuchi et al. 2013).
Therefore, compression and shifting mortality are observed respectively by changes
in the variability of the age at death and in the modal age at death. Both dynamics also
have different implications regarding changes in mortality: the former reflects changes in
lifespan disparities, while the latter provides information about changes in the timing of
mortality.
Considering the two periods of change in mortality development, two questions arise.
First, what is the impact of compression and shifting mortality dynamics on the increase
of life expectancy over time? Second, how and to what extent did one process replace
the other? Additionally, considering the impact of child and young adult mortality reduc-
tions on the appearance of compression, one might further ask, if only adult and old-ages
mortality is analyzed, how does the impact of both dimensions change?
To approach these questions, a new methodology to study changes in compression and
shifting mortality over time and their effect on life expectancy is presented. We quantify
the gains in life expectancy due to changes in the timing of mortality and changes in lifes-
pan disparities, respectively. Using newly developed parametric expressions of the force
of mortality (Horiuchi et al. 2013; Missov et al. 2015), we decompose the change in life
expectancy between two distributions by the contribution of a shift in the modal age at
death and a change in variability of the age at death.
This paper is divided into four sections, with this background as the first section. In
the following section, we introduce the decomposition methodology, at first in general
terms and then for the Gompertz, Gompertz-Makeham and Siler models. The third sec-
tion presents an illustration of the methodology applied to discrete data, followed by the
fourth section, in which we present our conclusions.
2. Methods and data
2.1 Decomposing life expectancy
In order to explain the dynamics behind changes in mortality, demographers have devel-
oped several techniques to decompose changes in life expectancy by different components
of mortality, such as ages and causes of death. Some methods focus on discrete differ-
ences between two life expectancies (Pollard 1982; Arriaga 1984; Pressat 1985; Andreev,
Shkolnikov, and Begun 2002; Firebaugh et al. 2014) while others consider continuous
changes (Vaupel 1986; Keyfitz 1977; Vaupel and Canudas-Romo 2003; Beltra´n-Sa´nchez,
Preston, and Canudas-Romo 2008; Horiuchi, Wilmoth, and Pletcher 2008). We follow
the latter approach of a continuous decomposition of changes in life expectancy by vari-
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ability and shifting effects using a recent expression of the Gompertz mortality model.
Figure 1 shows the distribution of deaths for Gompertz parameters under two scenar-
ios. It illustrates how changes in mortality can be decomposed into effects due to changes
in variability and the shifting of mortality. Assuming a general change of mortality be-
tween the two distributions (in Figure 1 as the arrow denoted as A), the shifting effect is
the hypothetical change resulting only if the modal age at death (M ) would have changed
between those two distributions (in Figure 1 as arrow B). The variability effect is the hy-
pothetical change produced only if the slope of the hazard function (β) changes from one
distribution to another (in Figure 1 as arrow C). The latter transformation C, of changing
the slope of the hazard distribution, also changes the shape of the density distribution,
and thus their variability (Wilmoth 1997).
Changes in life expectancy at birth over time (denoted as e˙0,t) can thus be decom-
posed into two components
e˙0,t = ∆β + ∆M , (1)
where ∆β and ∆M are the gains in life expectancy resulting from changes in the shape
parameter and modal age at death, respectively. In the following section we present the
methodology of the decomposition for the Gompertz force of mortality and then general-
ize it to other parametric functions of mortality.
Figure 1: Illustration of the shifting and variability effects in the density
function of the distribution of deaths for simulated data from a
Gompertz model with a combination of shape parameters
β1 = 0.10 and β2 = 0.13 and modal ages at deathM1 = 75 and
M2 = 90
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2.2 Decomposing senescent mortality: Gompertz
Gavrilov and Gavrilova (1991) defined the Gompertz (1825) law of mortality as one of
the most successful models expressing mathematically the senescent age-pattern of mor-
tality. In this article, we refer to senescent mortality as the increase over age in the force
of mortality occuring after a certain age, representing aging and physiological deteriora-
tion (Bongaarts and Feeney 2002; Bongaarts 2005; Horiuchi et al. 2013). The Gompertz
approach allows a good approximation of adult mortality patterns over age and time for
many countries. However, the Gompertz model does not fit infant, child and oldest-old
mortality well. Other parametric models, such as the Makeham (1860) and Siler (1979),
have addressed some of these problems by including additional parameters capturing
background and infant mortality. The Gompertz model is, however, broadly used to de-
scribe the distribution of adult death from age 30 to 90, having the advantage of being
simple and offering a good fit to senescent mortality. The decomposition methodology in-
troduced here will be presented through the Gompertz model, but it will be demonstrated
that the method can be applied to other parametric models.
It has been shown by Horiuchi et al. (2013) and Missov et al. (2015) that the hazard
rate as expressed by the Gompertz model can be rewritten using the modal age at death
instead of the timing parameter αt as
µx,t = αte
βtx = βte
βt(x−Mt), (2)
where βt is the shape parameter at time t of the Gompertz hazard function µx,t, and Mt
is the modal age at death. This parametrization has some advantages: 1) the parameter
Mt has a clearer interpretation than αt (Horiuchi et al. 2013), and 2) there is a lower
correlation between the parameters when the Gompertz is expressed using the modal age
at death (Missov et al. 2015).
The parametrization presented in equation (2) also gives a starting point for decom-
posing changes in life expectancy due to changes in variability and shifting mortality.
Shifting mortality is observed through changes in the modal age at death, which is cap-
tured by the parameter Mt. Additionally, as presented in Appendix A, it can analytically
be shown that the shape parameter βt is the main carrier of variability changes.
Let a dot on top of a variable denote its derivative with respect to time (Vaupel and
Canudas-Romo 2003). The change over time in the force of mortality (µ˙x,t) can be de-
composed into respective components of change for the shape (β˙t) and the mode (M˙t):
µ˙x,t = β˙t
[
µx,t(
1
βt
+ x−Mt)
]
− M˙t [βtµx,t]. (3)
Equation (3) can be expressed in more general terms to be used in other models of mor-
tality. The components of change for the shape (β˙t) and modal age at death (M˙t) are each
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multiplied by a weighting function of the corresponding hazard rate, denoted as fi(µx,t),
with i corresponding to the parameters β and M ,
µ˙x,t = β˙t fβ(µx,t) − M˙t fM (µx,t). (4)
As with the hazard distribution, we can derive the time change of life expectancy. In
general terms, life expectancy at birth is expressed as
e0,t =
∫ ω
0
la,t da,
where la,t is the survival function and the radix of the population is one. Therefore,
changes in life expectancy at birth through time (e˙0,t) can be expressed by:
e˙0,t =
∫ ω
0
l˙a,t da = −
∫ ω
0
la,t
∫ a
0
µ˙x,t dx da, (5)
where l˙a,t is the time derivative of the survival function la,t. By substituting equation (4)
in equation (5), we can estimate the change in life expectancy at birth due to changes in
the modal age at death and changes in the shape parameter as:
e˙0,t = −β˙t
∫ ω
0
la,t
∫ a
0
fβ(µx,t) dx da︸ ︷︷ ︸
∆β
+ M˙t
∫ ω
0
la,t
∫ a
0
fM (µx,t) dx da︸ ︷︷ ︸
∆M
. (6)
The first term in equation (6) represents the gain in life expectancy resulting from a
change in variability (∆β), corresponding to a compression pattern, while the second
term is the gain in life expectancy produced by a shift in the modal age at death (∆M ),
indicating a shifting pattern. These are the equivalent terms of equation (1) in the Gom-
pertz model.
Equations (4) and (6) allow further generalizations to other parametric models ex-
pressing senescent mortality using the modal age at death (M ) and a shape parameter
(β). Horiuchi et al. (2013) present this parametrization for the Logistic and Weibull mod-
els. Table 1 includes the elements of the decomposition equations for the Gompertz,
Logistic and Weibull models.
As mentioned previously, the Gompertz model does not fit young age mortality well,
and tends to fit mortality over age 30 better. Hence, for the application of the Gompertz
decomposition, we will start our life table at age 30, and e0,t will represent the life ex-
pectancy at age 30, indicated as e30,t in the tables.
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Table 1: Hazard (µx), modal age at death (M ), life expectancy at birth (e0)
and decomposition weights (fβ(µx,t) and fM (µx,t)) for three
mortality models
Gompertz Logistic Weibull
µx(α,β) αe
βx eα+βx
1+eα+βx
αβxβ−1
µx(M ,β) βe
β(x−M) βeβ(x−M)
1+βeβ(x−M)
(β−1)xβ−1
(M)β
M ln(β)−ln(α)β
ln(β)−α
β (
(β−1)
αβ )
1
β
e0
∫ ω
0
e−e
−βM (eβa−1)da
∫ ω
0
[
βe−βM+1
βeβ(a−M)+1
] 1
β
da
∫ ω
0
e
− (β−1)aβ
βMβ da
fβ(µx,t) µx,t(
1
βt
+ x−Mt) µx,t(
1
βt
+x−Mt)
1+βteβt(x−Mt)
µx,t [
1
(βt−1) + ln(
x
Mt
)]
fM(µx,t) βtµx,t
βtµx,t
1+βteβt(x−Mt)
µx,t
βt
Mt
Note: To simplify the equations, the time component (t) was not added as subscript to the parameters αt, βt and
Mt in the first four lines of the table. However, the parameters can also vary over time (t) in these equations.
2.3 Extending the model beyond senescent mortality
With the previous methodology, only senescent mortality can be decomposed. The de-
composition is thus limited to adult and old-age mortality, and might bring only limited
understanding of mortality changes over time. As mentioned previously, compression of
mortality has been strongly linked to reductions in infant, child and early adult mortality,
which is not considered when decomposing the Gompertz model. Modeling mortality at
all ages needs more complex models, and additional parameters often need to be added.
Equation (1) can be generalized to allow the inclusion of parameters other than β and
M , as
e˙0,t =
∑
i=1
∆i, (7)
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where ∆i is the change in life expectancy at birth due to a change in the parameter i.
2.3.1 Gompertz-Makeham
A Makeham (1860) variant can be added to each of the models presented in Table 1
(Horiuchi et al. 2013). Assuming that the modal age at death (Mt) estimated by the
Gompertz model in equation (2) applies to the Gompertz-Makeham model, the hazard
function can be expressed as
µx,t = ct + βte
βt(x−Mt), (8)
where ct is the Makeham term. Adding the parameter ct improves the fit of the Gompertz
function at younger ages, but still without capturing the decrease in infant mortality. The
Makeham term is an age-independent component which captures the extrinsic or “back-
ground” mortality risk. The Makeham term has a more influential effect at younger ages
and is often associated with adult or early adult mortality, which is especially important
for the variability effect.
Equivalent to the decomposition presented in equation (6), we can estimate the change
in adult life expectancy due to changes in the different parameters of the Gompertz-
Makeham model using equation (5). As expressed by equation (7), change in life ex-
pectancy is then estimated as
e˙0,t =− c˙t
∫ ω
0
la,t a da︸ ︷︷ ︸
∆c
− β˙t
∫ ω
0
la,t
∫ a
0
[eβt(x−Mt)(1 + βt(x−Mt))] dx da︸ ︷︷ ︸
∆β
+ M˙t
∫ ω
0
la,t
∫ a
0
[β2t e
βt(x−Mt)] dx da︸ ︷︷ ︸
∆M
, (9)
where c˙t is the change in the background mortality level, β˙t is the change in the rate of
mortality increase over age and M˙t is the change in the modal age at death.
2.3.2 Siler
The Siler (1979) model extends the Gompertz model by including two additional terms,
capturing both the decrease over ages of infant mortality and the “background” mortality
risk. By using the Gompertz model with the parametrization presented in equation (2),
we can express the Siler model as
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µx,t = αt e
−btx + ct + βteβt(x−Mt), (10)
where αt and ct are timing parameters for infant and background mortality, the parame-
ters bt and βt are the constant rates of mortality change over age for infant and senescent
mortality, respectively, and Mt is the modal age at death. By including the infant and
background parameters, the Siler model provides a more detailed estimation of the vari-
ability and shifting effect by modeling mortality at all ages.
Decomposition of changes in the Siler model is expressed by changes in 5 different
parameters: α˙t is the change with respect to t in the initial level of mortality (age 0),
b˙t is the change in the rate of infant mortality decrease over age, c˙t is the change in the
background mortality level, β˙t is the change in the rate of mortality increase over age for
senescent mortality, and M˙t is the change in the modal age at death.
As generally presented in equation (7), the gain in life expectancy at birth for the Siler
model is estimated by
e˙0,t =− α˙t
∫ ω
0
la,t
∫ a
0
[e−btx] dx da︸ ︷︷ ︸
∆α
+ b˙t
∫ ω
0
la,t
∫ a
0
[αte
−btxx] dx da︸ ︷︷ ︸
∆b
− c˙t
∫ ω
0
la,t a da︸ ︷︷ ︸
∆c
− β˙t
∫ ω
0
la,t
∫ a
0
[eβt(x−Mt)(1 + βt(x−Mt))] dx da︸ ︷︷ ︸
∆β
+ M˙t
∫ ω
0
la,t
∫ a
0
[β2t e
βt(x−Mt)] dx da︸ ︷︷ ︸
∆M
. (11)
There are, however, some implications of adding the Makeham term and the Siler infant
mortality term to the Gompertz parametrization presented in equation (2). The parame-
ter M , reflecting the modal age at death evaluated from senescent mortality only, could
differ from the modal age at death evaluated from the total mortality. Horiuchi et al.
(2013), however, found that the modal age at death for senescent mortality, when adding
a Makeham term to equation (2), is nearly equal to the modal age at death for total mor-
tality. We found similar results with the Siler model. For example, the total modal age at
death for Swedish female mortality in 2010 fitted with a Siler model was 88.46, and the
senescent modal age at death was 88.49. As the mortality level at old-ages tends to be de-
termined by senescent mortality, with only limited influence from infant and background
mortality, the senescent and total modal ages at death will generally be similar (Horiuchi
et al. 2013). It is important to recall that the modal age at death is determined by old-age
mortality only. To help understand the role of young age mortality on shifting and com-
pression, we decided to overlook these small differences. In the following sections, we
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will refer to the senescent modal age at death as the modal age at death.
When using the Gompertz model, the variability effect is captured by the parameter βt
(Appendix A) and the shifting effect by the parameter Mt. However, with a Gompertz-
Makeham model or a Siler model, more parameters will influence variability changes.
Canudas-Romo (2010) analytically demonstrated that, in a mortality declining scenario,
as the one experienced in developed countries, the mode will be maintained when re-
duction of mortality occurs at younger ages than the modal age at death. Using a Siler
model, Engelman, Caswell, and Agree (2014) showed that improvement in childhood
components of mortality (αt and bt) and in background mortality parameter (ct) influ-
enced lifespan variability reduction. The first four terms of the above equation would
then have an impact on variability reduction. The variability effect could then be divided
into four distinct effects: α˙t, b˙t, c˙t and β˙t. The shifting effect is still captured by M˙t. This
partition between the five Siler parameters emphasizes the impact of changing mortality
at young ages on lifespan disparities, in contrast with the effect of mortality reductions at
older ages on shifting mortality.
2.4 Data
The data source used in this study is the Human Mortality Database (HMD: http://www.
mortality.org). The HMD (2015) compiles census and vital statistics information for the
populations of entire countries. The HMD has high quality historical mortality data for
industrialized countries; the data series are constructed according to a common protocol,
making the HMD a unique comparison tool. For our illustrations, data for all the HMD
countries, excluding Eastern European countries, have been used for years 1900 to 2010
(Table 2). We justify the data exclusion because there are different age-patterns of mortal-
ity in the excluded countries than to those included in the illustrations in recent decades.
Nevertheless, our methodology can easily be extended to those countries although with
different mortality parameters.
The decomposition is applied to the mortality of Swedish females and to the average
female mortality in the selected HMD countries4. The Gompertz, Gompertz-Makeham
and Siler models are fitted to observed mortality trends using a Poisson log-likelihood
procedure. The estimation procedures of derivatives such as those in equations (6) to dis-
crete data are presented in Appendix B.
4The parameters of the mortality models are estimated for each country independently and then averaged over
all countries (with equal weight) to obtain the HMD average.
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Table 2: Selected HMD countries and years with available data used for the
illustration
Country Years Country Years
Australia 1925-2010 Japan 1947-2010
Austria 1947-2010 Luxembourg 1960-2009
Belgium 1900-2010 Netherlands 1900-2009
Canada 1921-2010 New Zealand 1948-2008
Chile 1992-2005 Norway 1900-2009
Denmark 1900-2010 Portugal 1940-2010
Finland 1900-2010 Spain 1908-2010
France 1900-2010 Sweden 1900-2010
Germany 1990-2010 Switzerland 1900-2010
Iceland 1900-2010 Taiwan 1970-2010
Ireland 1950-2009 United Kingdom 1922-2010
Israel 1983-2009 United States 1933-2010
Italy 1900-2009
Source: HMD (2015)
3. Illustration
3.1 Gompertz decomposition
Table 3 presents the decomposition of life expectancy at age 30 by M and β for Swedish
females at the beginning, middle, and end of the 20th century and for the HMD females
average, between 2000 and 2005. For the three periods selected and for both populations,
changes in the modal age at death (∆M ) are the main components driving the change in
life expectancy.
To further study the year-to-year changes, Figure 2 presents the decomposition from
1900 until 2010 in 5-year intervals for Swedish and HMD average females. Over most
periods, the gains in life expectancy at age 30 were mainly the result of a shift in the
modal age at death (∆M ). Until the end of the 1950s, variability reduction contributions
to changes in life expectancy (∆β) have been more important than in the following peri-
ods. However, even during those years, changes in life expectancy were mainly driven by
changes in the mode. Figure 7 in Appendix C presents similar results for 25 of the HMD
countries.
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Table 3: Female life expectancy at age 30 (e30,t) and its decomposition due to
changes in the Gompertz parameters, Sweden and HMD average,
1900, 1950, and 2000
Sweden HMD Average
1900 1950 2000 2000 (min, max)
e30,t 37.82 44.18 52.04 51.43 (49.23, 54.79)
e30,t+5 38.21 45.56 52.72 52.45 (50.40, 55.67)
e˙30,t 0.39 1.39 0.68 1.03
∆β -0.17 0.09 0.05 0.09 (-0.11, 0.22)
∆M 0.56 1.30 0.63 0.94 (0.48, 2.08)
∆β + ∆M 0.39 1.39 0.68 1.03
Source: HMD (2015) and authors’ own calculation.
Note: By rounding the numbers to the second decimal point in the table, the sum of the contributions (
∑
∆i)
might differ slightly from the difference in life expectancy (e˙30,t).
Figure 2: Trends over time of the Gompertz parameters’ contribution to
changes in female life expectancy at age 30 (e˙30,t), Sweden and
HMD average, 1900-2010
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Source: HMD (2015) and authors’ own calculation.
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Changes in variability of senescent mortality alone would not have been sufficient to
generate the important gains in life expectancy at age 30 observed since 1900. An ex-
planation for this small variability effect compared with the important shifting effect for
senescent mortality still needs to be provided. A possible explanation is that as only
senescent mortality is analyzed by the Gompertz model, it does not consider the ages
essentially responsible for mortality compression, i.e., infant, child and early adult (Che-
ung and Robine 2007). To address the latter aspect of how mortality at young ages has
influenced changes in life expectancy, we present results for the Gompertz-Makeham and
Siler models in the next sections.
3.2 Gompertz-Makeham decomposition
The Gompertz-Makeham model can help us understand the impact of early adult mor-
tality changes on compression and shifting mortality. Table 4 presents an application of
the decomposition of life expectancy at age 30 using the Gompertz-Makeham model for
Swedish and HMD average females at three points in time. Among the parameters influ-
encing variability changes (β and c), the Makeham term (c) has a similar influence on life
expectancy changes than the shape parameter β, for most of the times studied in Table 4.
Table 4: Female life expectancy at age 30 (e30,t) and its decomposition due to
changes in the Gompertz-Makeham parameters, Sweden and HMD
average, 1900, 1950, and 2000
Sweden HMD Average
1900 1950 2000 2000 (min, max)
e30,t 32.50 43.30 51.41 50.75 (49.02, 53.66)
e30,t+5 32.95 45.04 52.09 51.70 (49.52, 54.49)
e˙30,t 0.45 1.74 0.68 0.95
∆c 0.11 0.77 0.02 -0.09 (-0.73, 0.63)
∆β -0.12 -0.03 0.05 0.11 (0.00, 0.36)
∆M 0.46 1.00 0.61 0.93 (0.48, 2.01)
∆c+ ∆β + ∆M 0.45 1.74 0.68 0.95
Source: HMD (2015) and authors’ own calculation.
Note: By rounding the numbers to the second decimal point in the table, the sum of the contributions (
∑
∆i)
might differ slightly from the difference in life expectancy (e˙30,t).
Figure 3 presents the decomposition for 5-year periods between 1900 and 2010 for Swedish
and HMD average females. The gains in life expectancy at age 30 before the 1950s were
mainly driven by changes in variability of the age at death, which is essentially captured
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by changes in the parameter c. After this initial period of variability decline, changes in
life expectancy at age 30 are mainly the result of shifting mortality (∆M ).
The inclusion of a parameter capturing early adult background mortality appears es-
sential, then, to demonstrate the effect of variability reduction on life expectancy at age
30. Figure 8 in Appendix C shows similar results for the selected HMD countries. The
next section presents an application of the Siler decomposition, in order to understand the
role of infant mortality on the changes in life expectancy.
Figure 3: Trends over time of the Gompertz-Makeham parameters’
contribution to changes in female life expectancy at age 30 (e˙30,t),
Sweden and HMD average, 1900-2010
Period
Co
nt
rib
u
tio
ns
 to
 c
ha
ng
e 
in
 lif
e
 e
xp
ec
ta
nc
y 
at
 a
ge
 3
0
−1.0
−0.5
0.0
0.5
1.0
1.5
2.0
2.5
3.0
19
00
−0
5
19
05
−1
0
19
10
−1
5
19
15
−2
0
19
20
−2
5
19
25
−3
0
19
30
−3
5
19
35
−4
0
19
40
−4
5
19
45
−5
0
19
50
−5
5
19
55
−6
0
19
60
−6
5
19
65
−7
0
19
70
−7
5
19
75
−8
0
19
80
−8
5
19
85
−9
0
19
90
−9
5
19
95
−0
0
20
00
−0
5
20
05
−1
0
Sweden
19
00
−0
5
19
05
−1
0
19
10
−1
5
19
15
−2
0
19
20
−2
5
19
25
−3
0
19
30
−3
5
19
35
−4
0
19
40
−4
5
19
45
−5
0
19
50
−5
5
19
55
−6
0
19
60
−6
5
19
65
−7
0
19
70
−7
5
19
75
−8
0
19
80
−8
5
19
85
−9
0
19
90
−9
5
19
95
−0
0
20
00
−0
5
20
05
−1
0
HMD Average
 ∆ c
 ∆ β
 ∆ M
Source: HMD (2015) and authors’ own calculation.
3.3 Siler decomposition
Table 5 and Figure 4 present the results of life expectancy decomposition, using a Siler
model, for female mortality in Sweden and HMD average at ages 0 and older. Similar
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to the Gompertz-Makeham decomposition, the results suggest that changes in life ex-
pectancy at birth before the 1950s were mainly the result of variability reductions. Gains
in life expectancy due to changes in the parameter β are still small, and the main gains are
due to variability reductions coming from changes in infant and background parameters.
Since the mid-1960s, the modal age at death has been the key parameter leading the
changes in life expectancy. Changes in the modal age at death were responsible for more
than 70% of the increase in e0,t since 1965 for females from both Swedish and HMD
average. Figure 9 in Appendix C presents similar results for 25 of the HMD countries.
Table 5: Female life expectancy at age 0 (e0,t) and its decomposition due to
changes in the Siler parameters, Sweden and HMD average, 1900,
1950 and 2000
Sweden HMD Average
1900 1950 2000 2000 (min, max)
e0,t 56.06 72.78 81.68 80.93 (78.92, 84.16)
e0,t+5 58.00 74.44 82.34 81.99 (79.92, 85.01)
e˙0,t 1.94 1.66 0.66 1.06
∆α 0.52 0.06 0.01 0.01 (-0.04, 0.04)
∆b 0.54 0.02 -0.04 0.00 (-0.07, 0.05)
∆c 0.69 0.44 0.02 0.04 (-0.16, 0.23)
∆β -0.17 0.03 0.05 0.09 (-0.07, 0.26)
∆M 0.34 1.11 0.62 0.91 (0.48, 2.01)
∆α+∆b+ ∆c+∆β+∆M 1.94 1.66 0.66 1.06
Source: HMD (2015) and authors’ own calculation.
Note: By rounding the numbers to the second decimal point in the table, the sum of the contributions (
∑
∆i)
might differ slightly from the difference in life expectancy (e˙0,t).
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Figure 4: Trends over time of the Siler parameters’ contribution to changes
in female life expectancy at age 0 (e˙0,t), Sweden and HMD average,
1900-2010
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Note: Appendix D presents these results in terms of relative differences.
3.4 Life expectancy and modal age at death
Figure 5 shows the life expectancy at birth and the modal age at death between 1900 and
2010 for females from Sweden and HMD average. Until the beginning of the 1940s, life
expectancy increased around 4 months per year on average, while the modal age at death
stayed nearly constant. The gains in life expectancy over this first period were in great
part the result of improvements in infant and background mortality, and thus, variability
reductions (Figure 4).
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Figure 5: Modal age at death and life expectancy at birth and their
respective segmented regression for females, Sweden and HMD
average, 1900-2010
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Source: HMD (2015) and authors’ own calculation.
Note: The slopes and breakpoints of the modal age at death and life expectancy trends are calculated
with a segmented regression methodology (Camarda, Vallin, and Mesle´ 2012).
A second period followed in which the mode begins to increase at a faster pace while life
expectancy increase keeps its previous pace. Between 1940 and 1965, the mode contribu-
tion to changes in life expectancy increased, while variability contributions gradually lost
importance. During these years, variability contributions to changes in life expectancy
decreased from more than 60% to less than 30% of the total gains (Appendix D). This
period is one of acceleration in the increase of the modal age at death and marks the
transition from compression to shifting mortality.
Since the mid-1960s, the mode and life expectancy have been increasing at a com-
parable pace of around 2 months per year. This change in the pace of life expectancy
coincides with the change of pace observed by Vallin and Mesle´ (2009) for the best-
practice life expectancy. Life expectancy is still increasing at a marginally faster pace
than the mode due to small extra contributions from variability reduction. Nevertheless,
gains in life expectancy are mainly driven by changes in the modal age at death and thus
shifting mortality (Figure 4). This parallels the 3-phases transition described by Cheung
et al. (2009).
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4. Discussion and conclusion
Using recent parametrization of the Gompertz model, we separated changes in life ex-
pectancy by the variability reduction effect, captured by β, from the shifting mortality
effect, captured by M . The methodology is then extended to other parametric repre-
sentations of mortality, and particularly to the Gompertz-Makeham and Siler models, to
consider the effect of young adult, child and infant mortality changes. This new de-
composition method, using parametric models, allows us to understand and quantify the
respective impact of shifting mortality and variability changes on life expectancy.
Our results suggest that mortality compression was the main driver of change in life
expectancy at birth before the 1950s, due to a decrease in infant and background mor-
tality. After this period, changes in life expectancy became gradually dependent on the
shift in the senescent modal age at death. These results are consistent with the findings
of other studies looking at changes in the modal age at death and at different variability
measures (Wilmoth and Horiuchi 1999; Robine 2001; Yashin et al. 2001; Canudas-Romo
2008). The results also confirm the increasing importance of the modal age at death as a
key indicator of lifespan. The modal age at death has increased since the beginning of the
1940s and has become the main driver of longevity extension since the 1960s. An impor-
tant feature of this indicator is that, in populations that experience declining mortality, its
change is only determined by old-age mortality.
In the above illustrations, the results of the decomposition are presented for female
life expectancy only. However, similar results are found when decomposing male life
expectancy, but with a shifting pattern appearing later in time. Shifting mortality became
the main driver of life expectancy increase in the late 1970s for males (results available
from the authors).
We asked previously how and to what extent, one process replaced the other. Our
methodology allows us to observe and quantify the gradual replacement of a compres-
sion pattern by a shifting pattern in a relatively short period of time. We can also observe
that, even if shifting the modal age at death is explaining a great deal of the life expectancy
increase nowadays, lifespan variability reductions still play a role in mortality changes.
The results are, however, sensitive to the selected parametric model, and especially if
the model is able to include infant and background mortality parameters. The dominating
effect of variability reductions on life expectancy increase in the first half of the 20th cen-
tury can only be seen when using the Gompertz-Makeham and Siler models in the above
illustrations. When only senescent mortality is analyzed, the compression of mortality
only has a minor impact on life expectancy improvement, even before the 1950s. It could
thus be theorized that in a context where infant and young adult mortality is low, as it is
the case in most industrialized countries, variability reductions will have limited impact
on life expectancy, and shifting the modal age at death would be the main dynamic that
would allow life expectancy to increase.
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The choice of the parametric model for senescent mortality might also have influ-
enced the results. The illustration section presented the application of the methodology
to discrete data using a Gompertz model. Other models could, however, have been more
appropriate, such as the Logistic, to consider the deceleration in the hazard at very old-
ages. However, an application using the Logistic model shows that the results are very
similar to the findings obtained with the Gompertz model (Appendix E).
A previous attempt to quantify the effect of shifting the mortality schedule on life
expectancy has been done by De Beer and Janssen (2014). Their procedure consists in
evaluating the effect on life expectancy of changing the value of their model parame-
ters on life expectancy. However, to the authors’ knowledge, our current study is the
first attempt to quantify the gain in life expectancy produced by a change in variability
and shifting mortality. Our procedure allows us to differentiate between both underlying
mortality processes and their respective impact on life expectancy, and also to determine
when and how one process has replaced the other.
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Appendices
Appendix A: Changes in variability: effects of β andM
We stated that changing the parameter β of the Gompertz hazard equation will have an
effect on variability of the age at death. In this section, we evaluate this effect by looking
at a measure of variability, namely e-dagger (e†), and attest the contribution of each of
the parameters in the Gompertz hazard to the change in variability. Among the different
indicators used to measure variability of the age at death (Robine 2001; Wilmoth and
Horiuchi 1999; Vaupel, Zhang, and van Raalte 2011), we focus on e†, a measure of
lifespan disparity often interpreted as the average years of life expectancy lost due to
death:
e†t =
∫ ω
0
Hx,tlx,t dx, (A1)
where lx,t is the survival distribution, and Hx,t is the cumulative hazard, equal to:
Hx,t = e
βt(x−Mt) − e−βtMt = 1
βt
µx,t − e−βtMt .
Therefore, e†t can be written as
e†t =
1
βt
∫ ω
0
µx,tlx,t dx − e−βtMt
∫ ω
0
lx,t dx,
leading to
e†t =
1
βt
− e−βtMte0,t. (A2)
Wrycza (2014) also showed this relation for Gompertz-Makeham entropy using the stan-
dard parametrization. It is possible to quantify the respective effects of βt and Mt on e
†
t
by looking at its time derivative, denoted by a dot on top of the variable. From equation
(A2) changes in e†t over time (e˙
†
t ) can be expressed by components of changes for both
Gompertz parameters:
e˙†t = −β˙t
[
1
β2t e0,t
−Mte−βtMt
]
e0,t − e˙0,t[e−βtMt ] + M˙t[βte−βtMte0]. (A3)
As shown by equation (6), e˙0,t can be decomposed by a factor of change of Mt and
βt. Therefore, e0,t contributions to changes in e
†
t can be distributed into Mt and βt
contributions, obtaining
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e˙†t = −β˙t
[
1
β2t
− (Mte0,t + Fβ)e−βtMt
]
︸ ︷︷ ︸
δβ
+ M˙t[(βte0,t − FM )e−βtMt ]︸ ︷︷ ︸
δM
, (A4)
where δβ and δM are the gains in e†t produced by a change in parameters βt and Mt,
respectively, and Fβ and FM are the terms multiplying β˙t and M˙t respectively in equation
(6):
Fβ =
∫ ω
0
la,t
∫ a
0
µx,t(
1
βt
+ x−Mt) dx da (A5a)
FM =
∫ ω
0
la,t
∫ a
0
βtµx,t dx da. (A5b)
Table 6 shows an application of the e†t decomposition to Swedish and HMD average fe-
male data. It is shown that the main factor of variability changes comes from changes in
the parameter βt. However, increasing the modal age at death produced a small increase
in lifespan disparities.
Changes in e†t are thus driven by both Gompertz parameters. In general, increasing
βt will lead to a smaller variability of the age at death, while increasing Mt would have
the opposite effect. These results are consistent with the results of Engelman, Caswell,
and Agree (2014). Using a Siler model, the authors show that a decrease in the timing
parameter for senescent mortality (α2) will increase the variability (Engelman, Caswell,
and Agree 2014). However, Table 6 and Figure 6 show that this variability expansion
resulting from a shift in Mt will generally be too small to drive substantial changes in
lifespan disparities. The assumption that mortality compression is produced by an in-
crease in βt is then confirmed.
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Table 6: e-dagger (e†t ) and its decomposition due to changes in the Gompertz
parameters, Swedish and HMD countries average, females, 1900,
1950 and 2000
Sweden HMD Average
1900 1950 2000 2000
e†t 13.0425 9.7848 8.8384 9.2218
e†t+5 13.4824 9.6259 8.7529 9.0654
e˙†t 0.4399 -0.1589 -0.0855 -0.1564
δβ 0.4356 -0.1601 -0.0856 -0.1567
δM 0.0043 0.0012 0.0001 0.0003
δβ + δM 0.4398 -0.1589 -0.0855 -0.1564
Source: HMD (2015) and authors’ own calculation.
Note: By rounding the numbers to the fourth decimal point in the table, the sum of the contributions (
∑
δi)
might differ slightly from the difference in e-dagger (e˙†t ).
Figure 6: Trends over time of the Gompertz parameters’ contribution to
changes in e-dagger (e†t ) for females, Sweden and HMD average,
1900-2010
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Appendix B: Applying the decomposition to discrete data
The estimation procedure of our methodology can be done to discrete data by estimating
the functions at their midpoint over a certain time interval (Preston, Heuveline, and Guil-
lot 2001; Vaupel and Canudas-Romo 2003). As suggested by Vaupel and Canudas-Romo
(2003), if data are available between time t and t+ h, the midpoint value of the function
vx,t was estimated by
vx,t+h/2 = vx,t
(
vx,t+h
vx,t
)1/2
. (B1)
The derivative of the function vx,t+h/2 was estimated by
v˙x,t+h/2 = vx,t+h/2
ln[
vx,t+h
vx,t
]
h
. (B2)
In some cases, it could make more sense to assume a linear change in the interval (Vaupel
and Canudas-Romo 2003). In these cases, we used
vx,t+h/2 =
vx,t+h + vx,t
2
(B3)
and
v˙x,t+h/2 =
vx,t+h − vx,t
h
. (B4)
We used these latter estimates for the change over time of the life expectancy (e˙0,t).
The other functions were estimated by assuming an exponential change, as presented in
equations (B1) and (B2). It is important to note that these procedures generate annual
estimates, and also that the midpoint of each term multiplying β˙t and M˙t in equation
(6) should be estimated. For example, the annualized ∆M for the period t to t + h
(∆Mt+h/2) using the Gompertz model is calculated as
∆Mt+h/2 = M˙t+h/2
∫ ω
0
lx,t+h/2 βt+h/2 Hx,t+h/2 dx, (B5)
where Hx,t is the cumulative hazard at time t and age x. In the illustration section, the
results are presented for five-year periods. As the above equations are valid for annual
changes, the decomposition is applied to yearly differences, which are then summed up to
equal for longer periods. Yearly estimates are generally more accurate than the estimates
for longer periods. Similar methodology is also applied for the Gompertz-Makeham and
Siler models.
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Appendix C: International comparison
Figure 7: Trends over time of the Gompertz parameters’ contribution to
changes in female life expectancy at age 30 (e˙30,t), HMD countries,
1900-2010
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Figure 8: Trends over time of the Gompertz-Makeham parameters’
contribution to changes in female life expectancy at age 30 (e˙30,t),
HMD countries, 1900-2010.
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Figure 9: Trends over time of the Siler parameters’ contribution to changes
in female life expectancy at age 0 (e˙0,t), HMD countries, 1900-2010
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Appendix D: Relative differences
Figure 10: Female life expectancy at birth (e0,t) and relative gain in life
expectancy due to changes in the Siler parameters, Sweden and
HMD average, 1900-2010. The black and red lines are the life
expectancy at birth observed (in black) and modeled (in red)
presented in Figure 5.
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Note: The sum of the contributions (
∑
∆i) for each bar equal to 1 in this figure.
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Appendix E: Life expectancy decomposition: Gompertz, Logistic and
Weibull models
Table 7: Female life expectancy at age 30 (e30,t) and its decomposition due to
changes in the modal age at death (∆M ) and shape (∆β), using
Gompertz, Logistic and Weibull models, Sweden and HMD
average, 1900, 1950 and 2000
Sweden HMD Average
1900 1950 2000 2000 (min, max)
Gompertz
e30,t 37.82 44.18 52.04 51.43 (49.23, 54.79)
e30,t+5 38.21 45.56 52.72 52.45 (50.40, 55.67)
e˙30,t 0.39 1.39 0.68 1.03
∆β -0.17 0.09 0.05 0.09 (-0.11, 0.22)
∆M 0.56 1.30 0.63 0.94 (0.48, 2.08)
∆β + ∆M 0.39 1.39 0.68 1.03
Logistic
e30,t 37.93 44.25 52.13 51.50 (49.30, 54.90)
e30,t+5 38.33 45.64 52.80 52.53 (50.46, 55.78)
e˙30,t 0.40 1.39 0.67 1.02
∆β -0.17 0.07 0.04 0.08 (-0.15, 0.22)
∆M 0.57 1.32 0.62 0.94 (0.48, 2.12)
∆β + ∆M 0.40 1.39 0.67 1.02
Weibull
e30,t 38.50 44.33 52.09 51.46 (49.36, 55.05)
e30,t+5 38.98 45.77 52.74 52.47 (50.47, 55.88)
e˙30,t 0.48 1.44 0.65 1.01
∆β 0.05 0.02 0.02 0.04 (-0.03, 0.08)
∆M 0.42 1.41 0.62 0.97 (0.50, 2.10)
∆β + ∆M 0.48 1.44 0.65 1.01
Source: HMD (2015) and authors’ own calculation.
Note: By rounding the numbers to the second decimal point in the table, the sum of the contributions (
∑
∆i)
might differ slightly from the difference in life expectancy (e˙30,t).
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